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Abstract
1. Endothelium-derived hyperpolarizing factor (EDHF)-mediated 
vasodilatation responses are facilitated by the radial (endothelium to smooth 
muscle) and longitudinal (inter-endothelial cell or inter-smooth muscle cell) 
cell-to-cell transfer of hyperpolarization. Experiments were designed to 
investigate the contribution of gap junctions to both communication 
pathways.
2. Morphological studies demonstrated that connexin 40 and the small (S-) 
conductance calcium-activated potassium (Kca) channels were localized to 
endothelial cell borders and areas aligned with holes in the internal elastic 
lamina (IEL), whereas intermediate (I-) Kca channels were restricted to areas 
aligned with holes in the IEL.
3. In contrast to the non-selective gap junction uncoupler carbenoxolone, 
combinations of connexin-specific gap peptides did not affect the radial 
EDHF response to acetylcholine (ACh). A new technique based on pinocytic 
loading of cell-impermeant molecules was therefore established to 
selectively load the endothelium with anti-connexin antibodies. Connexin 40 
antibody was shown to mimic the effects of carbenoxolone.
4. Focal, abluminal application of acetylcholine (ACh) and levcromakalim 
(LVK) evoked robust longitudinally-conducted vasodilatation responses, 
which were attenuated by carbenoxolone but unaffected following selective 
pinocytic loading of anti-connexin antibodies.
5. Luminal perfusion of the nucleotides ATP, ADPpS, and UTP each evoked 
an EDHF-type dilatation response that was sensitive to blockade of SKca and 
IKca channels with apamin and TRAM-34, respectively. Inhibition of PKC 
with bisindolylmaleimide I (BIS I) enhanced the nucleotide-evoked 
dilatation response, but had no effect on dilatation to ACh.
6 . Focal, abluminal application of ADPpS evoked a robust spreading dilatation 
response, however dilatation responses to ATP and UTP were complicated 
by robust vasoconstriction when applied abluminally. In contrast, using a 
novel triple cannulation technique, dilatation responses to luminal perfusion 
of the three agonists were seen to spread longitudinally upstream into the 
parent artery.
n
These data highlight the difficulty in selectively inhibiting gap junctions, and 
provide new approaches that may be used to investigate the role of 
endothelium-dependent agonists in controlling arterial diameter.
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1.1. Arterial function and morphology
1.1.1. Function of resistance arteries
Resistance arteries are defined as small pre-capillary arteries and arterioles of diameter 
less than 500pm that may facilitate, under physiological control, a large drop in blood 
pressure as blood flows from the large conduit vessels to the capillaries (Fenger-Gron et 
a l , 1997; Mulvany & Aalkjaer, 1990). As blood moves through the vascular system the 
pressure gradient and the resistance to flow will influence blood flow. This can be 
expressed using an adaptation of Ohm’s Law where blood flow is equivalent to the 
current, and the pressure gradient to the electromotive force (Levy, 1979):
Blood flow = Pressure gradient 
Resistance
(1.1)
Resistance to blood flow is determined by the friction exerted on the vessel wall by the 
flowing blood and the resistance between the circulating cells and constituents of the 
blood (Lipowsky, 2005). Therefore the dimensions of a blood vessel and the blood 
viscosity are key determinants of vascular resistance. Assuming for simplicity that 
blood is Newtonian, i.e. the viscosity of blood does not change, the relationship 
between the flow of blood through a vessel may be described by the Hagen-Poiseuille 
equation (Ganong, 1999):
Blood flow = Hydrostatic pressure x n x Vessel radius4
8  x Viscosity x Length
(1.2)
Using equation 1.1 the Hagen-Poiseuille equation may be substituted such that,
Resistance = 8  x Viscosity x Length
(1.3)
71 x Vessel radius4
From equation 1.3 it is possible to see that resistance varies inversely with the fourth 
power of the radius. As such changes in vessel radius have the most significant effect on
2
Figure 1.1 Mesenteric segmental, 
fractional blood pressure drops taken 
from Fenger-Gron et al. (1995)
The figure shows the mean fractional blood 
pressure drops over the sections of the 
mesenteric vasculature indicated. Given 
systemic blood pressure was 121±2mmHg, 
blood pressure at the superior mesenteric 
artery may be calculated to be ~115mmHg, 
~77mmHg in the arcade arteries and 
~16mmHg in the intramural vessels.
resistance to blood flow. Vessels such as the resistance arteries, which can exert marked 
changes in diameter in response to physiological stimuli therefore have an important 
role in the regulation of blood flow and can facilitate the drop in blood pressure that is 
required as blood flows from larger arteries to the capillaries (Fenger-Gron et al., 1997; 
Fenger-Gron et a l, 1995; Mulvany & Aalkjaer, 1990). Given that cardiac output and 
total peripheral resistance determine blood pressure (Equation 1.4; Levy, 1979), the 
regulation of blood flow by the resistance arteries contributes significantly to the control 
of systemic blood pressure.
Blood pressure = Cardiac output x Total peripheral resistance
(1.4)
1.1.2. Anatomy of rat mesenteric arteries
Within this thesis vasomotor responses to isolated third order branches of the rat 
superior mesenteric artery were studied. The contribution of these small arteries to the 
maintenance of vascular resistance in the mesenteric bed was demonstrated functionally 
by Fenger-Gron and colleagues (1997; 1995) who measured the blood pressure in freely 
moving rats at the aorta and at four points in the mesenteric circulation. The small 
mesenteric arteries were shown to be one of two key sites contributing to mesenteric 
resistance, the second being the smaller arterioles of the intramural circulation (Figure 
1.1). These functional data correlate with anatomical observations that put their small 








Figure 1.2 Electron micrograph of a radial cross- 
section through an isolated, pressurized artery
A, Whole cross-section of an isolated, pressurized rat 
mesenteric artery with the endothelium, smooth 
muscle and adventitial layers indicated. B, Magnified 
cross-section illustrating the four layers of the smooth 
muscle, the IEL and the endothelium. Bar: A, 100pm;
B , 10pm. Electron microscopy and image 
construction performed by Dr. Shaun Sandow.
The structure of the rat small mesenteric artery (Figure 1.2) is similar to other resistance 
arteries: An outer layer, the tunica adventitia, consisting of connective tissue, nerve 
cells, macrophages, mast cells and fibroblasts, surrounding approximately four layers of 
smooth muscle cells (the tunica media), which are separated from the innermost, single 
layer of endothelial cells (the tunica intima) by the internal elastic lamina (Mulvany & 
Aalkjaer, 1990). Endothelial cells may project through holes in the IEL to contact the 
smooth muscle layer (Sandow & Hill, 2000).
The superior mesenteric artery supplies blood to the duodenum and transverse colon. 
Frequent branches in the artery form an arcade that allows perfusion of the gut via 
multiple routes and minimises tissue ischemia during instances where blood flow may 
be compromised. The level of blood flow differs markedly between fasting and feeding 
states and is largely regulated by the vasomotor responses of the small resistance 
arteries as described (third, fourth and fifth order branches of the superior mesenteric 
artery; section 1.1.1). Mesenteric arteries respond to metabolites released from the 
perfused tissue (active hyperaemia) and humoral, hormonal and neuronal (sympathetic) 
influences (Mulvany & Aalkjaer, 1990) and so constitute good models for resistance 
artery function. Given the rat small mesenteric artery is frequently used in the study of 
vasomotor responses experimental procedures for its use are also well reported.
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1.2. Vasoconstrictor mechanisms
1.2.1. Smooth muscle constriction
The contraction mechanism within smooth muscle is thought to principally rely on the 
global levels of cytosolic calcium (Ca2+) and the degree of myosin phosphorylation (for 
review see Somlyo & Somlyo, 1994). A rise in cytosolic Ca2+ concentration enhances 
the binding of Ca2+ to calmodulin and subsequently the association of this complex with 
the myosin light chain kinase (MLCK) catalytic subunit (Figure 1.3; Kamm & Stull, 
1985; Somlyo & Himpens, 1989). This activates the enzyme permitting phosphorylation 
of the 2 0 kDa regulatory myosin light chain (MLC20) of myosin II on a serine residue at 
position 19 (Kamm & Stull, 1985; Sweeney et al, 1994). Phosphorylation of the MLC20 
at serine 19 causes a net reduction in charge at the amino (N)-terminus, which facilitates 
a conformational change of the myosin ATPase allowing activation by actin (Sweeney 
et al, 1994). This allows the hydrolysis of adenosine 5’-triphosphate (ATP) and the 
formation of cross-bridges between the actin and myosin filaments resulting in 
generation of contractile force.
The extent of contractile force is attributed to the number of active cross bridges 
generating force additively, which is determined by acto-myosin ATPase activity 
(Figure 1.3; Kamm & Stull, 1985). As there is a correlation between phosphorylation of 
MLC and myosin ATPase activity in many smooth muscle preparations it is clear that 
the extent of MLC phosphorylation is crucial in determining the degree of contractile 
force in response to a given stimulus (Butler & Siegman, 1998; Buus et al, 1998; 
Chacko & Rosenfeld, 1982). In the rat small mesenteric artery preparation it has been 
demonstrated that a threshold of approximately 25% of the MLC needs to be 
phosphorylated to elicit even small increases in contractile force (Rembold & Murphy, 
1988). Whilst this mechanism of contraction is universal amongst all smooth muscle 
tissues the source of Ca2+ and the ion channels through which it passes, as well as the 
degree and mechanism of myosin phosphorylation varies between different preparations 
(McFadzean & Gibson, 2002). Additionally the coupling of these processes to receptor 













Ca2+ - Calm odulin
Figure 1.3 Smooth muscle contraction
Cartoon illustrating the mechanism of contraction in smooth muscle downstream of a 
rise in intracellular Ca2+ stimulated by a  1-adrenoceptor stimulation with PE. + and - 
represent stimulation and inhibition. P represents phosphorylation.
Two key mechanisms couple excitatory stimuli to the generation of contractile force: 
Electromechanical coupling and pharmacomechanical coupling (Somlyo & Himpens, 
1989; Somlyo & Somlyo, 1994; Somlyo & Somlyo, 1968). Electromechanical coupling 
refers to the effects of changes in membrane potential on cytosolic Ca2+ and the 
subsequent contractile response. Pharmacomechanical coupling refers to smooth muscle 
contraction evoked as a consequence of multiple cellular signalling mechanisms 
independently of a change in membrane potential (although changes may occur) 
(Somlyo & Somlyo, 1994). The relative importance of these two coupling mechanisms 
varies depending on the smooth muscle under study. In phasic smooth muscle tissues 
such as the smooth muscle layer within rat small mesenteric arteries it is thought that 
electromechanical mechanisms predominate (McFadzean & Gibson, 2002). The agonist 
used to evoke contraction can also dictate the coupling mechanisms involved, which are 
not always distinct. This is the case for PE-evoked smooth muscle contraction where 
both coupling mechanisms are employed.
1.2.2. Phenylephrine-evoked vasoconstriction
PE is frequently used in studies of vascular function as a  i-adrenoceptor activation 
contributes to, but does not wholly facilitate the effects of sympathetic nerve 
stimulation and the stress response in the rat circulation (Angus et al., 1988; Mulvany & 
Aalkjaer, 1990; Wier & Morgan, 2003). In isolated rat small mesenteric arteries PE acts 
on a i- adrenoceptors on the smooth muscle cell surface membrane (for review see
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Docherty, 1998). Controversy surrounds the ai-adrenoceptor-subtype that facilitates the 
functional response to PE. Studies supporting both the involvement of the aiA subtype 
(Marti et al., 2005) and the am subtype in PE-evoked vasoconstriction have been 
reported (Hussain & Marshall, 1997) with some investigators proposing a more 
heterogenic population of receptors in the vasoconstriction response to PE (Hussain & 
Marshall, 1997). Further definition of the receptor subtypes with regards to their affinity 
for prazosin has led to increased complexity with regards to ai-adrenoceptor 
classification that may reflect different receptor states of the same receptor genotype 
(Ford et al., 1997) or may represent a completely different sub set of receptors as 
suggested by Van der Graaf and colleagues (Stam et al., 1999; 1996). For the purpose 
of this thesis PE-evoked constriction mechanisms will therefore be discussed in terms of 
the consequences of ai-adrenoceptor-stimulation, ignoring subtype specificity.
1.2.3. Pharmacomechanical coupling downstream of the ai-adrenoceptor
1.23.1. Gq/n G protein-coupled responses
Each of the ai-adrenoceptor subtypes is a heterotrimeric Gq/n G-protein coupled 
receptor (GPCR; Docherty, 1998) and so is associated with the activation of 
phospholipase C (PLC) pi and Ca2+-sensitization pathways (Figure 1.3; for review see 
Berridge, 1993; Somlyo & Somlyo, 1994; Somlyo & Somlyo, 2000). Classically, the 
Gpy subunits of the G-protein trimer coupled to the receptor are thought to facilitate 
agonist binding with the associated receptor by stabilizing the interaction of the Ga 
subunit with guanosine diphosphate (GDP) whilst the Ga subunit mediates activation of 
downstream signalling pathways.
Ga subunit functionality firstly requires its dissociation from the other trimer composite 
proteins (Clapham & Neer, 1997). In brief, agonist binding elicits a conformational 
change in the receptor, which catalyzes the dissociation of GDP and association of 
guanosine triphosphate (GTP) with the subunits Ga and Gpy and subsequently 
dissociation of the component G-proteins and the receptor (Clapham & Neer, 1997). 
Once dissociated, the Gaq subunits activate PLC pi, facilitating the hydrolysis of the 
membrane-bound phospholipid, phosphatidylinositol-bisphosphate (PIP2) into
7
diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) (Berridge & Irvine, 1989; 
Lee et al., 1992; Wu et al, 1992).
1.2.3.2. IP3 and intracellular Ca2* stores
Within rat mesenteric arteries, IP3 receptor 1 (IP3Rl)-activated Ca2+ channels on the 
sarcoplasmic reticulum (SR) bind IP3, which in a concentration-dependent manner, 
opens the channel allowing the quantal movement of Ca2+ into the cytosol (Berridge, 
1993; Grayson et al, 2004; lino & Endo, 1992). A positive feedback mechanism then 
occurs whereby increasing intracellular Ca2+ concentrations further stimulate the release 
of Ca2+ through the IP3RI causing a propagating ‘all or nothing’ Ca2+ wave, the 
magnitude of which is independent of PE concentration: The increased probability of an 
individual cell responding to PE linked to increasing PE concentrations (Mauban et al, 
2001; Zang et al, 2001). The Ca2+ wave may subsequently extend throughout the cell 
and, together with other Ca2+ sensitizing mechanisms, influx of extracellular Ca2+ and 
modulation of the contractile apparatus, serve to maintain the vasoconstriction to PE. 
Further increases in intracellular Ca2+ then inhibit IP3R Ca2+ flux (Please see section 
1.2.2.3; Berridge, 1993; lino & Endo, 1992; Wier & Morgan, 2003).
The initial synchronous Ca2+ release from the SR following IP3R activation is sufficient 
to evoke a transient contraction. However, the limited Ca2+ in the SR, the extrusion of 
Ca2+ from the cell by active exchange and pumping mechanisms and the negative 
feedback pathways associated with high intracellular Ca2+ concentrations preclude a rise 
in intracellular Ca2+ sufficient to evoke a maintained response from depletion of 
intracellular stores alone (Lamont & Wier, 2004; Mauban et al, 2001; Nilsson et al, 
1998; Wier & Morgan, 2003; Zang et al, 2001). This is supported by experimental 
evidence whereby removal of extracellular Ca2+ was shown to abolish the maintained 
contraction response to PE in isolated rat small mesenteric arteries (Lagaud et al, 1999; 
Lamont & Wier, 2004; Mauban et al, 2001).
1.233 . Ryanodine receptors and intracellular Ca2+ stores
Ryanodine receptor Ca2+ channels (RyR) on the SR membrane may also enable Ca2+ 
influx from the SR into the cytosol. Of the three subtypes of RyR, all are present in rat 
small mesenteric artery smooth muscle (Neylon et al, 1995). Opening of these channels
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may be stimulated by a number of different mechanisms, although within vascular 
smooth muscle activation of these channels by the influx of Ca2+ through voltage- 
dependent Ca2+ channels is thought to predominate (Neylon et a l , 1995; Thomeloe & 
Nelson, 2005). In contrast to the IP3R, the primary role of the RyR in vascular smooth 
muscle contraction is one of negative feedback, whereby Ca2+ released from this 
channel as Ca2+ sparks activates plasmalemmal Kca channels situated in close proximity 
to the SR causing hyperpolarization and relaxation of the smooth muscle (please see 
section 1.2.2.4; Jaggar et a l , 1998; Lamont & Wier, 2004; Nelson et a l , 1995; Perez et 
a l , 1999; Thomeloe & Nelson, 2005; Wellman & Nelson, 2003).
1 .2 3.4. Influx of extracellular Ca2+ and store-operated Ca2* channels 
As described previously, influx of extracellular Ca2+ is crucial to maintain PE-evoked 
constriction in rat mesenteric arteries, but it is also required to replenish Ca2+ stores 
following IP3R activation as Ca2+ released into the cytosol may be actively pumped out 
of the cell (Lagaud et a l , 1999; Wier & Morgan, 2003). It has been proposed that the 
primary role of store depletion by activation of the IP3R is to stimulate the opening of 
Ca2+-permeable store-operated channels (SOC) on the plasma membrane, a 
phenomenon termed store-operated Ca2+ entry (SOCE) or capacitative Ca2+ entry 
(Putney, 1986). A role for SOCE in PE-evoked contraction in isolated rat mesenteric 
arteries is supported by a number of studies. Lamont and Wier (2004) reported a block 
of the contractile response to PE in a denuded rat mesenteric artery preparation by 2- 
aminoethoxydiphenyl borate (2-APB). Although originally described as an DP3R 
antagonist, 2-APB has also been shown to mediate other effects including potentiation 
of SOCE currents at concentrations of 1 to 5pM and inhibition of SOCE currents at 
concentrations greater than lOpM (Prakriya & Lewis, 2001; Smyth et al, 2006). 
Inhibition of maintained contractions of isolated rat mesenteric small arteries to PE was 
also reported following treatment with the putative SOCE blocker Mg2+. Furthermore, 
in the same study, a contraction was elicited following replacement of extracellular Ca2+ 
after depletion of intracellular stores by the Ca2+ chelator N,N,N\N’-tetrakis (2- 
pyridylmethyl) ethylenediamine (TPEN), indicative of SOCE channel activity (Zhang et 
al, 2 0 0 2 ).
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Transient receptor potential channels
The molecular identity of the SOC and the mechanisms associated with its activation 
have, however, remained elusive. Multiple currents may be evoked by store depletion of 
which the cation, relative selectivity and current size may vary (Smyth et al, 2006). The 
most discussed identity of the voltage-independent channel mediating the SOCE current 
first proposed by Putney (Putney, 1986) has, until recently been that of the canonical 
transient receptor potential channel (TRPC), a Ca2+-permeable cation channel, 
predominantly activated downstream of PLC activation. Numerous over-expression 
studies increasing SOC Ca2+ entry and knock down studies reducing SOC Ca2+ entry 
supported this hypothesis, particularly highlighting a role for TRPC1 and TRPC4 
(Brueggemann et al., 2006; Clapham, 2003; McFadzean & Gibson, 2002; Smyth et al, 
2006). Indeed, in rat small mesenteric arteries TRPC1, TRPC4 and TRPC6  have all 
been detected in the smooth muscle (Brueggemann et al, 2006; Hill et al, 2006). 
However, none of the TRPC channels are able to fully mimic the native SOCE current. 
Therefore, although these channels may contribute to a different store-operated inward 
current, or even comprise the receptor-operated cation channel (ROCC; see below) it 
seemed unlikely that they alone constitute the SOCE channel (Clapham, 2003; 
McFadzean & Gibson, 2002; Smyth et al, 2006).
STIM1
Two recent studies screening Drosophilia S2 cells for possible SOCE channels by 
studying the effects of small interfering RNA (siRNA) on SOCE currents in mammalian 
cells identified the Stim gene, and its mammalian protein counterpart STIM1 as a key 
component of the SOCE pathway (Liou et al, 2005; Roos et a l, 2005). Knock down of 
Stim in S2 cells or suppression of its homologue STIM1 in HEK293 and SH-SY5 cell 
lines was found to abolish SOCE currents without modification of intracellular Ca2+ 
concentration, SR Ca2+ release or modification of voltage-dependent Ca2+ influx (Roos 
et al, 2005). In HeLa cells siRNAs directed against STIM1 and STIM2 also abrogated 
the plateau phase of thapsigargin and histamine-evoked increases in intracellular Ca2+ 
concentration and inhibited Ca2+ influx upon replacement of extracellular Ca2+ (Liou et 
al, 2005). However, the single transmembrane domain structure of the protein and the 
relatively small enhancement of the SOC current by STIM1 overexpression made it 








Figure 1.4 Ca ’’ influx in smooth muscle
Cartoon illustrating the mechanisms associated with Ca2+ influx upstream of contraction 
in smooth muscle following stimulation of a  1-adrenoceptors with PE. + and -  represent 
stimulation and inhibition respectively. P represent phosphorylation.
(Roos et al., 2005). Instead it was proposed that STIM1 acts as the Ca sensing 
component of the SOCE mechanism, translocating to regions of the endoplasmic
 ^i
reticulum (ER) adjacent to the plasma membrane to convey the store depletion of Ca 
(Baba et al., 2006; Liou et al., 2005; Zhang et al., 2005).
Shortly after the identification of STIM1 the four transmembrane domain protein Orail 
was identified as a second essential component of the SOCE in two reports: One group 
describing a mutation in Orail that leads to malfunction of SOCE and subsequently 
non-functional nuclear transcription in T-cells resulting in severe combined 
immunodeficiency (Vig et al., 2006), the other identifying the same protein, termed as 
Ca2+ release activated Ca2+ modulator 1 (CRACM1) following a RNA interference 
screen of Drosophilia (Feske et al., 2006). Expression of Orail was found to restore 
SOCE currents in SCID T cells (Feske et al., 2006) whilst co-overexpression of Orail 
with STIM1 resulted in a larger IP3 and BAPTA-evoked SOCE current in HEK293 (60- 
fold) and Jurkat (10-fold) cells, that was potentiated and inhibited by 2-APB in a 
manner similar to that of native SOC currents (Peinelt et al., 2006; Soboloff et al., 
2006). Subsequent point mutations of conserved transmembrane regions of Orail 
resulted in modulation of the ion selectivity of the Orail current supporting a role for 
Orail as the pore of the SOC channel (Prakriya et al., 2006; Yeromin et al., 2006).
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Whether the SOC current evoked by Ca2+ depletion of the SR in the smooth muscle of 
rat small mesenteric arteries is mediated by STIM-1/Orail activation is unknown. 
Although this channel has been found to be important in airway smooth muscle- 
mediated contractions (Peel et a l , 2006) no studies in isolated rat mesenteric arteries, or 
indeed any vascular smooth muscle preparations have yet been reported. Furthermore, 
although a contribution of STIM1 and Orail may be key to the SOCE current, smaller 
Ba2+ and Sr2+ currents in STIM-l/Orai-1 overexpressed cells versus native SOCE 
currents have been reported suggesting that other proteins may contribute to the 
complete channel structure further modulating the channel pore and its ion permeability 
(Peinelt et al, 2006; Smyth et al, 2006).
1.23.5. Receptor-operated Ca2* channels
In addition to SOCE, influx of Ca2+ downstream of the ai-adrenoceptor may be 
mediated by activation of ROCCs with the subsequent cation influx leading to 
membrane depolarization and activation of voltage-dependent Ca2+ channels (VDCCs) 
and the 3Na+/Ca2+ exchanger in rat small mesenteric artery and other vascular 
preparations (Albert & Large, 2003; Hill et al, 2006; Inoue et al., 2001; Lagaud et al, 
1999; Thomeloe & Nelson, 2005). Indeed blockade of 3Na+/Ca2+ exchangers with 
amiloride and l,3-dimethyl-2-thiourea (DMTU) was shown to reduce both increases in 
intracellular Ca2+ and tension in response to noradrenaline following depletion of 
intracellular Ca2+ stores. Whilst blockade of VDCC and ROCC by nitrendipine and 1- 
[p-[3-(4-methoxyphenylpropoxy]-4-mehoxyphenethyl]-lH-imidazole hydrochloride 
(SKF 96365) respectively, was also shown to reduce noradrenaline-evoked increases in 
extracellular Ca2+ following intracellular store depletion in the same study (Lagaud et 
al, 1999). Like the SOCE current the ROCC current may have multiple identities, and 
is only clearly distinguished from the SOCE current by its activation occurring 
independently of store depletion and subsequent to agonist stimulation (Albert & Large, 
2003; McFadzean & Gibson, 2002; Thomeloe & Nelson, 2005). The most reported 
molecular identity of the ROCC is a composite of members of the TRPC family of 
channel proteins. However, in contrast to the rather mixed evidence available for the 
SOCE current, evidence in support of a role for TRPC channels in mediating the ROCC 
is more consistent between reports and more akin to native ROCC currents (Clapham, 
2003; Thomeloe & Nelson, 2005).
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Within rat small mesenteric arteries three TRPC subtypes have been identified of which 
TRPC1, TRPC4 (Brueggemann et al, 2006 only) and TRPC6  are localized to the 
smooth muscle whilst TRPC3 is found in the endothelium (Hill et al, 2006). Hill and 
colleagues (2006) demonstrated that the cell permeant analogue of DAG, l-oleoyl-2- 
acetyl-sn-glycerol (OAG), was capable of activating a TRPC6 -like non-selective cation 
channel current independently of protein kinase C (PKC) and potentiated by PKC 
inhibition. This is consistent with previous reports describing a PKC-independent role 
for DAG in activation of ROCC currents in rabbit portal vein myocytes and a more 
inhibitory action of PKC on TRPC-like currents in rabbit ear arteries (Albert & Large, 
2004; Helliwell & Large, 1997; Inoue et al, 2001). In the same study, it was 
demonstrated that PE when compared to OAG-evoked currents augmented the ROCC 
current. Given previous reports describing a synergistic action of inositol phosphates 
and DAG on native TRPC6  currents in rabbit portal vein myocytes in the presence of 
the Ca2+ chelator BAPTA (Albert & Large, 2003) it is likely that both second 
messengers contribute to activation of the TRPC6 -like ROCC current downstream of 
ai-adrenoceptor activation by PE (Albert & Large, 2003; Hill et al, 2006).
Although these data clearly support a TRPC6  component in the ROCC channel the 
heterogeneity of the ROCC current between various vascular beds and the heteromeric 
structure typical of many TRPC channels suggests that other TRPC proteins, 
particularly TRPC1, may play an important role in the ROCC in rat mesenteric artery 
smooth muscle contraction (Hill et al, 2006). Furthermore, the activation of the ROCC 
current likely goes beyond the actions of DAG and IP3 alone as modulation of ROCC 
by intracellular Ca2+ and numerous kinases has been reported in a range of preparations 
(McFadzean & Gibson, 2002; Please see the following for review and references 
therein; Thomeloe & Nelson, 2005).
1.2.3.6. Protein kinase C
The rise in intracellular Ca2+ following the activation of IP3R on the sarcoplasmic 
reticulum, in addition to direct initiation of the contractile process, may also stimulate 
translocation of PKC to the membrane and its subsequent activation by increasing the 
strength and specificity of PKC interactions with phosphatidylserine (Morgan &
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Leinweber, 1998). PKC translocation may also independently of Ca2+ be initiated by 
binding of DAG. This facilitates the incorporation of PKC into the cell membrane and 
thus reduces its requirement for Ca2+ (Kishimoto et al, 1980; Minneman, 1988; Morgan 
& Leinweber, 1998; Ohanian et al, 1996). The subsequent role for PKC in the 
contractile response is then controversial but may include direct phosphorylation, and 
thus inactivation of calponin, and indirectly (via phosphorylation and activation of 
mitogen activated protein kinase (MAPK)), the phosphorylation of caldesmon. Both 
calponin and caldesmon are actin-binding thin filament proteins which when 
unphosphorylated may inhibit myosin ATPase activity. Consequently, inhibition of 
these proteins by PKC would enhance contractile force (see Morgan & Leinweber, 1998 
for review). Such a role for PKC would be consistent with reports that prolonged 
treatment of isolated small rat mesenteric arteries with the phorbol ester phorbol 12,13- 
dibutyrate resulted in downregulation of the a  and 8  isoforms of PKC with a parallel 
reduction in the contractile response to the phorbol ester and the force of contractions 
elicited by noradrenaline at submaximal concentrations (Ohanian et al, 1996). One 
function of PKC activation that is also consistent with such experiments, particularly 
within isolated rat small mesenteric arteries is the contribution of PKC to Ca2+- 
sensitization and the subsequent maintenance of contractile force (Budzyn et al, 2006; 
Buus eta l, 1998).
1.23.7. Ca2+-sensitization
Ca2+ concentration is clearly a key component of the contractile mechanism. However, 
based on the force of contraction evoked by depolarization-induced rises in Ca2+, the 
level of contraction to GPCR agonist stimulation is often higher than expected (Somlyo 
& Somlyo, 1994). This suggests that a secondary Ca2+-sensitizing mechanism may be 
elicited upon GPCR activation. The dependence of contractile force on the degree of 
myosin phosphorylation implicates dynamic modulation of MLCK and myosin 
phosphatase in its regulation. This may arise from a number of second messenger or cell 
signalling pathways the nature of which depends on the tissue and the agonist used to 
evoke GPCR stimulation, (for review please see Fukata et al, 2001; Morgan & 
Leinweber, 1998; Somlyo & Somlyo, 1998; Somlyo & Somlyo, 1994; Somlyo & 
Somlyo, 2000).
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2+PKC and Ca -sensitization
PKC activation has been shown to facilitate Ca2+-sensitization in response to PE and 
noradrenaline in isolated rat mesenteric artery preparations (Budzyn et al., 2006; Buus 
et a l , 1998). This is achieved by direct phosphorylation and inhibition of myosin 
phosphatase (Itoh et al., 1993) and by the phosphorylation and subsequent activation of 
the myosin phosphatase inhibitor CPI-17 (Figure 1.3; Kitazawa et al, 2000). Both 
mechanisms allow increased phosphorylation of the myosin light chain thereby 
facilitating an increase in contractile force. Conflicting studies have been published with 
regards to the importance of PKC-mediated pathways in ai-adrenoceptor-mediated 
contractions in rat small mesenteric arteries (Buyukafsar et al, 2004; Ward et al, 
2002). Furthermore the selectivity of PKC inhibitors such as Ro 318220 and the 
physiological, rather than pathological, relevance of PKC-mediated Ca2+-sensitization 
has come under question (Davies et al, 2000; Somlyo & Somlyo, 1998). However, it 
would seem PKC at least partly contributes to Ca2+-sensitization in this preparation.
2 iRho kinase and Ca -sensitization
CPI-17 may also be activated downstream of the Rho-Rho kinase pathway (Kitazawa et 
al, 2000; Koyama et al, 2000). In brief (for details and review please see Fukata et al, 
2001 and references therein), the Rho kinase pathway begins downstream of the 
dissociation of the G-protein a  subunit from the agonist receptor. In addition to binding 
with PLC, activated a  subunits downstream of G12 and Gi 3-proteins can bind to the 
guanine nucleotide exchange factor pi 15 Rho GEF, which can catalyze the exchange of 
GDP-Rho to GTP-Rho (Somlyo & Somlyo, 2000). Rho is a small GTPase and a 
member of the Rho subfamily of Ras GTPases, which can bind to and activate Rho 
kinase. Downstream of Rho kinase the Zip-like kinase, M110 then mediates 
phosphorylation of both the myosin-binding subunit of myosin phosphatase and the 
inhibitory phosphoprotein CPI-17 (Kitazawa et al, 2000; Koyama et al, 2000; 
MacDonald et al, 2001a; MacDonald et al, 2001b; Somlyo & Somlyo, 2000). 
Phosphorylation of myosin phosphatase inhibits the enzyme, so combined with the 
effects of CPI-17, increased MLC20 phosphorylation is facilitated and consequently 
there is a greater contractile force for a given Ca2+ concentration (Figure 1.5).
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Figure 1.5 Ca2+-sensitization in rat small mesenteric artery smooth muscle
Cartoon illustrating the mechanisms associated with Ca“+ sensitization following 
stimulation of a  i-adrenoceptors with PE. Dotted lines indicate mechanisms not wholly 
defined or established in the rat mesenteric artery preparation. + and -  represent 
stimulation and inhibition respectively. P represents phosphorylation.
and Gn subtype, evidence from Gohla (2000) and later Chikumi and colleagues (2002) 
in cell culture systems suggests that Gq/i \ G-protein-coupled receptors may also activate 
this and other guanine nucleotide exchange factors. More recent evidence in rabbit 
aortic vascular smooth muscle preparations has subsequently coupled activation of the 
Rho kinase pathway to noradrenaline-induced G q/n  activation by calcium-dependent 
activation of class II phosphoinositide (PI)-3 kinases and possibly Ca2+-dependent 
activation of calmodulin-dependent protein kinase II (CaMKII; Sakurada et al., 2003; 
Wang et al., 2006). Whether this data translates to downstream signalling pathways in 
isolated mesenteric resistance arteries is as yet unknown.
9-4- • •In support of a role for Rho-kinase-mediated Ca“ sensitization in the rat mesenteric 
artery VanBavel and colleagues (2001) have reported a significant inhibition of PE- 
evoked constriction and pressure-induced tone in isolated rat mesenteric arteries 
following treatment with the selective Rho kinase inhibitor Y-27632. Additionally, in 
the perfused mesenteric bed a concentration-dependent inhibition of PE-evoked 
contraction by Y-27632 has been demonstrated (Buyukafsar et al., 2004). However, 
these findings are contrary to studies reporting a lack of Rho kinase activity downstream 
of PE-evoked contraction in isolated rat small mesenteric arteries (Asano & Nomura, 
2003; Budzyn et al., 2006; Shaw et al., 2004).
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1.2.4. Electromechanical coupling
Ion Extracellular free ion 
concentration (mM)




Na+ 150 1 0 - 2 0 +50
Cl* 140 4 0-70 - 2 0
K+ 3 -5 130-160 -90
Ca2+ 2 0.001-0.00001 * +150
Table 1.1 Typical ionic concentrations for smooth muscle ce Is in a physiological salt
solution and the associated equilibrium potentials as calculated using the Nemst 
equation. Table assimilated from values take from Hirst and Edwards (1989). *Free 
intracellular Ca2+ concentration.
A second component of ai-adrenoceptor-mediated contraction is facilitated by 
electromechanical coupling mechanisms, which principally rely on the effect of changes 
in membrane potential on cytosolic Ca2+ (Nilsson, 1998; Somlyo & Somlyo, 1994). The 
membrane potential and electrical excitability of most smooth muscle cells are 
principally governed by the concentration differences of free sodium (Na+), potassium 
(K+), Ca2+ and chloride (Cf) ions between the inside and outside of the cell and their 
equilibrium potential as estimated using the Nemst equation (summarized in Table 1.1) 
(Mulvany et al., 1982). Within vascular smooth muscle cells passive movement of K+ 
out of the cell is likely to be the largest contributory factor to resting membrane 
potential (Hirst & Edwards, 1989; Nelson & Quayle, 1995). This is supported by 
experimental in vitro values for the resting membrane potential of rat small mesenteric 
arteries of approximately -60mV, a value relatively near the equilibrium potential for K+ 
in this tissue, and the observed depolarization and subsequent contraction of arteries 
placed in high K+ solutions (Garland & McPherson, 1992; Mulvany et a l, 1982).
I.2.4.I. Maintenance of smooth muscle resting membrane potential
Within isolated rat small mesenteric artery smooth muscle the delayed rectifier subtype 
of voltage-dependent (Kv) channels contributes most significantly to the maintenance of 
resting membrane potential, as it is the dominant repolarizing current. A heteromeric 
assembly of the Kv subunits Kv1.2, Kv1.3, Kv1.5 and Kv2.1 most likely comprises the Kv 
channel that facilitates this major outward current (Xu et al., 1999).
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ATP-sensitive K+ channel (K atp) currents also contribute to the maintenance of basal 
tone. Treatment with the K Atp channel antagonists glibenclamide and 
tetraphenylphosphonium increased tone in the absence of a K atp channel opener and 
depolarized rat mesenteric artery smooth muscle preparations (Gardiner et al., 1996; 
Jackson, 2005; McPherson & Angus, 1991; Tang et al., 2005; Zhang et al., 1998). 
These channels are thought to be of a distinct small conductance subtype (~35pS; also 
referred to as Kndp), activated by products of metabolism including the cytosolic 
nucleoside diphosphates uridine diphosphate and guanidine diphosphate (Cole & 
Clement-Chomienne, 2003; Zhang & Bolton, 1995). However, the role for other K atp 
subtypes cannot be excluded as multiple K atp subtypes have been shown to be 
expressed in other vascular preparations (please see Cole & Clement-Chomienne, 2003 
for review). Electrophysiological data, in situ hybridization and analysis of recombinant 
K atp channels expressed in other cell types supports a heteromeric complex consisting 
of four pore-forming Kir6.1 channels and four modulatory sulfonylurea (SUR)2B 
subunits (Cole & Clement-Chomienne, 2003; Isomoto et al., 1996; Wang et al., 2003; 
Yamada et al, 1997). In contrast to the classical K atp channels found in cardiac and 
pancreatic cells the small conductance K atp channels are inhibited by a lack of ATP and 
high concentrations of ATP. Maximal activity is seen in the range of 0.1 and ImM 
ATP, facilitating their open state and contribution to membrane potential under resting 
conditions (Cole & Clement-Chomienne, 2003; Zhang & Bolton, 1995). Indeed the 
contribution of K atp to the resting membrane potential in rat mesenteric arteries is 
thought to be facilitated by steady-state activation of 3'-5'-cyclic adenosine 
monophosphate (cAMP)-dependent protein kinase (PKA) and subsequent association of 
A-kinase anchoring protein (AKAP) with the K atp channel complex in a nucleotide 
dependent manner (Cole & Clement-Chomienne, 2003; Hayabuchi et al., 2001).
A small depolarization of rat small mesenteric arteries under resting conditions may be 
evoked by treatment with the inwardly rectifying K+ channel (K^) inhibitor barium. 
However, an outward current through K* has only been measured in the endothelium of 
this preparation so electrical conductance through myoendothelial gap junctions 
(MEGJ) would have to facilitate the transfer of this voltage change to the smooth 
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Figure 1.6 Ion channels in the smooth muscle plasma membrane contributing to 
maintenance of smooth muscle membrane potential
Cartoon illustrating the ion channels, exchangers and active pumping mechanisms 
contributing to the maintenance of the smooth muscle resting membrane potential at 
approximately -60mV. Arrows indicate the direction of ion flux across the plasma 
membrane. The absence of an arrow indicates channel closure. Dotted lines represent 
currents that are not yet clearly recognised in rat mesenteric artery smooth muscle tissue 
but that could contribute to the maintenance of resting membrane potential. The red 
lines and text indicate the commonly used inhibitors for each channel.
Furthermore, at the commonly reported resting membrane potential of approximately 
-60mV, although the Kjr would likely be active (Crane et al., 2003b) whether or not this 
channel would contribute significantly to resting membrane potential in these arteries is 
contentious (Doughty et al., 2001; Hirst & Edwards, 1989).
A more significant contribution to resting membrane potential is made by the large 
conductance calcium-activated K+ (BKca) channel. This channel is though to be located 
in plasmalemmal regions adjacent to the sarcoplasmic reticulum (SR) and is frequently 
activated in a transient nature by the small, single RyR channel release of Ca2+ sparks 
from the SR that may occur even when the artery is in the resting state (Jaggar et al., 
1998; Perez et al., 1999; Wellman & Nelson, 2003). Such activation of the BKCa 
channel elicits a transient outward K+ current (described as a spontaneous transient 
outward current (STOC) by Benham and Bolton (1986)) by shifting the basal activation 
and voltage sensitivity of this channel to the range of resting membrane potential (Perez 
et al., 2001). As such it is thought to contribute to the reversal of pressure-induced tone 
and myogenic tone within numerous vascular preparations, including the rat mesenteric 
artery (Dora et al., 2002; Jaggar et al., 1998; Nelson et al., 1995; Wellman & Nelson, 
2003; Wesselman et al., 1997).
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The ~20mV difference between the equilibrium potential for K+ and resting membrane 
potential implies the involvement of a small inward current at resting tone. In rat 
mesenteric artery preparations a smooth muscle, volume sensitive, outward chloride 
(C l) conductance could contribute to a more positive resting membrane potential as the 
more positive equilibrium potential of Cl' (Table 1.1) would encourage an outward 
movement of the ion following channel activation (Doughty et a l , 2001; Hirst & 
Edwards, 1989). Spontaneous transient inward currents (STICs) have been detected in a 
number of smooth muscle tissues, and like BKca, the channels mediating this current are 
thought to be activated under resting conditions by Ca2+ sparks released from the SR. 
Indeed the sensitivity of STICs to Cl" channel inhibitors suggests that STICs may reflect 
the activation of Ca2+-dependent Cl' (C l'c a )  channels (Wellman & Nelson, 2003). At 
resting membrane potential the activation of both Cl" channel STICs or BKca channel 
STOCs by Ca2+ sparks has been observed and treatment with the Cl' channel inhibitors 
IAA-94 and niflumic acid resulted in hyperpolarization of ~20mV in rat mesenteric 
arteries mounted under isometric tension supporting this proposal (Nilsson et a l , 1998).
Recent evidence suggests that two types of Cl’ca channels may exist in rat small 
mesenteric smooth muscle preparations, those that are dependent on 3’5’-cyclic 
guanosine monophosphate (cGMP) and those that are not (Matchkov et a l , 2004a; 
Piper & Large, 2004). However it was proposed that neither would greatly contribute to 
resting membrane potential in this tissue as alteration of the transmembrane gradient for 
Cl' had only a small (~+7mV) effect on membrane potential (Matchkov et al., 2004a; 
Nilsson et al, 1998). Instead, expanding on previous reports it was proposed that Cl'ca 
channels likely to contribute to the maintenance of voltage-dependent calcium entry 
following depolarization and that cGMP-dependent Cl‘ca channels in particular 
contribute to the oscillations in membrane potential seen following a-adrenoceptor 
stimulation (Doughty et al, 2001; Matchkov et al, 2004a; Peng et al, 2001; Piper & 
Large, 2004; Thomeloe & Nelson, 2005).
A small influence on smooth muscle resting membrane potential is attributed to the 
3Na+/2K+-ATPase which exchanges three Na+ to the extracellular solution in exchange 
for two K+ and in so doing evokes a small hyperpolarization of the smooth muscle cell
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(~3-5mV) (Nilsson, 1998). Although Na+ conductance is seen as relatively small and so 
would likely be reflected by a low 3Na+/2K+ ATPase pump activity, treatment of 
isolated rat small mesenteric arteries with ouabain evoked a small depolarization and 
increase in vessel tension (Aalkjaer & Mulvany, 1985; Crane et a l , 2003b; Hirst & 
Edwards, 1989; Mulvany et al, 1984). An inward Na+ current through non-selective 
cation channels (NSCC) or voltage-dependent Na+ channels (Nav) does not contribute to 
resting membrane potential as raising extracellular Na+ had little effect on the inward 
current observed in isolated rat mesenteric artery myocytes. Furthermore, it is unlikely 
that at the resting membrane potential Nav are open (Berra-Romani et al, 2005; 
Matchkov et al, 2004a; Thomeloe & Nelson, 2005).
I.2.4.2. a-Adrenoceptor-evoked smooth muscle cell depolarization
Early experiments performing simultaneous measurements of membrane potential and 
smooth muscle tension coupled an increase in tension in response to noradrenaline to a 
concomitant depolarization of rat mesenteric artery smooth muscle cells to 
approximately -34mV (Mulvany et al, 1982). However, the authors described only a 
38% increase in tension following treatment with K+ at concentrations able to elicit 
depolarization over the membrane potential range of noradrenaline-evoked contractions. 
Electromechanical coupling is therefore only thought to partially contribute to 
noradrenaline-evoked responses in this preparation, the remainder of the contractile 
response attributable to pharmacomechanical coupling mechanisms (please see 
sectionl.2.3 for review). However, within rat mesenteric artery preparations at least, 
depolarization is crucial for initiation of the response as blockade of VDCC with 
nifedipine or felodipine inhibited the initial peak constriction and rise in Ca2+ in 
response to PE in the majority of arteries tested. Indeed Ca2+ entry through VDCC 
contributes significantly to the initial peak and maintenance of PE-evoked contraction 
(Nelson et al, 1988; Nilsson et al, 1994; Thomeloe & Nelson, 2005; Zhang et al, 
2002).
Within rat small mesenteric artery smooth muscle cells depolarization is achieved by 
the influx of K+, Na+ and Ca2+ whilst Cl- efflux is associated with oscillations in tone 
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Figure 1.7 Ion channels in the smooth muscle plasma membrane contributing to a- 
adrenoceptor-evoked depolarization
Cartoon illustrating the ion channels, exchangers and active pumping mechanisms 
contributing to the depolarization evoked by smooth muscle a-adrenoceptor activation. 
Arrows indicate the direction of ion flux across the plasma membrane. The absence of 
an arrow indicates channel closure. Broken lines represent currents that are not yet 
clearly recognised in rat mesenteric artery smooth muscle tissue but that could 
contribute to a-adrenoceptor-evoked smooth muscle cell depolarization. The red lines 
and text indicate the commonly used inhibitors for each channel.
(Aalkjaer & Mulvany, 1985; Doughty et a l, 2000; Matchkov et al., 2004a; Mulvany et 
al., 1984; Nilsson, 1998; Nilsson et a l,  1998; Peng et al., 2001; Piper & Large, 2004). 
Although a rise in intracellular Ca2+ is essential to the contractile mechanism and 
contributes significantly to depolarization, a reduced depolarization response (~50% of 
control) has been evoked in rat mesenteric small arteries following removal of 
extracellular Ca2+ and emptying of intracellular stores suggesting that influx of Na+ and 
K+ contribute substantially to the initial a-adrenoceptor-evoked decrease in membrane 
potential (Nilsson et al., 1998).
Influx of Na+, K+ and Ca2+ may be mediated by the activation of ROCC downstream of 
a-adrenoceptor activation as has previously been described (please see section 1.2.3). 
However closure of the various K+ channels thought to contribute to the outward K+ 
current key to the maintenance of resting membrane potential may also contribute to 
PE-evoked depolarization (please see section 1.2.4.1). Elevated intracellular Ca2+ and 
activation of PKC are thought to close both K v and K Atp channels contributing to a rise 
in intracellular K+ and membrane depolarization in various arterial preparations 
including the rat mesenteric artery (Bonev & Nelson, 1996; Cole & Clement- 
Chomienne, 2003; Cole et al., 2000; Jackson, 2000; Jackson, 2005; Kubo et al., 1997; 
Wilson et al., 2000). Within rat aortic smooth muscle cells protein phosphatase-2B
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activation has been shown to play a role in the Ca2+-sensitivity of the K atp channel, 
with its activation in response to raised Ca2+ leading to channel closure (Wilson et al.,
2000). The details of this mechanism and whether it applies to the low conductance 
K atp channels of the rat small mesenteric artery remain to be determined.
Importantly, upon depolarization to ~-30mV Kv channels may be opened activating a 
negative feedback mechanism that may also contribute to the regulation of vascular tone 
(Jackson, 2000). Similar negative feedback mechanisms are achieved by activation of 
BKca- Although Ca2+ sparks may be inhibited with increasing concentrations of PE 
(Mauban et al., 2001) BKca may be activated by membrane depolarization and the 
raised intracellular Ca2+ caused following receptor stimulation (Jackson, 2000). Indeed, 
a role for BKca in regulation of tone within rat mesenteric artery preparations is 
supported by the observation of an iberiotoxin-sensitive smooth muscle cell current 
following PE stimulation (Crane et al, 2003b).
In contrast to the maintenance of resting membrane potential Na+ plays a key role in the 
initiation and maintenance of depolarization. Upon ROCC activation the potential for 
Na+ to move into the cell is far higher than Ca2+ such that Na+ is likely to be the 
predominating inward current (Nilsson, 1998). In addition, Na+ influx may be mediated 
by the opening of Nav, a channel recently identified in rat smooth muscle cells that may 
open as a consequence of the membrane depolarization evoked by other inward currents 
(Berra-Romani et al., 2005; Matchkov et al., 2004a; Thomeloe & Nelson, 2005). These 
observations are supported by experimental evidence whereby a decrease in the 
extracellular Na+ concentration reduced noradrenaline-evoked depolarization in rat 
mesenteric small arteries (Mulvany et al., 1984). To a lesser extent, a reversal of 
3Na+/Ca2+-exchange mechanisms may also be initiated by the influx of Na+ further 
contributing to an increase in cytosolic Ca and contraction, however the contribution 
of this mechanism to depolarization in rat mesenteric arteries is unclear (Berra-Romani 
et al., 2005; Nilsson, 1998). As with K+, negative feedback mechanisms may also exist 
for the Na+ inward current in the form of the Na+/K+ ATPase, which may be activated at 
high intracellular Na+ concentrations following Na+ influx, and following K+ efflux via 
smooth muscle BKca and K^ on the endothelium (Dora & Garland, 2001; Nilsson, 1998; 
Richards et al, 2001; Weston et al., 2002).
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Both high voltage-activated L-type Ca2+ channels and low voltage-activated T-type Ca2+ 
channels have been shown to contribute to VDCC currents in various vascular smooth 
muscle cell tissues, with L-type channels contributing to the initial peak influx of Ca2+ 
whilst T-type channels mediate the maintained influx of Ca2+ (Cribbs, 2006). The 
dihydropyridine sensitivity of the PE and noradrenaline-evoked currents in rat 
mesenteric arteries and the expression of the mRNA encoding the pore-forming 
subunits of these arteries in the resistance-sized vessels supports a role for the L-type 
VDCC (Gustafsson et al, 2001; Lagaud et al, 1999; Nilsson, 1998; Nilsson et al, 
1994; Thomeloe & Nelson, 2005). The pore-forming subunit (Cav3.1) of the T-type 
channel has also been identified at the mRNA level in rat mesenteric arteriole and 
resistance artery smooth muscle (Gustafsson et al, 2001; Jensen et al, 2004). Indeed 
these authors demonstrated a role for this mibeffadil-sensitive channel in contraction 
evoked by raised extracellular K+ in the small arterioles of this vascular bed. However, 
the same laboratory have also reported an absence of the pore forming subunits of the 
L-type Ca2+ channel (Cav1.2) in the same preparation (Gustafsson et al, 2001). 
Therefore, it may be that as with numerous other aspects of vascular pharmacology the 
importance of the L-type and T-type Ca2+ channels varies with vessel size and as such 
further functional studies would be required to confirm a role for the T-type channel in 
PE-evoked contractions of rat mesenteric resistance arteries.
1.2.5. KCl-evoked vasoconstriction
For many years the contractions evoked by raising extracellular K+ have been attributed 
to Ca2+ influx through L-type VDCC following a change in the potential for K+ to move 
out of the cell (Bolton, 1979; Nelson et al, 1988). This was supported by observations 
in isolated rat small mesenteric arteries that the depolarization evoked by KC1 preceded 
contraction whilst upon removal of K+, repolarization exactly paralleled the decrease in 
wall tension (Mulvany et al, 1982). However, more recently it has become apparent in 
some vascular beds that the Ca2+-sensitizing and intracellular release mechanisms 
associated with G protein-coupled receptor evoked contraction are also activated 
downstream of a rise in extracellular K+ (for review please see Ratz and colleagues 
2005). One clear pathway for activation of Ca2+ sensitization is the activation of 
CaMKII (please see section 1.2.3.7). Whether this kinase is activated in rat small
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Figure 1.8 KCl-evoked contraction mechanisms.
Cartoon illustrating the possible mechanisms associated with contraction in response to 
depolarization evoked by KC1. Dotted arrows represent pathways not clearly defined in 
rat mesenteric artery smooth muscle tissue, but reported in other vascular smooth 
muscle preparations. AEm corresponds to the change in membrane potential evoked by 
K+. + and -  represent stimulation and inhibition respectively. P represents 
phosphorylation.
mesenteric arteries remains to be established. Although, activation of Rho can occur 
downstream of CaMKII (Ratz et al., 2005; Sakurada et al., 2003) and Rho Kinase has 
been implicated in KCl-evoked contraction of rat mesenteric artery smooth muscle 
(Asano & Nomura, 2003). How depolarization by KC1 evokes Rho Kinase activation 
ina mode independent of G-protein activation is currently unknown (Ratz et a l, 2005). 
In rabbit aortic smooth muscle the Class II PI-3 Kinase a-isoform may be activated by 
raised Ca2+ and could subsequently activate Rho (Wang et al., 2006), however, such 
reports are not yet available for the rat small mesenteric artery.
1.3. M echanisms of vasodilatation
The balance between contractile and relaxant stimuli acting on vascular smooth muscle 
regulates the level of vascular tone. Vasodilatation may therefore be evoked either by 
removal of the contractile stimuli (passive dilatation) or by activation of dilatation 
mechanisms that reverse the contraction (active dilatation). Active vasodilatation is
I
principally achieved by two mechanisms: A reduction in smooth muscle Ca or a 
reduction in myosin phosphorylation (Woodrum & Brophy, 2001). Both mechanisms
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may be achieved as a result of direct action of agonists on the smooth muscle or by 
endothelium-dependent pathways.
1.3.1. Endothelium-independent vasodilatation
Numerous physiological molecules are able to evoke a vasodilatation response at least 
partly by their actions on the smooth muscle. In the rat mesenteric artery these include 
JV-arachidonyl ethanolamide (anandamide; Ho & Hiley, 2003) adenosine (Mian & 
Marshall, 1995), adrenomedullin (Ross & Yallampalli, 2006), calcitonin gene-related 
peptide (cGRP; Champion et a l , 2001; Zygmunt et a l , 1995), vasoactive intestinal 
peptide (Ganz et a l , 1986), nitric oxide (NO; Ignarro et al, 1987; MacLeod et al, 
1987; Palmer et al, 1987) and endothelium derived hyperpolarizing factor(s) 
(EDHF(s)) (Busse et al, 2002; Feletou & Vanhoutte, 2006; Fleming & Busse, 2006; 
Griffith, 2004; McGuire et al, 2001; Sandow & Tare, 2007). The latter two, released 
from the endothelium in response to other vasoactive agonists are regarded as mediators 
of endothelium-dependent vasodilatation and so will be discussed in section 1.3.2. 
However all of the dilators listed evoke a dilatation response by one or more of the 
following mechanisms; increasing cyclic nucleotide concentration, decreasing 
intracellular Ca2+, opening smooth muscle K+ channels and reducing Ca2+-sensitivity 
and myosin phosphorylation (Brain & Grant, 2004; Brayden, 2002; Kleppisch & 
Nelson, 1995; MacLeod et al, 1987; McGuire et al, 2001; Mistry & Garland, 1998; 
Plane et al, 1996; Ross & Yallampalli, 2006; Sandow & Tare, 2007; Standen et al, 
1989; Tanaka et al, 1999). For the purpose of this study the modes of action of LVK, a 
synthetic K atp channel opener and adenosine will be discussed. Comprehensive reviews 
for the other agonists may be found elsewhere (Brain & Grant, 2004; Brayden, 2002).
13.1.1, Levcromakalim
LVK, the more potent enantiomer of cromakalim (Quast & Villhauer, 1993) is a 
member of the benzopyran group of K+ channel openers and can directly facilitate 
relaxation by opening K atp channels on the smooth muscle (Cole & Clement- 
Chomienne, 2003; Criddle et al, 1994; Standen et al, 1989). Helices 12 to 17 of 
transmembrane domain 2 of the SUR2B subunit of the K atp channel (please see section
1.2.4.1) are thought to modulate the binding and activity of LVK with LVK acting as a 
substrate for the SUR subunit of the channel. At least for the SUR-Kir6.2 complex it is
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then proposed that the conformational changes evoked by LVK acting upon SUR are 
transmitted to the closely associated K* domain, causing distortion of the channel, 
transforming the channel into the open state (Moreau et al, 2005). Opening the KAtp 
channel enables K+ efflux and hyperpolarization of the smooth muscle cell (Standen et 
al, 1989; Takano et al, 2004; Weston & Abbott, 1987; White & Hiley, 2000). This 
leads to closure of VDCC and inhibition of IP3 synthesis by PLC causing a reduction in 
intracellular Ca2+ and as a result a gradual reduction in excitation-contraction coupling 
and smooth muscle relaxation (Figure 1.9; please also see section 1.2.1 and 1.2.4.2; 
Cook, 1988; Criddle et al, 1994; Ito et al, 1991; Quast & Baumlin, 1991).
Cromakalim and its derivatives have also been found to cause stimulation of endothelial 
cell hyperpolarization in the perfused mesenteric bed and rat isolated mesenteric artery 
preparations (Feleder & Adler-Graschinsky, 1997; White & Hiley, 1997b). White and 
Hiley (1997b) demonstrated a distinct rightward shift in the concentration-response 
curve to LVK following removal of the endothelium and inhibition of cannabinoid 
receptors on the smooth muscle, indicative of a role for anandamide (although please 
see section 1.3.2.6 for further details), whilst in other reports inhibition of the 
endothelial NO synthase (eNOS; please see section 1.3.2.5) with N“-nitro-L-arginine 
methyl ester (L-NAME) attenuated LVK-evoked responses (Feleder & Adler- 
Graschinsky, 1997).
More recent data suggests that rather than acting directly upon endothelial cell K atp 
channels, hyperpolarization of the endothelium is evoked by the gap junction-mediated 
transfer of hyperpolarization from the smooth muscle to the endothelium. Indeed, 
treatment with the putative gap junction blockers 18-a glycyrrhetinic acid and 18-P 
glycyrrhetinic acid blocked endothelial cell hyperpolarizations to LVK in both rat and 
rabbit mesenteric arteries (Beny & Pacicca, 1994; Murai et al, 1999; White & Hiley, 
2000; Yamamoto et al, 1998), whilst LVK had no effect on the resting membrane 
potential of isolated rat mesenteric endothelial cells (Takano et al, 2004). Endothelial 
cell hyperpolarization could subsequently initiate other endothelium-dependent 
mechanisms of vasodilatation such as the synthesis and release of NO and EDHF by 
increasing the electrochemical gradient for Ca2+ (White & Hiley, 1997b). Given 
previous reports describing such hyperpolarization-driven influxes of Ca2+ into
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Figure 1.9 Mechanisms of 
LVK-evoked vasodilatation
Cartoons illustrating the 
different mechanisms
possibly associated with 
LVK-evoked vasodilatation 
in rat mesenteric arteries. A,
Each numbered panel 
depicts a different aspect of 
the vasodilatation
mechanism that are brought 
together in B (next page). 1,
Direct hyperpolarization of 
the smooth muscle by the 
action of LVK on smooth 
muscle cell (SMC) KATP 
channels leads to closure of 
VDCC and SMC relaxation.
2, The hyperpolarization
may be transferrred to the igure . A
endothelium via gap junctions (GJ) stimulating endothelial cell (EC) Ca2+ influx. 3, The rise in Ca2+ can stimulate NO release which can 
subsequently act directly on SMC B l ^  channels to cause SMC hyperpolarization, again causing relaxation as in 1. 4, NO may also evoke 
SMC cGMP synthesis resulting in activation o f PKG and possible (dashed line) inhibition of intracellular Ca2+ release from the SR 
promoting relaxation. 5, A rise in EC Ca2+ may also activate IKq , and S K ^  channels causing EC hyperpolarization which may be 
transferred to the SMC via GJ. 6, Additionally the K+ effluxed through the K ^  channels may act upon SMC 3Na+/2K+-ATPase leading to 
hyperpolarization and a decrease in SMC Ca2+, both contributing to SMC relaxation. +, stimulation; inhibition.
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endothelial cells such a hypothesis is entirely plausible (Campbell et al, 1991; 
Groschner et al, 1994; Luckhoff & Busse, 1990a; Luckhoff & Busse, 1990b).
More recent reports investigating the ability of LVK to evoke conducted vasodilatation 
responses (please see chapter 5) in rat isolated and pressurized mesenteric arteries 
documented that the LVK-evoked spread of hyperpolarization and depolarization was 
endothelium-dependent, but that neither the local or remote responses to LVK were 
accompanied by a rise in endothelial cell Ca2+ (Takano et al, 2004). Within this 
preparation therefore it would seem an increase in endothelial cell membrane potential 
does not necessarily always drive Ca2+ into the cell. Indeed a report investigating 
endothelial cell Ca2+ influx in response to ACh in the rat mesenteric artery also showed 
that the maintained phase of the Ca2+ response, that associated with Ca2+ influx from the 
extracellular space (please see section 1.3.2.2), was unaffected following inhibition of 
endothelial cell hyperpolarization, implying that each process can occur independently 
(McSherry et al, 2005). Crucially, however, the image resolution and magnification in 
the experiments of Takano et al (2004) and McSherry et al (2005) would not have 
allowed visualization of any transient and localized rises in endothelial cell Ca2+, for 
example in the microdomains associated with eNOS (Fleming & Busse, 2003; Frank et 
al, 2003). Therefore, NO, or given recent observations (please see chapters 3 and 6 ; 
Sandow et al., 2006) EDHF may still have a role in the LVK-evoked response described 
by White & Hiley (1997b).
The production of NO, stimulation of smooth muscle adenylyl cyclases (please see 
section 1.3.1.2) or activation of an EDHF would be expected to augment the dilatation 
response in intact arteries when compared to denuded arteries. However, experimentally 
this is not always the case. Within the perfused rat mesentery and small mesenteric 
arteries it was demonstrated that basal release of NO from the endothelium or addition 
of S-nitroso-N-acetylpenicillamine (SNAP) reduced the dilatation response to LVK 
(McCulloch & Randall, 1996; White & Hiley, 1998b). Additionally, LVK and another 
structurally distinct K atp channel opener pinacidil inhibited carbachol-induced EDHF- 
type dilatations, leaving NO-mediated responses intact (White & Hiley, 1998a). This 
interaction could arise as a result of a change in the relative K+ concentrations inside 
and outside of the cell following each of the modes of smooth muscle cell and
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endothelial cell stimulation (please see sections 1.3.2.6 and 1.3.2.9; White & Hiley, 
1998b).
In the absence of any other modulators of tone or membrane potential, stimulation of 
Katp will allow movement of K+ out of the smooth muscle cells. This will increase the 
K+ concentration outside of the cell bringing both the endothelial and smooth muscle 
cell membrane potentials nearer the equilibrium potential for K+. As a result efflux of 
K+ through the endothelial cell Kca following agonist stimulation will be limited so 
endothelial cell hyperpolarization and the drive for Ca2+ influx will be diminished 
(please see section 1.2.4). Activation of SKca and IKca by stimulation of the 
endothelium with agonists such as carbachol (White & Hiley, 1998a), or indeed 
activation of smooth muscle BKca by NO (Mistry & Garland, 1998; Plane et al, 2001) 
would similarly prevent efflux of K+ from smooth muscle Katp, thus attenuating LVK- 
evoked dilatation responses (McCulloch & Randall, 1996).
The differential LVK-evoked activation and inhibition of EDHF and NO pathways in 
the same preparation is difficult to reconcile solely by this mechanism. However, other 
factors, beyond the efflux of K+ clearly overlap between these pathways. Both cGMP 
and cAMP are implicated in NO and EDHF-mediated dilatation pathways (Griffith et 
al, 2004; Griffith et al, 2002; MacLeod et al, 1987). Given that K atp channels are also 
regulated by these nucleotides (please see below) and feedback pathways exist to 
regulate their accumulation, the production of cAMP and cGMP could have a 
significant effect on LVK-evoked responses in the intact preparation (McCulloch & 
Randall, 1996; Omar et al, 2000; Plane et al, 1996; Plane et al, 2001; White & Hiley, 
1998b). Indeed, within the rat mesenteric artery exogenous NO-evoked dilatation was 
inhibited by the presence of the endothelium in a cGMP-dependent manner (Plane et al,
2001) whilst in the superior mesenteric artery removal of basal NO or the endothelium 
was shown to augment LVK-evoked responses in a manner that could be reversed by 
addition of 8 -bromo cGMP (McCulloch & Randall, 1996).
cAMP, PKA and K a t p
Activation of K atp by LVK partly reflects the actions of endogenous mediators such as 
adenosine and CGRP, which have been shown to activate K atp in various vascular
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preparations including the rat mesenteric artery (Cheng et al., 2004; Cole & Clement- 
Chomienne, 2003; Dart & Standen, 1993; Garland & McPherson, 1992; Jackson, 2005; 
Standen et al, 1989; Tang et al., 2005; Weidelt et al, 1997; Wellman et al, 1998). To 
evoke vasodilatation adenosine and CGRP act respectively on A2 and CGRP1 receptors 
on the smooth muscle (Brain & Grant, 2004; Hiley et al, 1995; Prentice et al, 1997; 
Rubino et al, 1995). Both receptors are seven transmembrane domain Gs-coupled 
GPCR that upon activation undergo a conformational change to allow dissociation of 
the Gas subunit from the inhibitory Gpy subunits. The Gas subunit subsequently interacts 
with adenylyl cyclase to activate the enzyme and initiate the transformation of ATP to 
cAMP (Kamenetsky et al, 2006). In addition to other effector proteins such as the 
cyclic nucleotide gated ion channels, cAMP may bind to cAMP-dependent protein 
kinase (PKA), promoting dissociation of the catalytic subunit from the inhibitory 
subunit and activation of the serine-threonine kinase (Kamenetsky et al, 2006). 
Association of PKA with AKAP localizes the enzyme to specific microdomains near 
the plasma membrane enabling the serine-threonine kinase to phosphorylate and 
activate, amongst other proteins, the K Atp channel (Figure 1.10; Cole & Clement- 
Chomienne, 2003; Hayabuchi etal., 2001; Michel & Scott, 2002).
cGMP, PKG and K a t p
In contrast to CGRP and adenosine, NO activates K atp independently of cAMP. NO 
may be released from the endothelium or perivascular nerves (Boric et al, 1999; Ferrer 
et al, 2000) and diffuse to the smooth muscle where it may bind to a prosthetic heme 
group in the soluble guanylate cyclase complex activating the enzyme (Carvajal et al, 
2000). Like adenylate cyclase, guanylate cyclase catalyzes a cyclization reaction: the 
formation of cGMP from guanosine-5’-triphosphate. cGMP then activates a range of 
effector proteins including ion channels, cGMP-sensitive phosphodiesterases and 
soluble cGMP-sensitive protein kinase G (PKG) (Carvajal et al, 2000). Activation of 
PKG stimulates translocation of the protein from the cytosol to the plasma membrane 
where in addition to other cellular targets it may phosphorylate K atp leading to its 
activation as described for PKA (please see section 1.3.2.5 for details of further NO- 
mediated dilatation pathways).
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Physiological activation of K a t p  in the rat mesenteric artery
As described several physiological agonists including CGRP, adenosine, hydrogen 
sulphide (H2S) and NO activate the K atp channel. However the importance of K Atp to 
smooth muscle cell hyperpolarization and dilatation varies depending on the agonist 
used to evoke K Atp channel activation and the vascular bed under study (Cole & 
Clement-Chomienne, 2003; Dart & Standen, 1993; Jackson, 2005; Standen et a l , 1989; 
Wellman et al., 1998). CGRP-evoked a hyperpolarization response in rat small 
mesenteric artery smooth muscle cells and porcine coronary artery smooth muscle cells 
that was completely blocked by application of the SUR blocker glibenclamide 
(Hayabuchi et al., 2001; Wellman et al., 1998). Similarly H2S-evoked endothelium- 
independent dilatation responses are abolished by glibenclamide (Cheng et al., 2004). 
Attenuation of an adenosine-evoked hyperpolarizing current with glibenclamide in 
rabbit mesenteric artery and pig coronary artery smooth muscle cells has also been 
described (Dart & Standen, 1993; Kleppisch & Nelson, 1995). However, despite 
numerous reports of a vasodilatation response to adenosine in rat mesenteric artery 
preparations the relaxation response was not found to be sensitive to K Atp channel 
blockers (Hiley et al., 1995; Mian & Marshall, 1995; Prentice et al., 1997; Rubino et 
al., 1995). This may reflect the multi-faceted mechanism by which adenosine evokes a 
dilatation response, with other mechanisms compensating for the loss of KATp-evoked 
hyperpolarization (please see section 1.3.1.2). Alternatively it may reflect the 
observation that within rat isolated mesenteric arteries activation of K Atp does not 
necessarily correlate with a vasodilatation response. K Atp is reportedly activated by NO 
in rat mesenteric arteries and has been shown to contribute to NO-evoked smooth 
muscle hyperpolarization in this preparation in the absence of tone (Garland & 
McPherson, 1992). However, in arteries depolarized with noradrenaline, KATp-evoked 
hyperpolarization or vasodilatation was not observed in response to NO (Garland & 
McPherson, 1992; White & Hiley, 1998b).
Despite the inconsistencies observed with physiological activation of the K Atp channel 
the demonstration of robust hyperpolarization and dilatation responses in isolated 
mesenteric arteries in response to LVK supports the presence of these channels in this 
preparation and their significant influence on membrane potential and vascular tone 
(Omar et al., 2000; Takano et al., 2004; White & Hiley, 1997b; White & Hiley, 2000;
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White & Hiley, 1998b). Indeed, the sensitivity of the channel to intracellular nucleotide 
concentrations, CO2 and pH supports a key role for Katp in regulation of vascular tone 
under various metabolic and hypoxic conditions (Brayden, 2002; Dart & Standen, 1993; 
Kleppisch & Nelson, 1995; Mian & Marshall, 1995; Wang et a l , 2003). Therefore the 
use of LVK as an agonist to evoke dilatation responses in the rat isolated mesenteric 
artery, although not wholly reflecting physiological events, may at least partly mimic 
the effects of endogenous mediators such as adenosine (please see section 1.3.1.2) and 
CGRP, which have been shown to be present and effective in this vascular bed.
I.3.I.2. Adenosine
Adenosine is a purine nucleoside that can be released into the circulation from a number 
of sources. Under conditions of acute and chronic hypoxia adenosine may be released 
from the endothelium of rat mesenteric arteries and skeletal muscle arterioles (Bryan & 
Marshall, 1999b; Mian & Marshall, 1995; Skinner & Marshall, 1996). In skeletal 
muscle preparations adenosine may also be released into the circulation as a product of 
metabolism following increased muscle contraction. However it is the endothelium- 
derived adenosine that is thought to mediate the local and spreading dilatation responses 
(please see chapter 5) required to improve tissue blood flow (Bryan & Marshall, 1999b; 
Duza & Sarelius, 2003; Murrant & Sarelius, 2002; Skinner & Marshall, 1996). 
Adenosine may also be produced (Figure 1.10) either as a result of the gradual 
breakdown of ATP by various intracellular and extracellular nucleotidases or as a result 
of the hydrolysis of S-adenosylhomocysteine by S-adenosylhomocysteine hydrolase 
(Gorlach, 2005). Given that ATP may be released into the circulation from circulating 
cells, nerve terminals and the vascular wall itself there is a strong likelihood that 
endogenous adenosine would be present in a number of vascular beds, if not all 
(Bumstock, 2006; Bumstock, 1999; Gonzalez-Alonso et a l , 2002; Pearce et a l , 1996; 
Rosenmeier et a l , 2004).
The classical pathway by which adenosine mediates vasodilatation is by a direct action 
on vascular smooth muscle cells as has previously been described (Figure 1.11). 
Adenosine acts upon smooth muscle A2A/B G protein-coupled receptors to stimulate 
adenylyl cyclase and the production of cAMP (Rubino et a l , 1995) . However, in 
addition to the activation of Katp observed in some vascular beds (please see section
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Figure 1.10
Adenosine production in the endothelium (adapted from Gorlach et a l 2005)
Cartoon illustrating the adenosine synthesis and degradation pathways both within the 
endothelium and on its external surface. 1, Cytosolic 5’- and membrane-bound ecto-5’- 
AMP nucleotidases produce adenosine from AMP. 2, AMP may be formed 
intracellularly by the breakdown of ATP by adenylate kinase or extracellularly by the 
breakdown of ATP by ecto-Apyrase enzymes. 3, Adenosine may also be transferred 
across the membrane by the equilibrative nucleoside transporter (ENT) or via ATP- 
permeable channels. 4, Alternatively, adenosine may be produced intracellularly from 
S-adenosyl homocysteine.
1.3.1.1), cAMP may also regulate a number of other effector proteins to mediate 
relaxation of vascular smooth muscle (Figure 1.11).
cAMP and smooth muscle relaxation
cAMP-evoked smooth muscle relaxation is associated with a decrease in the cytosolic 
Ca2+ concentration and a reduction in myosin phosphorylation. Within rat isolated 
mesenteric artery preparations this was shown to be a two-stage process initially 
dependent on a reduction in cytosolic Ca2+, but at later stages requiring recruitment of 
Ca2+-independent mechanisms (Taylor et al., 1999).
A reduction in cytosolic Ca2+ may be mediated by VDCC closure as a result of the 
hyperpolarization caused by activation of K atp channels by cAMP as has been
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described (please see section 1.3.1.1). Additionally activation of vascular smooth 
muscle Kca channels downstream of cAMP and PKA activation may also contribute to 
smooth muscle hyperpolarization and VDCC closure in the rat mesenteric artery (Ross 
& Yallampalli, 2006). Further reductions in cytosolic Ca2+ are achieved by cAMP- 
mediated activation of the SR Ca2+-ATPase and through enhanced Ca2+ extrusion as a 
consequence of cAMP-facilitated activation of the 3Na+/2K+ ATPase and subsequent 
3Na+/Ca2+ exchanger activation by cAMP (Nishimura, 2006). Furthermore, release of 
Ca2+ from intracellular stores by activation of IP3R may be inhibited by PKA-dependent 
acceleration of Gaq sequestration (please see section 1.2.3.1; Abdel-Latif, 2001).
Nishimura and van Breemen (Nishimura & van Breemen, 1989) demonstrated that 
cAMP could also mediate a decrease in tension independently of the cytosolic Ca2+ 
concentration. Pre-treatment with cAMP was shown to abolish phorbol 12,13 dibutyrate 
(PDBu)-induced contractions indicating a cAMP-mediated Ca2+-desensitization of the 
contractile apparatus. Based on earlier proposals it was suggested that cAMP would 
induce smooth muscle cell relaxation by activation of PKA and subsequent 
phosphorylation and inactivation of MLCK (please see section 1.2.1; Adelstein et a l , 
1978; Nishimura & van Breemen, 1989). More recently, in non-vascular smooth muscle 
preparations PKA has also been shown to mediate both direct and indirect (via Rho) 
recruitment and activation of myosin phosphatase (please see section 1.2.3.7; Abdel- 
Latif, 2001; Murthy et al., 2003; Taylor et al, 1999). Interestingly the cAMP-mediated 
decrease in Ca2+-sensitivity in branches of the rat superior mesenteric artery and in the 
perfused anterior mesenteric artery has also been demonstrated to be dependent on 
activation of PKG (Kawada et al, 1997; Northover & Northover, 1997). Removal of 
vascular smooth muscle cell PKG was shown to result in an increase in cytosolic Ca2+ 
in response to forskolin treatment of rat aortic smooth muscle cells, possibly reflecting 
the increased open probability of VDCC documented in the presence of cAMP and 
(Kawada et al, 1997; Lincoln et al, 1990; Taguchi et al, 1997). Indeed in rat aortic 
smooth muscle cells exogenous PKA was shown to be far less effective than PKG at 
activating the smooth muscle Ca2+-ATPase (Rashatwar et al, 1987) and PKG was 
found to mediate the cAMP-induced inhibition of Ca2+ release from intracellular stores 
by phosphorylation of the IP3R (Komalavilas & Lincoln, 1996). Cross talk between 
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Figure 1.11 Mechanisms of adenosine-evoked vasodilatation
Cartoons illustrating the different mechanisms possibly associated with adenosine or CGRP-evoked 
vasodilatation in rat mesenteric arteries. A, Each numbered panel depicts a different aspect of the 
vasodilatation mechanism that are brought together in B (next page) with the endothelium-dependent 
mechanisms described previously in Figure 1.9 panel A (numbers 2-6) arising from the transfer of 
hyperpolarization from the smooth muscle cell (SMC) to the endothelium. 1, Activation of Gas G protein- 
coupled receptors by adenosine or CGRP results in activation of adenylyl cyclase and production of cAMP, 
subsequently leading to PKA activation. 2, PKA may then phosphorylate ((P)) various proteins leading to their 
activation. These include the KATP channel and the 3Na+/2K+-ATPase, which may both result in SMC 
hyperpolarization and closure of VDCC, causing a reduction in SMC Ca2+. 3, Additionally PKA may 
phosphorylate and activate the SR Ca2+-ATPase, leading to Ca2+ sequestration within the intracellular stores, 
again causing a decrease in SMC Ca2+. 4, The reduction in SMC Ca2+ prevents the association of Ca2+ with 
calmodulin and hence MLCK activation. PKA itself may also limit myosin phosphorylation by activating 
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are sensitive to cAMP and cGMP (Figure 1.11). Furthermore the differing sensitivities 
of the serine-threonine kinases can be modulated by autophosphorylation enhancing 
their sensitivity for the opposite nucleotide (Lincoln et al., 1990; Northover & 
Northover, 1997).
More recently adenosine has also been reported to have endothelium-dependent effects 
in some vascular beds including the rat superior mesenteric arterial bed (Bryan & 
Marshall, 1999b; Ray & Marshall, 2005; Rubino et a l , 1995). Within skeletal muscle 
vascular beds and aortic preparations a nitric oxide-dependent vasodilatation component 
downstream of Ai and A 2 a  receptor activation has been documented that was 
associated with endothelial cell K atp channel activation, hyperpolarization, Ca2+ influx 
and prostacyclin production (Bryan & Marshall, 1999a; Bryan & Marshall, 1999b; Ray 
et al., 2002; Ray & Marshall, 2005; Ray & Marshall, 2006; Skinner & Marshall, 1996). 
Within rat small mesenteric arteries an endothelium-dependent component for 
adenosine-evoked dilatation responses has not been reported indeed K atp channels are 
not thought to be localized to the endothelium (Takano et al, 2004; White & Hiley,
2000). However, given the recent report describing the transfer of hyperpolarization 
from the smooth muscle to the endothelium in response to LVK and the subsequent 
release of NO from the endothelium it is highly likely that such a mechanism could 
exist in response to A2A activation (White & Hiley, 2000).
1.3.2. Endothelium-dependent vasodilatation.
The role of the endothelium in regulating subjacent smooth muscle cells and thus 
agonist-induced vasodilatation and smooth muscle hyperpolarization has long been 
established (Furchgott & Zawadzki, 1980). Numerous chemical and mechanical stimuli 
such as ACh, bradykinin, ATP, UIP, substance P and shear stress evoke vasodilatation 
by endothelium-dependent mechanisms (Buvinic et al, 2002; Edwards et al, 2000; 
Furchgott, 1983; Furchgott & Zawadzki, 1980; Malmsjo et al, 2002; Malmsjo et al, 
1998; Pohl et al, 1986; Thorsgaard et al, 2003). The factors produced by the 
endothelium to mediate these dilatation responses include the endothelium-derived 
relaxing factor NO (Ignarro et al, 1987; Palmer et al, 1987), prostacyclin (Moncada & 
Vane, 1978) and the non-NO, non-prostanoid EDHF(s) (Chen et al, 1988; Feletou & 
Vanhoutte, 1988; Taylor et al, 1988; Taylor & Weston, 1988). The nature and
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importance of these endothelium-derived mediators of relaxation varies according to the 
size and species of the vessel (Shimokawa et a l , 1996); NO being the main mediator of 
relaxation in the larger vessels of the arterial tree whilst having no obligatory role in 
smaller vessels where EDHF is thought to predominate (Garland & McPherson, 1992; 
Hill et al, 2001; Shimokawa et al, 1996; Urakami-Harasawa et al, 1997).
Within this thesis dilatation responses to the endothelium-dependent GPCR agonists 
ACh, ATP, UTP, ADPpS and ATPyS were studied (Furchgott & Zawadzki, 1980; 
Malmsjo et al, 2002; Malmsjo et al, 1998; Mistry et al, 2003). Within the mesenteric 
circulation ACh is regarded as an agonist for the endothelial cell muscarinic (M)3 
receptor, a Gq/n GPCR (Blin et al, 1995; Fujimoto & Matsuda, 1991; Wu et al, 1997). 
Within the rat mesenteric artery preparation ATP, UTP, ADPpS and ATPyS also all 
evoke endothelium-dependent vasodilatation responses, predominantly by their actions 
on the P2Y family of GPCRs; more specifically the P2Yi, P2 Y2, P2 Y4 and P2Y6 Gq/n G 
protein-coupled receptors (Buvinic et al, 2002; Malmsjo et al, 2000a; Malmsjo et al, 
2002; Malmsjo et al, 1999; Mistry et al, 2003). Therefore, for the purposes of this 
thesis only the mechanisms associated with endothelium-dependent dilatation responses 
to Gq/n GPCR activation will be discussed with reference to section 1.2.3. For a 
detailed discussion of dilatation responses to physical stimuli such as shear stress and 
the downstream signalling processes associated with P2Y receptor activation readers are 
directed to the following reviews (Busse & Fleming, 2003; Ralevic & Bumstock, 1998).
I.3.2.I. Endothelial cell G q/n  G protein-coupled receptor activation
As described previously (please see section 1.2.3.1), agonist binding to Gq/n GPCRs 
activates PLCpl, catalyzing the synthesis of IP3 and DAG from PIP2 (Berridge, 1993; 
Lee et al, 1992; Newby & Henderson, 1990; Pirotton et al, 1987; Wu et al, 1992). As 
IP3RI, IP3R2  and IP3R3  are all expressed on the endothelium of the rat small mesenteric 
artery, IP3 could theoretically activate each of these receptors to stimulate Ca2+ release 
from the ER (Grayson et al, 2004). However, given the differing IP3 sensitivities of the 
receptors it is likely that the subtype of IP3R activated depends upon the type of 
vasoactive stimuli and the level of that stimulus. Whichever IP3R is activated the 
subsequent rapid rise in endothelial cell Ca2+ (Figure 1.13) is then key to the initiation
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of the stimulus-secretion/hyperpolarization response (Berridge, 1993; Freay et al, 1989; 
Fukao et al., 1997b; Muller et al., 1999).
I.3.2.2. Endothelial cell sources of Ca2*
In the isolated, pressurized rat small mesenteric artery the endothelial cell Ca2+ response 
is characterized by an increase in Ca2+ that is maintained for the duration of the period 
of stimulation (Figure 1.12; McSherry et al, 2005). However, the endothelial cell Ca2+ 
response actually comprises two phases that may be distinguished pharmacologically: a 
rapid increase in cytosolic Ca2+ that is dependent on the release of Ca2+ from 
intracellular stores and a second sustained rise that is dependent on the influx of 
extracellular Ca2+ (Cannell & Sage, 1989; Hallam & Pearson, 1986; McSherry et al, 
2006; McSherry et al, 2005).
When Hallam & Pearson (1986) observed that the ATP-evoked increase in intracellular 
Ca2+ became transient following removal of extracellular Ca2+, although the importance 
of extracellular Ca2+ to the response was highlighted (see below), it was also recognised 
that an intracellular Ca2+ source must exist to enable this transient Ca2+ response. 
Studies applying IP3 to isolated endothelial cells subsequently demonstrated that this 
intracellular Ca2+ release likely reflected the DVdependent quantal release of Ca2+ from 
ER stores (please see section 1.2.3.2; Freay et al, 1989; Huser et al, 1999). Reports to 
the contrary have demonstrated that in rabbit aortic endothelial cells the ACh-evoked 
rise in endothelial cell Ca2+ may be dependent on the release of Ca2+ from a ryanodine- 
and caffeine-sensitive store (please see section 1.2.3.3; Wang et al, 1995). However, 
within the rat mesenteric artery, the ACh-evoked Ca2+ response would appear to be 
dependent on ^-stimulated intracellular Ca2+ stores as ryanodine was shown to have 
no effect on the ACh-evoked, Ca2+-dependent hyperpolarization response, whilst both 
thapsigargin and CPA significantly attenuated ACh-evoked smooth muscle cell 
hyperpolarization and dilatation responses (please see section 1.3.2.7; Fukao et al, 
1997b; McSherry et a l , 2005).
As described, a role for extracellular Ca2+ is clear. Indeed, early experiments performed 
to characterise the endothelium-dependent response to ACh in the rat aortic ring 
preparation demonstrated a marked attenuation of the dilatation response following
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Figure 1.12 Average endothelial cell Ca2+ response to ACh in the rat isolated and 
pressurized mesenteric artery modified from McSherry et a l 2005
The figure demonstrates the change in relative fluorescence (F/F0) of the Ca2+-sensitive 
dye fluo-4 AM averaged from 16 endothelial cells of an intact rat isolated, pressurized 
mesenteric artery in response to application of ACh (0.3pM) in the presence of 
extracellular Ca2+ (control) and in Ca +-free solution.
removal of extracellular Ca2+ (Long & Stone, 1985; Singer & Peach, 1982; Winquist et 
al., 1985). More recent studies performed in a number of preparations including the rat 
mesenteric artery expand these observations to demonstrate that removal of 
extracellular Ca2+ or treatment with the NSCC antagonists SKF-96365 and mefenamic 
acid attenuated agonist-evoked endothelial cell Ca2+, hyperpolarization and dilatation 
responses such that only transient increases in each were observed (Fukao et al., 1997b; 
Fukao et a l, 2001; McSherry et al., 2005).
The poor sensitivity of the agonist-evoked endothelial cell Ca2+ response to 
dihydropyridine treatment and the absence of a depolarization-induced increase in 
endothelial cell Ca2+ preclude a role for L-type VDCC in the response (Cannell & Sage, 
1989; Colden-Stanfield etal., 1987). Indeed, the pathway for influx of Ca2+ was initially 
attributed to the movement of Ca2+ down its electrochemical gradient following 
endothelial cell hyperpolarization (please see section 1.3.2.7; Campbell et a l, 1991; 
Groschner et al., 1994; Luckhoff & Busse, 1990b). Within intact rat small mesenteric 
artery preparations however, recent evidence demonstrating that the frequency of Ca2+ 
oscillations and the time course of the Ca2+ response to ACh was unchanged following 
inhibition of the endothelial cell hyperpolarization response suggest that the influx of 
Ca2+ can occur independently of any changes in endothelial cell membrane potential 
(McSherry et al., 2005), although small changes in intracellular Ca2+ downstream of
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endothelial cell hyperpolarization cannot be ruled out by this study (please see section
1.3.1.1). Reports detailing thapsigargin and CPA evoked hyperpolarization responses of 
~12mV (Fukao et al., 1997b) and the previously described blockade of the 
endothelium-dependent Ca2+, hyperpolarization and dilatation responses with SKF- 
96365 or the PLC inhibitor l-(6-((17p-3-methoxyestra-l,3,5(10)-trien-17- 
yl)amino)hexyl)-lH-pyrrole-2,5-dione (U-73122) support Ca2+ influx via SOCE and 
ROCC in the rat mesenteric artery following Gq/n GPCR stimulation (Fukao et al., 
1997b; McSherry et al, 2005).
I.3.2.3. The identity of the endothelial cell Ca2+ influx channel
Both SOCE and ROCC currents in the vascular endothelium are characterized by a 
NSCC current (Freichel et al., 2001; Groschner et al., 1998; Leung et al., 2006; Nilius 
et al, 2003), possibly facilitating an influx of Ca2+ (Figure 1.13) via activation of the 
reverse phase of the 3Na+/Ca2+ exchanger (Bondarenko, 2004; Sedova & Blatter, 1999; 
Teubl et al., 1999; Winquist et al., 1985). As such both currents could be associated 
with activation of the TRP family of ion channels (please see sections 1.2.3.4 and 
1.2.3.5; Freichel et al, 2001; Groschner et al., 1998; Leung et al., 2006; McFadzean & 
Gibson, 2002; Nilius et al., 2003; Yao & Garland, 2005).
Members of each of the three TRP channel subfamilies, canonical (TRPC), vanilloid 
(TRPV) and melastatin (TRPM) have been documented within the vascular 
endothelium, the most widely expressed channels being members of the TRPC and 
TRPV subfamilies (please see Nilius et al., 2003; Yao & Garland, 2005 for review). 
The ability of these channels to form heteromultimers within the limits of each 
subfamily has led to difficulties associated with the identification of each TRP channel 
and its relationship to endogenous Ca2+ entry pathways (Nilius et al., 2003; Yao & 
Garland, 2005). However, a role for TRPC3 either as a ROCC or SOCE channel has 
been proposed within a number of cell culture preparations. Indeed, within human 
umbilical vein endothelial cells many of the characteristics of the TRPC3 current mimic 
those of the endogenous NSCC current (Nilius et al., 2003), whilst the endogenous IP3- 
evoked SOCE current can be inhibited by expression of the dominant-negative N- 
terminal fragment of TRPC3 (Groschner et al., 1998). However, within the rat 
mesenteric artery, where TRPC3 is well expressed in the endothelium (Hill et al, 2006)
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acute knock down of TRPC3 had only small effects on bradykinin-evoked dilatation 
responses and absolutely none on those to ATP, CPA and histamine suggesting that at 
least within this preparation other TRP channel subtypes or indeed channel proteins 
(please see section 1.2.3.4) contribute to the vasodilatation response (Liu et al, 2006b).
In support of this hypothesis robust rises in endothelial cell Ca2+ have been observed 
downstream of the activation of both TRPV1 and TRPV4 channel subtypes. (Kotlikoff, 
2005; Marrelli et al, 2006; Nilius et al, 2003; Vriens et al, 2005; Watanabe et al, 
2003; Yao & Garland, 2005). Furthermore, targeted endothelial cell knock out of 
TRPC4 markedly reduced ATP- and ACh-induced endothelial cell Ca2+ influx and 
attenuated the ACh-evoked dilatation response in mouse aortic and pulmonary arteries 
(Freichel et al, 2001). Indeed, other channel proteins and signalling molecules distinct 
from the TRP family for example the STIMl/Orail pathway could also contribute to the 
influx of Ca2+ in response to store depletion (please see section 1.2.3.4).
I.3.2.4. Prostacyclin
Prostacyclin is a product of the metabolism of arachidonic acid by cyclooxygenase 
(COX) enzymes expressed within the endothelium and as such is ultimately dependent 
on the activation of the enzyme PLA2, which produces arachidonic acid from membrane 
phospholipids (Busse & Fleming, 2003; Moncada & Vane, 1978; Parkington et al, 
2004). PLA2 may be activated by both an increase in intracellular Ca2+ and by Ca2+- 
independent mechanisms (Busse & Fleming, 2003). Once produced, prostacyclin is able 
to diffuse to the smooth muscle where it may activate the IP-prostanoid receptors 
stimulating the production of cAMP (Alexander et al, 2006; Breyer et al, 2001; 
Parkington et al, 2004), which by mechanisms described previously including smooth 
muscle cell hyperpolarization (please see sections 1.2.3.7 and 1.3.1.2), may decrease 
smooth muscle cell Ca2+ and the Ca2+ sensitivity of the contractile machinery 
(Parkington et al, 2004). However, within the rat mesenteric artery endogenous 
prostacyclin release is not thought to contribute significantly to the endothelium- 
dependent vasodilatation or hyperpolarization response (Chen & Cheung, 1997; 




In contrast a role for NO in the endothelium-dependent dilatation response of the rat 
mesenteric artery is well established (Garland & McPherson, 1992). Indeed some of the 
earliest experiments documenting the endothelium-dependent dilatation responses to 
agonists such as ACh and bradykinin detailed the release of the endothelium-dependent 
relaxing factor (EDRF) NO (Ignarro et al., 1987; Palmer et al., 1987) and showed it to 
be dependent on the influx of extracellular Ca2+ (Adams et al., 1989; Furchgott, 1983; 
Luckhoff et al, 1988). Soon after its identification, NO was shown to be generated from 
the precursor L-arginine (Palmer, 1988) thus enabling the production of various 
inhibitory analogues and the subsequent identification of the synthetic enzyme, nitric 
oxide synthase (NOS) (Vane, 1994). Three subtypes of NOS have since been identified: 
neuronal (n-) NOS (NOS I), inducible (i-) NOS (NOS II) and the constitutively active 
subtype endothelial (e-) NOS (NOS HI), the latter of which is regarded as the enzyme 
largely responsible for the production of endothelium-derived NO under normal 
conditions (Busse & Fleming, 2003; Vane, 1994). eNOS activity was shown to be 
dependent on the presence of raised intracellular Ca2+, which binds to calmodulin and 
with the activation of various kinases and phosphatases facilitates activation of the 
enzyme (Bredt & Snyder, 1990; Vane, 1994). However, the production of NO when 
activated by endothelial cell surface shear stress may be maintained after the Ca2+ 
response has ceased as eNOS can be activated following phosphorylation by the 
serine/threonine kinases Akt (PKB) and PKA in the presence of basal levels of Ca2+ 
(Boo & Jo, 2003; Busse & Fleming, 2003; Corson et al., 1996; Dimmeler et al., 1999; 
Fleming & Busse, 2003; Fleming et al., 2005; Muller et al, 1999; Tarbell & Pahakis, 
2006). Multiple mechanisms mediate the transduction of the shear-induced signal to the 
activation of eNOS. These include the recruitment of caveolae to the plasma membrane 
and the subsequent association of signalling molecules with eNOS in these 
plasmalemmal domains, including platelet-endothelial cell adhesion moleule-1  
(PECAM-1), heparan sulphate proteoglycans and PKC (Boo & Jo, 2003; Dusserre et 
al, 2004; Fleming et al., 2005; Frank et al., 2003; Rizzo et al., 1998; Tarbell & 
Pahakis, 2006). For review please see Tarbell & Pahakis (2006) and Busse et al. (2003)
Following its synthesis in the endothelium, NO subsequently diffuses to the smooth 
muscle where it may bind to soluble guanylate cyclase, stimulating cGMP formation,
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and subsequently activating PKG (Figure 1.13) (Andriantsitohaina et a l , 1995; 
MacLeod et al., 1987; Martin et al, 1985; Rapoport & Murad, 1983). In addition to the 
stimulation of smooth muscle K Atp channels (please see section 1.3.1 .1) PKG mediates 
a decrease in smooth muscle cytosolic Ca2+ and hyperpolarization by a number of direct 
and indirect mechanisms (Figure 1.13). These include stimulating the sarcoplasmic 
Ca2+-ATPase, thus promoting Ca2+ uptake into the intracellular stores, direct reduction 
of the open probability of the VDCC, phosphorylation of PLCp (please see section
1.2.3.2), phosphorylation and inactivation of the IP3R and acceleration of the 
sequestration of the Gaq subunit (please see section 1.2.3.1; Abdel-Latif, 2001; 
Andriantsitohaina et al, 1995; Carvajal et al, 2000; Komalavilas & Lincoln, 1996; 
Murthy et al, 2003; Rashatwar et al, 1987; Taguchi et al, 1997; Twort & van 
Breemen, 1988). Like PKA-facilitated smooth muscle relaxation the PKG-evoked 
response also has a second Ca2+-desensitization phase (Taylor et al, 1999). PKG may 
reverse the Rho-mediated inhibition of myosin phosphatase and it may activate thin 
filaments such as calponin (Figure 1.13), both of which inhibit phosphorylation of the 
MLC20 (please see section 1.2.3.7; Murphy & Walker, 1998; Murthy et al, 2003; 
Nishimura & van Breemen, 1989).
Although the activation of K atp by NO was reported not to contribute to smooth muscle 
cell hyperpolarization in noradrenaline-constricted rat mesenteric arteries (please see 
section 1.3.1.1; Garland & McPherson, 1992) higher concentrations of exogenous NO 
can evoke a hyperpolarization response in this artery and a range of other vascular 
preparations via activation of BKca, and to a lesser extent Kv channels (Plane et al, 
2001). In some blood vessels this occurs via cGMP (Archer et al, 1994; Robertson et 
al, 1993) but in rat mesenteric arteries the hyperpolarizing action of NO appears to 
occur by a direct action of NO on the K+ channels (Bolotina et al, 1994; Mistry & 
Garland, 1998; Plane et al, 1996; Plane et al, 2001).
NO may also be released basally from the endothelium as demonstrated by the ability of 
NOS inhibitors to augment vasoconstrictor-evoked responses and reduce basal smooth 
muscle cGMP (Dora et al, 1997; Dora et al, 2000b; Fukuda et al, 1992; Tuttle & 
Falcone, 2001). Indeed, the basal release of NO is reported to have an important 
modulatory role on the ability of exogenous NO or indeed other dilator agonists to
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evoke hyperpolarization and relaxation. This could be a result of extracellular 
accumulation of K+ and the reversal of the electrochemical gradient or, alternatively, the 
activation of negative feedback pathways associated with cGMP accumulation (please 
see section 1.3.1.1; Plane et al, 1996; Plane et al, 2001). TRPV4, which is widely 
expressed in the endothelium and may contribute to the agonist-induced Ca2+ influx 
(please see section 1.3.2.3) may be constitutively activated at body temperature (Nilius 
et al, 2003) and thus could enable basal NO production. Alternatively the production of 
NO in the absence of endothelial cell stimulation may reflect the activation of eNOS 
following diffusion of Ca2+ from the smooth muscle to the endothelium through 
MEGJ(please see section 1.3.2.9) following, for example a-adrenoceptor stimulation 
(Dora et al, 1997; Dora et al, 2000b; Oishi et al, 2001; Schuster et al, 2001; Yashiro 
& Duling, 2000).
1.3.2.6. EDHF
A third endothelium-derived relaxing factor, EDHF, may also be released from the 
endothelium following agonist or mechanical stimulation (Chen et al, 1988; Feletou & 
Vanhoutte, 1988). The EDHF-facilitated dilatation response is characterized by the 
transfer of endothelial cell hyperpolarization to the smooth muscle resulting in closure 
of VDCC and a reduction in smooth muscle intracellular Ca2+ (Busse et al, 2002; Busse 
& Fleming, 2003; McGuire et al, 2001; Sandow & Tare, 2007). Thus endothelial cell 
membrane potential is key to the regulation of the EDHF-type dilatation response. 
Experimental values for the resting membrane potential of isolated endothelial cells 
range from -80mV to OmV under differing experimental conditions (Nilius & 
Droogmans, 2001), although recent evidence in the rat small mesenteric artery suggests 
endothelial cell resting membrane potential to be ~-50mV (McSherry et al, 2005; 
Sandow et al, 2002; White & Hiley, 2000).
1.3.2.7. Regulation of endothelial cell resting membrane potential
Endothelial cells are not considered to be electrically excitable, as they do not have 
VDCC (Cannell & Sage, 1989; Colden-Stanfield et al, 1987; Nilius & Droogmans, 
2001). The setting of endothelial cell membrane potential (if regarded independently of 
the subjacent smooth muscle layer) is instead facilitated mainly by the regulation of K* 
conductance, specifically through Kca, and possibly also Kv channels, although an
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additional depolarizing C1‘ current has also been proposed (Nilius & Droogmans, 2001). 
To date, only channels have been shown to contribute to the regulation of 
endothelial cell resting membrane potential (Doughty et a l , 2001; Nilius & Droogmans,
2001), the open channel enabling an outward K+ current leading to hyperpolarization 
of the endothelial cell as has previously been described (please see section 1.2.4.1) 
(Crane et al, 2003b; Doughty et al, 2001; Nilius & Droogmans, 2001). The other 
endothelial cell ion channels are only activated upon agonist or mechanical stimulation 
(Gao et al, 2003; Nilius & Droogmans, 2001). Indeed the dominant regulatory 
component of the endothelial cell resting membrane potential is actually thought to be 
he underlying smooth muscle, partly accounting for the variation in the membrane 
potential of isolated endothelial cells.
In contrast to the endothelial cell membrane potential in intact arterial preparations, the 
resting membrane potential of isolated rat mesenteric endothelial cells was ~-19mV 
suggesting that the underlying smooth muscle layer likely plays a key role in the 
regulation of the endothelial cell membrane potential, possibly via the transfer of 
current through MEGJ (please see sections 1.2.4.1 and 1.3.3; McSherry et al, 2005; 
White & Hiley, 2000). Indeed results comparing the incidence of MEGJ and 
hyperpolarization responses in the rat femoral and mesenteric arteries demonstrated that 
the large difference in the resting membrane potential of femoral artery endothelial 
(~-26mV) and smooth muscle (~-58mV) cells correlated with the absence of MEGJs in 
this preparation. Whereas in the intact rat mesenteric artery, where the endothelium and 
smooth muscle are well coupled electrically, the resting membrane potential for the 
endothelial (~-54mV) and smooth muscle (~-57mV) cells were more aligned (Sandow 
et al, 2002). Indeed, blockade of gap junctions in this preparation with 18-a 
glycyrrhetinic acid evoked a large depolarisation of the resting membrane potential of 
the endothelium (from —51mV to —28mV) (White & Hiley, 2000) supporting the 
influence of the smooth muscle on the endothelial cell resting membrane potential.
I.3.2.8. Direct endothelial cell hyperpolarization
Within rat mesenteric arteries hyperpolarization following endothelial cell Gq/n GPCR 
stimulation has been shown to be dependent on an increase in endothelial cell Ca2+ and 
has been shown to last for the duration of the Ca2+ response (please see section 1.3.2.2)
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(Fukao et al., 1997b; McSherry et al., 2005). Early reports documenting the sensitivity 
of the hyperpolarization response to raised K+, endothelial cell 86Rb efflux and K+ 
currents in response to ACh implied an important role for K+ channels (Busse et a l , 
1988; Olesen et al., 1988; Taylor et al, 1988; Taylor & Weston, 1988; Waldron & 
Garland, 1994). Within the rat mesenteric artery both K atp channels and BKca channels 
are thought to be restricted to the smooth muscle layer as LVK and the BKca channel 
activator, NS1619, had no direct effects on endothelial cell conductance (Takano et al, 
2004; Walker et al, 2001; White & Hiley, 2000). Evidence in support of a role for Kv 
channels in regulation of the endothelial cell membrane potential is currently 
unavailable. However, within a range of arteries combined blockade of IKca (with 
charybdotoxin, maurotoxin, TRAM-34 or TRAM-39) and SKca channels (with apamin) 
completely blocked agonist-evoked endothelial cell hyperpolarization (Edwards et al, 
1998; Edwards et al, 2000; Eichler et al, 2003; Gluais et al, 2005; Hinton & Langton,
2003) and subsequently smooth muscle hyperpolarization and relaxation supporting the 
suggestion that these two channels comprise the endothelial cell agonist-evoked 
outward K+ current (Figure 1.13) that is an essential component of the EDHF response 
(Chataigneau et al, 1998; Chen & Cheung, 1997; Crane et al, 2003a; Doughty et al, 
1999; Edwards et al, 1998; Edwards et al, 2000; Eichler et al, 2003; Hinton & 
Langton, 2003; McSherry et al, 2005; Petersson et al, 1997; Ungvari et al, 2002; 
Zygmunt & Hogestatt, 1996). Recent experiments within rat aortic endothelial cells also 
support a role for the reverse mode of the electrogenic 3Na+/Ca2+-exchanger in the 
ACh-evoked hyperpolarization response (Bondarenko, 2004). Such a hypothesis is 
consistent with the influx of Ca2+ required to evoke the response and the activation of an 
inward Na+ current following store-depletion as has been described previously (please 
see section 1.3.2.2; Figure 1.13). However, the relevance of this observation to the rat 
mesenteric artery preparation has yet to be ascertained.
Although agonist stimulation of the endothelium clearly evokes a hyperpolarization 
response, following blockade of endothelial cell K+ channels ACh has also been shown 
to evoke a small depolarization (Marchenko & Sage, 1993; McSherry et al, 2005). This 
depolarization response has been attributed to the activation of the volume-regulated 
anion channel (VRAC) and Cl' transporters activated by the ion fluxes caused by 
agonist stimulation of the endothelium (Doughty et al, 2001; Marchenko & Sage, 1993;
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McSherry et al, 2005; Nilius & Droogmans, 2001; Ohashi et al, 1999). Interestingly 
however, unlike the hyperpolarization response within the rat mesenteric artery 
preparation, the depolarization is not conducted to the underlying smooth muscle 
(McSherry et al, 2005). Furthermore, the basal activation of the volume-sensitive 
current in both isolated rat mesenteric arteries and calf pulmonary artery endothelial 
ceils has been shown to be highly variable, possibly contributing to the variable resting 
membrane potential described previously (Doughty et al, 2001; Nilius & Droogmans, 
2001; Voets eta l, 1996).
I.3.2.9. Candidates for the identity of EDHF
Mechanisms associated with the generation of hyperpolarization within the endothelium 
are well established. However the identity of the EDHF, and whether the transfer of 
hyperpolarization from the endothelium to the smooth muscle is in fact a contact- 
mediated cell-to-cell transfer of hyperpolarization (please see section 1.3.3) rather than 
the transfer of a diffusible factor (EDHF) is still unclear. Indeed, some investigators 
have proposed that the response is mediated by multiple EDHFs thus further 
complicating their identification and characterization (Busse et al, 2002; Dora & 
Garland, 2001; Edwards et al, 1998; Edwards et al, 2000; Mather et al, 2005; 
McGuire et al, 2001; Sandow & Tare, 2007; Triggle & Ding, 2002). Whichever 
identity the transfer of hyperpolarization takes one universally accepted characteristic is 
that its generation must be abolished by blockade of endothelial IKca and/or SKca 
channels (Busse et al, 2002; Dora & Garland, 2001; Fleming, 2004; Garland & Plane, 
1996; Sandow & Tare, 2007).
Potential candidates for the classically, non-prostacyclin, non-NO EDHF response 
include diffusible factors such as K+ efflux from the endothelium (Edwards et al., 
1998), the products of arachidonic acid metabolism by cytochrome P450-dependent 
monooxygenases (CYP), the epoxyeicosatrienoic acids (EETs)(Campbell et al, 1996; 
Popp et al, 1996), endogenous cannabinoids (Randall et al, 1996), C-type natriuretic 
peptide (CNP; Chauhan et al, 2003b) and hydrogen peroxide (H2O2; Matoba et al, 
2000). For excellent reviews of the EDHF response and potential candidates for its 
identity please see McGuire et al (2001) and Feletou & Vanhoutte (2006).
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A K+ identity for EDHF was proposed when Edwards et al (1998) detailed the 
charybdotoxin- and apamin-sensitive release of K+ into the myoendothelial space and 
the dilatation of rat mesenteric and hepatic arteries to increasing concentrations of K* 
(Edwards et a l , 1998). The authors documented that both EDHF-type responses, that to 
K+ and that to ACh, were sensitive to the 3Na+/2K+-ATPase and Kjr inhibitors ouabain 
and barium, proposing that agonist stimulation evoked release of K+ from the 
endothelium, which stimulated the 3Na+/2K+ATPase and on the smooth muscle to 
facilitate smooth muscle hyperpolarization, relaxation and subsequently vasodilatation 
(Figure 1.13; please see section 1.2.4; Edwards et al (1998)). However, subsequent 
studies also using the rat mesenteric artery reported contrary observations (Doughty et 
a l , 2000; Lacy et a l , 2000). Firstly, reports from a number of groups documented that 
the barium-sensitive component of the dilatation response to exogenous K+ was 
removed upon denudation of the artery. This indicated that the channels were 
restricted to the endothelium and thus did not directly contribute to the K+-evoked 
hyperpolarization of the smooth muscle, but instead likely augmented endothelial cell 
hyperpolarization (Doughty et al, 2000; Lacy et al, 2000). Indeed, the endothelial cell 
location of the was later confirmed in both intact rat mesenteric artery and isolated 
cell preparations (Crane et al, 2003b; Dora & Garland, 2001).
Perhaps of most relevance to this thesis however (please see chapter 4), are the 
observations detailed by Doughty et al (2000) and Lacy et al (2000) that exogenous K+ 
was unable to evoke consistent EDHF-type dilatation responses in either pressurized or 
wire-mounted rat mesenteric arteries of the same profile or magnitude as that seen in 
response to ACh. Indeed within both preparations only 30-40% of arteries evoked any 
kind of dilatation response to exogenous K+ (Doughty et al, 2000; Lacy et al, 2000). 
Richards et al (2001) then demonstrated that the degree of smooth muscle 
depolarization influenced the K+-evoked hyperpolarization response: Robust, 
endothelium-dependent hyperpolarization responses to 5mM KC1, consistent with those 
observed by Edwards et a l (1998) were observed in the absence of PE-evoked 
depolarization, however following depolarization of the smooth muscle in response to 
lpM PE and subsequently IOjiM PE, K+-evoked hyperpolarization responses were 
attenuated in a concentration-dependent manner.
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Richards et al (2001; Weston et al, 2002) subsequently demonstrated that this effect of 
PE could be reversed by treatment with iberiotoxin, a BKca channel blocker. This 
observation was consistent with the activation of BKca channels following smooth 
muscle depolarization (Dora et al, 2000b; Jackson, 2000) (please see section 1.2.4.2). 
Thus, it was proposed that following high levels of smooth muscle cell stimulation, K+ 
effluxed from the smooth muscle through BKca channels formed a ‘K+ cloud’ in the 
interstitial space. Hence upon activation of the smooth muscle maximal stimulation of 
the 3Na+/2K+-ATPase could occur, preventing further activation by exogenous K+ 
(Richards et al, 2001; Weston et al, 2002). Indeed, these observations were consistent 
with reports from Dora et al (2001; 2002) demonstrating that K+ evoked dilatation and 
hyperpolarization responses could be achieved under conditions of submaximal PE- 
evoked contraction that were not possible under conditions of increased PE-evoked 
tone. Furthermore these observations were extended to show that activation of 
endothelial cell Kca, likely as a result of diffusion of Ca2+ from the smooth muscle to 
the endothelium though MEGJ (Dora et al, 1997; Dora et al, 2000b; Oishi et al, 2001; 
Schuster et al, 2001; Yashiro & Duling, 2000) also contributed to the ‘K+ cloud’ within 
isometric preparations (Dora et al, 2002). Importantly, however, each of these studies 
demonstrated that even in the presence of barium and ouabain an endothelium- 
dependent dilatation and hyperpolarization response to ACh could still be evoked, 
indicative of a second candidate for EDHF within the rat mesenteric artery (Dora & 
Garland, 2001; Doughty et al, 2000; Edwards et al, 1998; Lacy et al, 2000).
EETS
EETs are the products of arachidonic acid metabolism by CYP 2C epoxygenases so 
their synthesis depends on endothelial cell Ca2+ influx and the subsequent formation of 
arachidonic acid by PLA2 (Figure 1.14). The increased arachidonic acid then initiates 
the CYP 2C -mediated generation of 5,6-, 8,9-, 11,12-, 14,15- EETs (Busse & Fleming, 
2003; Campbell et al, 1996; Fisslthaler et al, 1999; Fleming, 2004). The EETs were 
classed as mediators of the EDHF-type vasodilator response as agonist-evoked 
dilatation responses sensitive to charybdotoxin and the non-selective Kca inhibitor, 
TEA, were also sensitive to selective inhibition of CYP 2C8/34 (Campbell et al, 1996; 
Fisslthaler et al, 1999; Popp et al, 1996). Furthermore when applied exogenously, or
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their production upregulated following chemical or physical stimulation of the 
endothelium, EETs facilitated smooth muscle cell hyperpolarization (Busse & Fleming, 
2003; Campbell et al, 1996; Fisslthaler et al, 1999; Huang et al, 2005; Popp et al, 
1996); either by increasing Ca2+ spark frequency and thus BKca channel activity via 
activation of smooth muscle TRPV4 channels (Earley et al, 2005) or by activating 
smooth muscle cell BKca (Li & Campbell, 1997).
It has been proposed, however that the lipophilic nature of the EETs would limit their 
diffusion to the smooth muscle implying that EETs could not be an EDHF but would 
rather act to amplify the endothelial cell hyperpolarization response (Fleming, 2004). 
EETs have been reported to regulate gap junctional communication (Popp et al, 2002) 
and activate endothelial cell TRPV4 channels, the latter increasing endothelial cell Ca2+ 
and hyperpolarization (Nilius et al, 2003; Vriens et al, 2005; Watanabe et al, 2003) so 
such a hypothesis is entirely feasible. Indeed, it is perhaps more likely in arteries such as 
the rat mesenteric where firstly, iberiotoxin is not an effective inhibitor of the EDHF 
response (Doughty et al, 1999; Vanheel & Van de Voorde, 1997), secondly, 
arachidonic acid was unable to evoke a smooth muscle hyperpolarization or dilatation 
response (Fukao et al, 1997a; White & Hiley, 1998c) and thirdly, the suicide substrate 
inhibitors of the CYP enzymes, 17-octadecynoic acid (17-ODYA) and eicostetraeinoic 
acid (ETYA), also did not affect ACh-evoked rat mesenteric smooth muscle cell 
hyperpolarization (Fukao et al, 1997a; Vanheel & Van de Voorde, 1997). Although this 
latter point could perhaps preclude even a modulatory role for the EETs both 17-ODYA 
and ETYA are non-selective for the CYP isoforms. Therefore their lack of efficacy 
could reflect the dual inhibition of arachidonic acid metabolite-evoked 
hyperpolarization and depolarization responses (the latter mediated by the ©-terminal 
hydroxyeicosatetraenoic acids (HETEs), arachidonic acid metabolites of the CYP 4A ro­
ily droxylase enzymes) (Fleming, 2004; McGuire et al, 2001). Indeed, Wang et a l 
(2001) recently detailed a contribution of 20-HETE to constrictor responses within 
hypertensive rat mesenteric resistance arteries, whilst Earley et a l (2003) described the 
upregulation of CYP 2C, an elevation in endothelial cell 11, 12-EETs and attenuated 
smooth muscle reactivity in rat small mesenteric arteries following chronic hypoxia.
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Figure 1.14 EET synthesis and mechanism of action
Cartoon illustrating the mechanisms associated with endothelial cell EET synthesis and 
the EET-evoked smooth muscle cell hyperpolarization. EC, endothelial cell; SMC, 
smooth muscle cell. + and -  represent stimulation and inhibition. P represent 
phosphorylation.
Endogenous cannabinoids
The identification of the novel chemical mediator 7V-arachidonyl ethanolamide 
(anandamide), also a metabolite of arachidonic acid and an endogenous cannabinoid, 
prompted Randall et al. (1996) to investigate its potential as an EDHF in the rat 
mesenteric arterial bed. The authors demonstrated a severe attenuation of the 
anandamide response in the presence of raised K+ and a partial blockade following 
removal of the endothelium. This combined with the observation of an arachidonic acid 
metabolite from the perfusate following carbachol stimulation led the authors to 
speculate that an endothelium-derived cannabinoid could act as an EDHF in this 
vascular bed (Randall et al., 1996). Subsequent studies in the rat isolated small 
mesenteric artery demonstrated that although anandamide could evoke a substantial 
high K+-sensitive repolarization and dilatation response, the sensitivity of the dilatation 
response to K+ channel antagonists was not consistent with a role for the cannabinoid as 
an EDHF (Plane et al., 1997; White & Hiley, 1997a). Later reports subsequently 
demonstrated that anandamide-evoked vasodilatation of the mesenteric bed was 
associated with activation of sensory perivascular nerve TRPV1 receptors and the 
stimulation of CGRP production (Harris et al., 2002; Ho & Hiley, 2003a; White et al., 
2001; Zygmunt et al., 1999) and to a lesser extent the direct endothelium-independent
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stimulation of a smooth muscle (Randall et al, 1996; White & Hiley, 1997a) abnormal- 
cannabidol (abn-cbd) receptor, distinct from the classical CB1 and CB2 receptors 
(Harris et al, 2002; Ho & Hiley, 2003a). Although the cannabinoid derivatives are not 
candidates for EDHF more recent studies have demonstrated that in addition to actions 
involving stimulation of sensory nerves and direct smooth muscle relaxation, 
compounds such as virodhamine, N-arachidonyl dopamine and oleamide can evoke an 
endothelium-dependent vasodilatation response by their actions on the abn-cbd receptor 
and other as yet unidentified receptors. Furthermore the vasodilatation responses are 
dependent on the activation of IKca and SKca channels, characteristic of an EDHF-type 
response (Ho & Hiley, 2003b; Ho & Hiley, 2004; Hoi & Hiley, 2006; O'Sullivan et al, 
2004).
CNP
CNP is a member of the natriuretic peptide family and is stored as a pro-hormone prior 
to conversion to the active peptide by a mechanism not yet fully clarified, although the 
production of CNP has been demonstrated downstream of a range of inflammatory 
mediators (Ahluwalia & Hobbs, 2005; Stingo et al, 1992). CNP would appear an ideal 
candidate for EDHF as it is present in high concentrations within the endothelium 
(Stingo et al, 1992), the receptors for CNP (natriuretic peptide receptor (NPR)-B and 
NPR-C) are highly expressed in vascular smooth muscle (Chen & Burnett, 1998) and 
crucially, CNP is able to stimulate vasodilatation by hyperpolarization of the vascular 
smooth muscle (Honing et al, 2001). Indeed, recent experiments performed in rat 
mesenteric arteries imply that CNP is a candidate for EDHF (Chauhan et a l, 2003b). 
Ahluwalia and Hobbs (Ahluwalia et al, 2005; Chauhan et al, 2003b) demonstrated that 
CNP could be released from the endothelium in response to ACh and that both 
endogenous EDHF and CNP-evoked dilatation responses could evoke endothelium- 
independent vasodilatation and hyperpolarization responses that were sensitive to 
pertussis toxin and the NPR C receptor antagonist M372049. Both ACh- and CNP- 
evoked hyperpolarization responses were also identical in their amplitude and 
sensitivity to barium and ouabain and indeed the dilatation response to both ACh and 
CNP were both attenuated by the combination of barium and ouabain or by raising 
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Figure 1.15 CNP mechanism of action
Cartoon illustrating the mechanisms associated with endothelial cell CNP-evoked 
smooth muscle cell hyperpolarization. EC, endothelial cell; SMC, smooth muscle cell. + 
and -  represent stimulation and inhibition. P represent phosphorylation.
Based on the inhibitory effects of tertiapin, a G protein-gated inwardly rectifying K+ 
(GIRK) channel inhibitor, it was proposed that the NPR-C receptor on the smooth 
muscle was coupled to activation of smooth muscle GIRK channels, thereby facilitating 
K+ efflux and smooth muscle hyperpolarization upon CNP binding (Figure 1.15; 
Chauhan et al., 2003). Although a role for MEGJ coupling was proposed based on the 
inhibitory effects of the gap junction uncoupler 18a-glycyrrhetinic acid (please see 
sections 1.3.3 and 4.1), the non-selective nature of this class of compounds mean such 
an interpretation requires further investigation (Chaytor et al., 2000; Matchkov et al., 
2004b; Sandow & Tare, 2007; Tare et a l, 2002). Indeed, although the capability of 
CNP to act as an endothelium-derived hyperpolarizing and relaxing factor has been 
demonstrated, the inhibition of CNP release following blockade of IKca and SKca 
channels has not been reported precluding the identification of EDHF as CNP (Garland 
& Plane, 1996; Sandow & Tare, 2007).
H20 2
A role for H2O2 in the regulation of vascular tone has been recognised for over 20 years 
(Rubanyi & Vanhoutte, 1986). However, the concept of H2O2 as an EDHF was only 
advanced when Matoba et al (2000) documented ACh evoked H2O2 synthesis in the 
endothelium of mice small mesenteric arteries and the attenuation of ACh-evoked
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vasodilatation and smooth muscle hyperpolarization with catalase. H2O2 may be 
synthesized from superoxide anion (O2’), which is produced by a number of enzymes 
including eNOS, CYP, and COX (Ellis & Triggle, 2003; Feletou & Vanhoutte, 2004; 
McGuire et al., 2001; Shimokawa & Matoba, 2004). Most reports suggest that the 
vascular smooth muscle hyperpolarization to H2O2 occurs via activation of smooth 
muscle K ca channels although K Atp and K v channels may also be modulated by H2O2 
(Barlow & White, 1998; Gao et a l , 2003; Matoba et al., 2000; Shimokawa & Matoba,
2004) and additional mechanisms associated with the activation of endothelial cell Kca 
have been proposed (Bychkov et a l , 1999).
Within rat mesenteric arteries ATP- and flow-evoked dilatation responses have been 
associated with a catalase-sensitive dilatation and hyperpolarization response that was 
sensitive to raised K+ (Liu et a l , 2006a). However, a number of studies, albeit some 
using far higher concentrations of H2O2, document a limited hyperpolarization response 
to H2O2 (Chaytor et al, 2003; Ellis et al, 2003) and a range of indirect and in some 
cases toxic side effects of the metabolite (Ellis & Triggle, 2003; Iesaki et al, 1996; 
Mian & Martin, 1997) lending caution to the appreciation of this report (for a detailed 
an balanced review please see Ellis & Triggle (2003)). Furthermore, although the 
possibility of a physiological mechanism of dilatation cannot be ruled out the 
observation by Liu et a l (2006a) that the flow-evoked dilatation responses were 
insensitive to a combination of charybdotoxin and apamin means that by the definitions 
documented previously (please see section 1.3.2.9) H2O2 cannot be defined as an 
EDHF.
NO
As described, EDHF vasodilatation responses are classically characterized as non-NO 
and non-prostacyclin, endothelium dependent dilatation and smooth muscle 
hyperpolarization responses. However, in some vascular beds, including the superior 
mesenteric artery, treatment with L-NAME or nitro-L-arginine (L-NNA) is not 
sufficient to block endothelial cell NO release, the residual NO arising from NO stores 
resistant to blockade of eNOS (Chauhan et al, 2003a; Cohen et al, 1997; Kemp & 
Cocks, 1997; Stankevicius et al, 2006). As NO is able to evoke hyperpolarization of the 
smooth muscle (please see section 1.3.2.5) it is possible that responses deemed
59
dependent on an EDHF distinct from NO or prostacyclin may in fact be the result of 
NO-evoked hyperpolarization. Within the rat small mesenteric artery the importance of 
residual NO to the ACh response is somewhat unclear. Some reports have shown that 
ACh-evoked hyperpolarization and dilatation responses are unchanged in the presence 
of oxyhaemoglobin whilst NO-evoked hyperpolarization and dilatation is blocked 
(Garland & McPherson, 1992; Hwa et a l , 1994). However, more recently the combined 
use of L-NAME and oxyhaemoglobin was shown to attenuate the EDHF-type 
hyperpolarization and dilatation response in this preparation (Chauhan et a l , 2003a). 
The differences between the studies are unclear. The concentrations of oxyhaemoglobin 
used by Chauhan et al (2003a) although greater than Garland & MacPherson (1992) are 
the same as those used by Hwa et a l (1994). However, Chauhan et al (2003a) do 
describe a second application of oxyhaemoglobin prior to ACh that is not detailed in the 
earlier experiments (Garland & McPherson, 1992; Hwa et a l , 1994). Whether in the 
absence of this second application of oxyhaemoglobin eNOS activity would be 
sufficient to overwhelm the concentrations of oxyhaemoglobin in the bath solution 
would require further study. Crucially, however, the blockade of agonist-evoked NO 
release by inhibitors of IKca and SKca is still required to demonstrate a role for NO as 
an EDHF in this preparation.
In contrast within conduit arteries there is a general agreement over a role for stored NO 
as an EDHF (Stankevicius et a l , 2006). Indeed in a recent report using the superior 
mesenteric artery ACh evoked the endothelial cell release of NO that was sensitive to 
charybdotoxin and apamin or raised K+ (Stankevicius et a l , 2006). Furthermore, 
complete removal of NO by combined inhibition of eNOS and the use of a NO 
scavenger completely abolished ACh-evoked vasodilatation. In the rat small mesenteric 
artery an EDHF-type response was still evoked under these conditions (Chauhan et al, 
2003a) indicating that additional EDHF mechanisms, are present within this preparation 
that either wholly account for the EDHF response (Garland & McPherson, 1992; Hwa 
et al, 1994) or with NO contribute to the EDHF response (Chauhan et al, 2003a).
1.3.3. Direct cell-to-cell transfer of hyperpolarization through gap junctions
Gap junctions are aqueous channels that exist within dynamic plaques in the plasma 
membrane (Gaietta et al, 2002; Lauf et al, 2002). By allowing the transfer of small
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molecules (clOOODa) and current across the lipid bilayer they enable cell-to-cell 
communication and the coordination of multicellular responses within tissues (Evans & 
Martin, 2002; Unger et al, 1999). Within a range of isolated cell preparations the 
extracellular release of signalling molecules such as ATP from connexons or 
hemichannels has also been documented and is proposed to contribute to the 
coordination of responses between adjacent cells (Evans et al, 2006; Goodenough & 
Paul, 2003).
13.3.1. Gap junction structure
Functional gap junctions can exist singularly or in plaques formed from the union of 
pentilaminar aggregates of connexons originating from adjacent cells (Bukauskas et al, 
2000; Christ et al, 1996; Figueroa et al, 2006). In order to make the close contact 
required for union of the connexons, MEGJ are commonly located on endothelial cell 
projections that pass through the basal lamina to the underlying smooth muscle 
membrane (Figure 4.7; Mather et al, 2005; Sandow & Hill, 2000). Gap junctions are 
formed by the docking of two hemichannels or connexons, one from each of the 
adjacent cells (Figure 1.16; Christ et al, 1996). The nature of the connexon docking 
(Figure 1.16) reflects a 30° rotation and interdigitation of the six connexins that 
constitute the hexameric hemichannel structure (Harris, 2001).
Approximately twenty connexin subtypes have been identified in the human and mouse 
genomes, differing mainly in the length of their carboxy (C)-terminal domain (Herve,
2005). Of those identified, four have been reported to exist in the vasculature, connexins 
37, 40, 43 and 45 (Figueroa et al, 2006), of which at least connexins 37, 40 and 43 are 
present in rat mesenteric arteries (Gustafsson et al, 2003; Kansui et al, 2004; 
Matchkov et al, 2006; Sandow et al, 2006). The distribution of the connexins between 
the endothelium and smooth muscle varies between species and tissue preparations.
Within the rat mesenteric artery connexins 37 and 40 are consistently found within the 
endothelium (Gustafsson et al, 2003; Kansui et al, 2004; Matchkov et al, 2006; 
Sandow et al, 2006). However, the presence of connexin 43 is much more variable 
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Figure 1.16 Structure of the gap junction and inhibitor binding sites
The cartoon illustrates the structure of a gap junction (4), the formation of a gap 
junction from its constituent connexins (1 to 4) and the connexin structure. The 
connexins contain four transmembrane segments with the N-terminus, intracellular loop 
(IL) and C-terminus located intracellularly. Gap peptides homologous to the two 
extracellular loops (EL) have been designed as selective inhibitors of the gap junctions. 
Within this thesis antibodies directed against the intracellular C-terminus were also used 
to modulate gap junctional communication. 1) The connexon or hemichannel comprises 
six connexins. 2) Connexons are inserted into the membrane before gap junction 
formation occurs between two adjacent cells. Gap junctions are formed by the docking 
of two connexons facilitated by 3) a 30° rotation of the hemichannels and 4) an 
interdigitation of the connexin subunits. Cartoon modified from Harris (2001) and Saez 
et al (2003).
(Gustafsson et al., 2003; Hong & Hill, 1998; Kansui et a l , 2004; Matchkov et a l,
2006). Smooth muscle cell connexin expression is much more scarce and even absent in 
some cases (Gustafsson et al., 2003) although where reported, low levels of connexins 
37 and 43 have been documented within the medial layers of the rat mesenteric artery 
(Kansui et al., 2004; Matchkov et al., 2006).
1.3.3.2. Evidence for the direct cell-to-cell transfer of hyperpolarization via MEGJ
The direct, radial electrotonic transfer of hyperpolarization from the endothelium to the 
smooth muscle via MEGJ was one of the first mechanisms suggested for the 
hyperpolarization-driven dilatation response (Chaytor et al., 1998; Garland &
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McPherson, 1992; Segal & Duling, 1986b). Reports documenting a correlation between 
smooth muscle and endothelial cell membrane potential have since been detailed 
supporting such a proposal (Coleman et al, 2001; Emerson & Segal, 2000a; Haddock et 
al, 2006; Sandow et al, 2002; Takano et al, 2004; Yamamoto et al, 1998). Perhaps 
key are the observations of Emerson & Segal (2000a) who using intact hamster feed 
arterioles simultaneously measured endothelial cell and smooth muscle cell membrane 
potentials in response to a range of stimuli including current injection and application of 
ACh, demonstrating synchronous changes in membrane potential thoughout the 
experiment. Crucially, the incidence of MEGJ (demonstrated morphologically using 
electron microscopy) has also been shown to correlate with the extent to which 
endothelium-derived hyperpolarization contributes to the dilatation response, providing 
further evidence for a direct cell-to-cell pathway for the transfer of hyperpolarization 
(please also see section 1.3.2.7). In the femoral artery, where endothelial cell-derived 
hyperpolarization of the smooth muscle is absent no MEGJs were reported (Sandow et 
al, 2002). In contrast in the rat mesenteric artery, where endothelial cell 
hyperpolarization was efficiently transferred to the smooth muscle (endothelial cell 
hyperpolarization response, 22mV; smooth muscle cell hyperpolarization response, 
18mV) approximately 7 MEGJ were documented per 5 pm endothelial cell length 
(Sandow et al, 2002). Similarly, in the juvenile rat saphenous artery where MEGJ are 
prevalent (11 MEGJs per 5pm endothelial cell length), a robust endothelium-derived 
smooth muscle hyperpolarization response could be measured (~14mV) that was 
severely attenuated in adult arteries (~5mV) where the incidence of MEGJ was reduced 
(1 MEGJ per 5pm endothelial cell length) (Sandow et al, 2004).
In addition to the accumulating physiological evidence for the importance of the MEGJ 
communication in the endothelium-dependent dilatation response in a range of vascular 
preparations, a number of reports have also documented the attenuation of endothelium- 
dependent smooth muscle cell hyperpolarization and dilatation following treatment with 
the gap junction uncouplers the gap peptides (please see Figure 1.16) (Chaytor et al, 
2005; Chaytor et al, 1998; Chaytor et al, 2001; Dora et al, 1999; Edwards et al, 1999; 
Griffith et al, 2002; Matchkov et al, 2006; Sandow et al, 2002) and the less specific 
glycyrrhetinic acid derivatives (please see section 4.1) (Dora et al, 2003a; Edwards et 
al, 1999; Goto et al, 2002; Hill et al, 2000; Taylor et al, 1998; Yamamoto et al,
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1998). Indeed the dye coupling that is often apparent in electrically-coupled cells (Dora 
et al., 2003a; Emerson & Segal, 2000a; Sandow et al., 2002; Takano et a l , 2004; 
Yamamoto et al., 2001) is attenuated following treatment with the gap peptides (Dora et 
al., 1999; Martin et al, 2005) consistent with the increased input resistance observed in 
electrically-coupled smooth muscle cell preparations following treatment with the gap 
peptides (Matchkov et al, 2006). Thus it would seem that a role for MEGJ in the 
transfer of hyperpolarization from the endothelium to the smooth muscle is key in a 
range of vascular preparations including the rat mesenteric artery (please also see 
chapter 4).
1.4. Research aims
The experiments documented within this diesis were designed to investigate radial 
(endothelium to smooth muscle) and longitudinal (inter-endothelial cell or inter-smooth 
muscle cell) cell-to-cell communication pathways that contribute to vasodilatation 
within resistance arteries (Figure 1.1.7). Accordingly, this thesis had the following 
aims:
1. To evaluate how arterial structure can potentially facilitate the radial and
longitudinal cell-to-cell conduction of hyperpolarization using 
immunohistochemical and cell labelling techniques.
2. To establish the contribution of gap junctions to both the radial EDHF-type
dilatation and the longitudinal conduction of the dilatation response by 
evaluating the effects of gap junction uncouplers on ACh- and LVK-evoked 
dilatation responses.
3. To evaluate the individual contribution of the SKca and IKca channels to the
EDHF-type response evoked by the physiological agonists ATP and UTP 
(Dubyak & el-Moatassim, 1993; Malmsjo et al, 1999; Ralevic & Bumstock, 
1998) and subsequently to investigate how these dilatation responses may be 
modulated by desensitization mechanisms involving PKC (Chen & Lin, 
1999; Hardy et al, 2005).
4. To evaluate the ability of the nucleotides to evoke a spreading dilatation
response in resistance-sized arteries, particularly comparing conducted 











Figure 1.17 Arterial radial and longitudinal cell-to-cell communication 
pathways
Cartoon illustrating the longitudinal and radial directions o f cell-to-cell 





2.1. Rat mesenteric artery isolation and cannulation
Rat mesenteric arteries were used in all studies described within this thesis. Tissue 
isolation was performed as follows: Male Wistar rats (200-250g) were killed by cervical 
dislocation and exsanguinations according to requirements detailed under Schedule 1 of 
the Animals (Scientific Procedure) Act 1986 (UK) and monitored by the Home Office 
(UK). The mesentery was removed and placed in ice-cold 3-[N- 
morpholino]propanesulfonic acid (MOPS) buffer (for composition see section 2.7.2). 
Third-order branches of the superior mesenteric artery were isolated and dissected free 
of adherent tissue to give a final length of approximately 2 mm (>2 mm where possible 
for conducted response experiments) with a mean diameter 349.6 ± 2.6pm (n=196; 
248.8 -  469.0pm) with no visible side branches.
2.2. Pressure myography
Pressure myography (Figure 2.1) was used throughout this thesis for both functional 
and imaging studies. Initially performed by cannulation of one end of a rabbit cerebral 
or mesenteric resistance artery (50 - 250pm) (Uchida et al, 1967), but later developed 
into a method whereby both ends of an arteriole (12-112pm) were cannulated (Duling et 
al, 1981) the method allows evaluation of the responses of isolated, small resistance 
arteries by measurement of diameter under near-physiological conditions without 
disruption of the vessel wall (Shaw et al, 2004). Furthermore the technique allows the 
luminal solution to be changed independently of the surrounding bath solution, which 
can (depending on the capacity of the solute to cross the IEL) result in minimal 
treatment of the smooth muscle layer.
Isolated rat mesenteric arteries (section 2.1) were cannulated at each end with small 
pipettes (2 0 0 pm), which were either fixed into a static pressure myograph bath (1 0 ml) 
(120CP; Danish Myo Technology, Denmark; Figure 2.1) or mounted onto stands and 
positioned independently of the microscope into a custom-made perspex bath (0.5 - 
lml) using micromanipulators (Figure 2.2 and Figure 2.3a). The custom-made bath was 
seated in a heated stage insert (PH-5, Warner Instruments, CT, USA; Figure 2.3a). 
Arteries in both set-ups were then pressurized to 50mmHg and allowed to equilibrate 
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Figure 2.1 The 120CP pressure myograph set-up.
The figure shows a diagrammatic representation of an artery mounted onto 
two cannulation pipettes within a small organ bath chamber filled with 
MOPS-buffered salt solution fitted within the 120CP pressure myograph 
(Danish Myotechonology, Denmark). Each pipette is connected to gravity- 
fed tubing filled with MOPS-buffered salt solution from a reservoir so that 
changing the height o f the reservoirs changes the pressure applied to the 
artery. Luminal flow may be instigated if the two reservoirs are at different 
heights or if  tubing attached to a small peristaltic or syringe pump is attached 
to one cannulation pipette.
68
larrow organ
icromanipulator for left-han< 
side cannulating pit
leated super 
inlet tube leading 
Erom
Condenser of inverted microscof
Micromanipulator for right-hand side cannulating pipette
>S buffer-filled 





iravltyTeb, wiuHS buffer-fil 
tubing attached to 
canau&Btipn pipetteirwulati i 
111 Heated stage insert
Thermistor
rmpus inverted
Figure 2.2 The set-up used for spreading response experiments.
The figure shows a photograph illustrating the experimental set-up used for spreading response experiments. As with the 120CP pressure set­
up arteries are mounted onto two pipettes and luminally-perfused with gravity-fed MOPS-buffered salt solution from reservoirs raised to exert 
50mmHg pressure on the artery. Luminal flow is achieved as previously stated (Figure 2.1).
longitudinally straightened and stretched a further 1 0 % of the artery length to optimise 
responses to PE (Coats & Hillier, 1999). The pressure was then decreased to 50mmHg 
and maintained at that level for the duration of experiments unless otherwise stated. 
Endothelium viability was assessed as a >90% control relaxation to ACh (lpM) 
following pre-constriction with PE (l-3pM).
2.3. Focal stimulation of pressurized arteries
Focal stimulation is frequently used to observe conducted vasomotor responses within 
isolated arteries (Dietrich et a l , 1996; Dora et a l , 2003b; Emerson et a l , 2002; 
Emerson & Segal, 2001; Emerson & Segal, 2000b; Rivers et al, 2001; Takano et al, 
2004; Walker & Segal, 1998; Xia & Duling, 1995; Yashiro & Duling, 2003). Within 
this thesis, conducted vasomotor responses were studied in isolated rat mesenteric 
arteries mounted on pipettes held in a custom-made narrow bath as described (Sections 
2.1 and 2.2; Figure 2.2 and Figure 2.3a). This set-up was used to optimise uni­
directional flow and preclude direct stimulation of cells upstream from the local site as 
has been demonstrated previously (Takano et al, 2004). Flow direction was monitored 
by inclusion of small beads (5pm diameter microspheres; Molecular Probes Invitrogen, 
Paisley, UK) in the superfusate solution. Agonists were applied using a bevelled 
borosilicate glass micropipette (5pm tip; World Precision Instruments, Stevenage, UK) 
positioned at least 2 0 0 pm from the downstream end of the artery using a 
micromanipulator (Scientifica, Uckfield, UK). A pneumatic pico pump (lOpsi, PV 820, 
World Precision Instruments, Stevenage, UK) was used to eject the agonist from the 
pipette. Superfusion was maintained at ~2 ml min1 throughout spreading response 
experiments. Maximum diameter was assessed at the end of each experiment using 
papaverine (150pm).
2.4. The pinocytic loading method for selective endothelial cell 
loading of cell impermeant molecules
A novel method for introducing molecules into endothelial cells within intact arteries 
has recently been reported (Mather et al, 2005; Vequaud & Thorin, 2001). This 
technique is based on a pinocytic loading method originally developed for cell culture 













Figure 2.3 The downstream position of the stimulating micropipette in 
spreading response experiments.
A, B, The micropipette is positioned downstream o f the superfusate flow 
such that only the downstream end of the artery is stimulated by the short 
bolus doses o f agonist which are released from the stimulating micropipette 
by pressure ejection. B, Any response seen upstream is a spreading response 
and occurs indpendently o f direct agonist stimulation.
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mechanisms whereby cells may internalize macromolecules by fluid-phase endocytosis 
(pinocytosis; Conner & Schmid, 2003). In contrast to receptor-mediated endocytosis 
(phagocytosis), which only a small number of specialized cell types such as 
macrophages and neutrophils carry out extensively, some form of pinocytosis is 
available to most cell types including endothelial cells (Conner & Schmid, 2003). The 
method of Okada & Rechsteiner (1982) is based on the observation that it was possible 
to increase vesicle formation and pinocytosis in L929 cells by increasing the osmolarity 
and tonicity of the medium surrounding the cells. This observation is consistent with the 
hypothesis that endothelial cell uptake of macromolecules may be governed by the 
relative tonicity, osmotic pressure and concentration gradients that may act on both 
sides of the endothelium (Simionescu & Simionescu, 1984). Importantly Okada & 
Rechsteiner (1982) observed that if a substrate (for example, horseradish peroxidase) 
was included in the medium, that substrate would be taken up into the vesicles. The 
vesicles could then be ruptured and the substrate released uniformly into the cell 
cytoplasm by lowering the osmolarity and tonicity of the culture medium (Figure 2.4).
Using a commercially available pinocytic reagent, Vequad & Thorin (2001) described 
selective internalization of FITC-labelled IgG into the endothelium of intact pressurized 
arteries. Incorporation of antibodies directed against the G-protein coupled-receptor 
otq/n-subunits into the endothelium using this technique was shown to inhibit 
vasodilatation responses to the muscarinic (M) receptor agonist ACh (thought to be 
acting on the M3 subtype) whilst leaving responses to oxymetazoline, (thought to be 
acting via the a 2-adrenoceptor) unaffected (Vequaud & Thorin, 2001).
Experiments conducted within this laboratory found the commercial reagent to 
irreversibly block functional responses in isolated arteries (Mather et a l, 2005). 
Therefore an adaptation of the approach developed by Okada & Rechsteiner (1982) was 
employed (Figure 2.4; Mather et al., 2005). In brief, luminal pressure of isolated, 
pressurized arteries was reduced to ~4mmHg. A microperistaltic pump (LKB, Bromma; 
~100pl min'1) was used to luminally perfuse hypertonic solution (100pl; 
800milliosmolar (mosM); please see section 2.7.3 for solution compositions), with 
which the arteries were incubated for lOmin. Arteries were then flushed with hypotonic 
solution (200pl; 180mosM; -lOOpl min'1) which remained in the arteries for a further
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Step 1 The luminal pressure of an isolated, pressurized artery is 
decreased to ~4mmHg.
Arterial wall Endothelial cell lining the 
lumen of an artery.
Artery lumen containing isotonic MOPS buffer
Step 2 Hypertonic solution containing the substrate to be loaded into the 
endothelium is perfused into the artery lumen and incubated (10min).
In an effort to balance the
 tonic and osmotic
difference between the 
-— inside (300mosM) and 
outside (800mosM) of the 
cell water moves out of 
the cell whilst vesicles 
form within the endothelial 
cell. These vesicles 
contain the hypertonic 
solution and substrate to 
be loaded.
Artery lumen containing hypertonic solution with 
substrate
Step 3 Hypotonic solution is perfused into the artery lumen and incubated
(2min). u «  —  Due to the change in
osmotic pressure
(180mosM) and tonicity 
outside of the cell water 
moves into the cell 
causing the vesicles to 
burst releasing substrate 
into the cytoplasm.
Artery lumen containing hypotonic solution
Step 4 The artery is perfused with luminal isotonic MOPS solution and then 
luminal pressure increased to 50mmHg
The substrate has been 
loaded into the cytosolic 
compartment of the
endothelial cell in the 
lumen of the artery.
Artery lumen containing isotonic MOPS buffer 
Figure 2.4 The pinocytic loading protocol.
Cartoon illustrating the steps taken to selectively load cell-impermeant 
macromolecules into arterial endothelium using the pinocytic loading 
protocol.
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2min before luminally perfusing isotonic MOPS (250pl; 300mosM; ~100pl min'1). At 
this stage, superfusion of the artery with isotonic MOPS was also carried out. After 2 - 
5min, arteries were re-equilibrated to 50mmHg and functional or visual studies 
performed.
2.5. Artery diameter measurement and recording
2.5.1. Diameter measurement for single site analysis
Arteries were visualized using an inverted microscope (1X70, Olympus, Japan) with 
either, a 4x/0.13 numerical aperture (NA; UplanFl, Olympus, Japan) or a 10x/0.30NA 
objective (UplanFl, Olympus, Japan). Artery diameter was recorded using a variety of 
methods depending on equipment availability and the restraints of other aspects of the 
experiment. Typically, when measuring changes in artery diameter at a single site (for 
example when agents were added to the bath) a CCD video camera (Nikon, Japan) was 
attached to the inverted microscope and images stored to videotape. Diamtrak software 
(T. O. Neild, Flinders University, Adelaide, Australia) was used to measure outer 
diameter online at 2Hz. This set-up was also used to record concentration-response 
curves to ACh during spreading response protocols unless otherwise stated (please see 
section 2.5.2). When diameter measurement studies were carried out in conjunction 
with fluorescence imaging techniques brightfield images were captured with a laser 
scanning confocal microscope (FV500-SU, Olympus, Japan; 10x/0.30NA objective) 
connected to an inverted microscope and recorded at 1Hz (Tiempo software; Olympus 
Japan). Recordings were then stored to disc and outer diameter measurement performed 
offline using motion analysis software (Metamorph, Universal Imaging, USA).
2.5.2. Diameter measurement for conducted vasodilatation responses
Segments of arteries (where possible >2mm in length) were visualized using an inverted 
microscope (1X70, Olympus, Japan) with a 4x/0.13 NA objective (UplanFl, Olympus, 
Japan) to enable the visualization of >2mm of artery length, and therefore the 
simultaneous measurement of diameter at multiple sites on the artery (giving a 
resolution of 5pm being equivalent to one pixel). In these experiments the frequency of 
diameter measurement was increased to 12Hz to enable rates of spread of dilatation to 
be analyzed. Arteries were visualized using either a CCD video camera (Nikon, Japan) 
with which images were displayed online using Diamtrak software (T. O. Neild,
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Flinders University, Adelaide Australia) and stored to videotape or an Andor Ixon 
digital camera (Gilden Photonics, Coventry, UK) with which images were displayed 
online and stored to disk using photometric software (Andor iQ1.3, Gilden Photonics, 
Coventry, UK). Videotaped images were digitized using iMovie software for the Mac 
OS X (Apple Computer, Inc USA) prior to offline diameter measurement. Motion 
analysis software (Metamorph, Universal Imaging USA) was used to simultaneously 
measure artery outer diameter at multiple sites at calibrated distances from the site of 
focal stimulation (Figure 2.5).
2.6. Solutions, drugs and cell markers
2.6.1. Solutions
2.6.1.1. MOPS physiological buffer and isotonic high K+ solution
All experiments were carried out in a MOPS buffer of composition (mM): NaCl 145.0, 
KC1 4.7, CaCl2.2H20  2.0, MgS04.7H20  1.17, MOPS 2.0, NaH2P0 4.H20  1.20, glucose 
5.0, pyruvate 2.0, EDTA 0.02 NaOH 2.75 adjusted to pH 7.40±0.02 . Isotonic high K+ 
(150mM) solution comprised (mM): KC1 150.0, CaCl2.2H20  2.0, MgS04 .7H20  1.17, 
MOPS 2.0, NaH2P04 .H20  1.20, glucose 5.0, pyruvate 2.0, EDTA 0.02 NaOH 2.75 
adjusted to pH 7.40 ± 0.02.
2.6.1.2. Solutions for pinocytic loading
Hypertonic solution for loading a lOp.1 volume of cell impermeant macromolecule 
comprised polyethylene glycol (PEG) 1000 (10% w',1) and sucrose (0.49M) in MOPS. 
Hypotonic solution comprised a dilution of MOPS (60%vv'1) in MilliQ water.
2.6.2. Drugs
All drugs were purchased from Sigma Chemical Company (Poole, UK) with the 
exception of apamin (Latoxan, France), BIS I, PEG 1000 (Calbiochem) Cx43Gap 26 
(sequence VCYDKSFPISHVR), Cx37’Cx43Gap 27 (sequence SRPTEKTTFII) and 
Cx40Gap27 (sequence SRPTEKNVFTV) (Severn Biotech Ltd., UK), FITC-conjugated 
dextran (3000Da) (Molecular Probes Invitrogen, Paisley, UK), levcromakalim (a 
generous gift from GlaxoSmithKline) and TRAM-34 which was a generous gift from 
Dr. H. Wulff (University of California, Irvine, CA USA). All drug concentrations are 
expressed as final organ bath concentrations. Stock solutions were prepared in MilliQ
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Figure 2.5 The motion analysis software used for diameter measurement.
The figure shows an annotated frame of the motion analysis software program Metamorph (Universal Imaging, USA) used for 
simultaneous diameter measurement of multiple sites at calibrated distances (500pm, illustrated by the length o f the large coloured 
rectangles) from the focal point o f stimulation, as used when analysing spreading response experiments. The objects (small rectangular 
coloured boxes) placed at 500pm intervals follow the external dark edges of the artery wall relative to the light of the bath solution to trace 
changes in artery diameter. These values are given as different pixel values, which are later calibrated and plotted as outer diamter values 
using Excel (Microsoft, USA) software. For the analysis of bath-applied agonist concentration-response curves a single site towards the 
centre o f the artery would be chosen with objects placed on each external edge o f the artery.
water (lOmM) with the exception of ADPpS (50mM), ATPyS, adenosine (lOOmM), 
BIS 1 (lOOpM) and TRAM-34 (IOOjiM in dimethylsulfoxide (DMSO)). All drugs were 
diluted in physiological buffer prior to use in experiments. The gap peptides were 
prepared daily directly into MOPS buffer from the anhydrous peptide to give a 
concentration of 300|iM. The triple gap peptide solution pH was adjusted from a mean 
of 6.50±0.07 to 7.41 ±0.00. The gap peptide solutions were used to directly replace the 
organ bath and luminal solutions. All inhibitors were incubated in the bath and lumen of 
arteries for a minimum of 20min prior to obtaining responses except for 2'deoxy-V6- 
methyladenosine 3' 5' diphosphate diammonium salt (MRS2179; 5min), apamin (lh) 
and the gap peptides (bath solutions changed every 40min for 2h).
2.7. Data analysis
Results are summarized as means ± s.e.means of n arteries where n = 1 is equivalent to 
one animal. Statistical comparisons of parametric data were made using one-way 
ANOVA followed by Bonferroni's post-test and paired t-tests as indicated. Statistical 
comparisons of non-parametric data were made using the Kruskal-Wallis test followed 
by Dunn's multiple comparison post-test. In all cases P<0.05 was considered significant. 
The relaxation evoked by each agonist was calculated as the % maximum dilatation of 
PE-contracted arteries: 100% being the maximum diameter seen for each experiment. 
Similarly, the constriction evoked by each agonist was calculated as the % maximum 
constriction: 1 0 0 % being the minimum diameter seen for each experiment (evoked with 
IOjjM PE). Values for artery diameter were obtained from traces plotted for each 
experiment using Excel software (Microsoft, USA) following calibrations appropriate 
for the camera, objectives and imaging software used. Concentration-response curves 
and histograms were prepared using Prism version4.0 software (GraphPad Software, 
USA). Sigmoidal concentration-response curves were fitted where possible and were 
drawn using the variable plot function in Prism (equation 2.1). Agonist potency was 
expressed as the negative logarithm to base 1 0  of the EC50 value provided for each 
curve by the Prism software (PD2).
y =  Bottom+(T op-B ottom)_____
(l+10A((LogEC50-x)*Hill slope)) (equation 2.1)
Where; x = the logarithm of concentration, y = the response
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Molecular, electrophysiological and functional assays may all be used to clarify the 
presence and function of ion channels, receptors or signalling molecules within a cell or 
tissue. However, often it is difficult to fully appreciate the interactions between lipid 
and protein moieties without being able to visualize their positions relative to each other 
and to the structural components of the cell and tissue. Advances in fluorescent 
labelling technologies and the development of laser scanning confocal and two-photon 
microscopes have enabled accurate, quantitative visualization of both dynamic 
processes and structural localization within live cells and tissues such that in recent 
years the use of fluorescent markers has accelerated substantially (Lichtman & 
Conchello, 2005).
Within studies of vascular function in rat mesenteric arteries, fluorescent imaging has 
been widely used for the study of Ca2+ signalling within the arterial wall (Lagaud et al., 
1999; Lamont & Wier, 2004; Matchkov et a l , 2004b; Mauban & Wier, 2004; McSherry 
et al., 2005; Nilsson et al, 1994; Nilsson et al, 1998; Oishi et al, 2001; Shaw et al, 
2004; Shaw et al, 2006; Takano et al, 2004; VanBavel et al, 2001; Zang et al, 2001; 
Zhang et al, 2002) and for the study of immunohistochemical and fluorescent 
localization of various receptors and proteins key to arterial function. Indeed, 
fluorescence immunohistochemistry is now a well-established method of cellular 
protein detection and localization.
The most common fixation methods used for detection of arterial proteins require either 
whole animal perfusion prior to tissue isolation or incubation of isolated arteries with 
fixative prior to membrane permeabilization and antibody incubation (Briones et al, 
2003; Gardener et al, 2004; Gonzalez et al, 2005; Grayson et al, 2004; Gustafsson et 
al, 2003; Hill et al., 2006; Mather et al, 2005; Sandow et al, 2006; Weston et al, 
2005; Weston et al, 2002). The whole animal perfusion method is advantageous as it 
allows an approximation of protein localization under physiological conditions in vivo. 
However, as many studies are carried out in vitro fixation by this method may not 
accurately capture protein expression under conditions of tissue isolation. Functional 
differences reported in studies of spreading dilatation responses support such a proposal 
(Budel et al., 2003).
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Figure 3.1
Commonly used arterial cross-sections for immunohistochemical studies
Cartoon illustrating A, vertical and B, horizontal cross-sections through the arterial wall 
made possible by A, serial sectioning, B, longitudinal dissection or A,B, by using a 
confocal microscope.
Studies using mesenteric arteries isolated prior to fixation have been frequently reported 
(Gardener et a l, 2004; Gustafsson et a l, 2003; Hill et al., 2006; Weston et a l, 2005; 
Weston et al., 2002). However for the tissue to be visualized arteries were either 
embedded or frozen whilst pinned out then sectioned or further cut longitudinally such 
that the tissue may be laid flat on a coverslip. Both methods are technically difficult 
(Sandow et al., 2006). However the first allows the experimenter to obtain excellent 
vertical cross-sectional images of the whole artery (Figure 3.1a), enabling simultaneous 
estimation of protein localization in each of the layers of the artery wall, albeit with 
limited quantitative knowledge (Gardener et al., 2004; Gustafsson et al., 2003; Hill et 
al., 2006; Weston et al., 2005; Weston et al., 2002). In contrast, the method of 
longitudinal dissection enables visualization of the vascular wall on one focal plane 
(Figure 3.1b). If a number of sequential sections are studies using confocal fluorescence 
microscopy it is possible to render and re-construct the images enabling an estimation of 
protein distribution throughout the wall of the artery (Grayson et al., 2004; Mather et 
al., 2005; Murphy et al., 2001).
Within this thesis a modified immunohistochemical method for localization of proteins 
in isolated, pressurized arteries that is based upon the protocol of Murphy and 
colleagues (2001) was used. Whilst investigating the effects of intravascular pressure on 
tyrosine phosphorylation within the smooth muscle layer of isolated rat cremaster 
arterioles the investigators fixed arteries when pressurized and maximally dilated.
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Subsequently the arteries were permeabilized and treated with antibodies using 
conventional protocols applied to the mounted and pressurized artery. Upon completion 
of the procedure the artery was dismounted and placed on a coverslip for visualization. 
By subsequently measuring differences in fluorescence intensity they were able to 
demonstrate quantitative differences in protein phosphorylation following fixation at 
different levels of transmural pressure, or following incubation with pervanadate, 
tyrphostin A47, angiotensin n, Ca2+-free solution, verapamil and forskolin (Murphy et 
a l , 2001).
Using a further modification of this technique we visualized arteries whilst still 
mounted to enable minimal disruption of tissue integrity. We subsequently carried out 
preliminary studies of von Willebrand factor and a-smooth muscle actin staining before 
evaluating the localization of three ion channels fundamental to the mechanism of 
EDHF in rat mesenteric arteries: Connexin 40, SKca and IKca (Chen & Cheung, 1997; 
Crane et a l , 2003a; Doughty et a l , 1999; Hinton & Langton, 2003; Mather et a l , 2005; 
Walker et a l , 2001). Using well-established cell membrane and vesicular dyes 
preliminary experiments were also performed to evaluate other methods that may be 
used, either alone or in conjunction with immunohistochemical methods, to evaluate 
arterial structure and function.
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3.2. Methods
3.2.1. Rat mesenteric artery isolation and cannulation
Please see section 2.1 for methods of artery isolation.
3.2.2. Pressure myography
Arteries were mounted in both custom-built organ baths (0.5 -  1ml; Figure 2.2) and a 
commercially available pressure myograph (10ml; 120CP, Danish Myo Technology, 
Denmark; Figure 2.1) for visualization of arterial structure. For cannulation and 
equilibration methods please see section 2.2. Endothelial cell viability was assessed as a 
>90% control dilatation to ACh (lpM) following pre-constriction with PE (1 - 3jiM). 
Arteries were maintained at 50mmHg and 37°C unless otherwise stated.
3.2.3. Visualization of endothelial and smooth musde cell layers using di-8- 
ANEPPS
Endothelial cells were loaded by luminal perfusion (2min; lOOpl min*1) and then 
incubation (38min) with the membrane potential sensitive dye di-8-ANEPPS (lpM) 
following a decrease in luminal pressure to ~7mmHg. Smooth muscle cell loading was 
achieved by addition of di-8-ANEPPS (lpM; 19min) to the bath solution. Prior to 
imaging arteries were washed with MOPS-buffered salt solution and the intraluminal 
pressure increased to 50mmHg.
3.2.4. Quinacrine and Alexa Fluor® 633 staining of rat mesenteric arteries
Quinacrine (lpM; 2h) or wheat germ agglutinin conjugated to Alexa Fluor® 633 
(lOOpg ml*1; 50min) was incubated abluminally. Arteries were washed with MOPS- 
buffered salt solution prior to imaging.
3.2.5. Pinocytic loading of fluorescent molecules to visualize artery layers
The pinocytic loading method described in section 2.4 was used to load the 
endothelium, IEL and perivascular nerves with carboxyfluorescein (~lmg ml*1) or the 
cell impermeant dye lucifer yellow (saturated solution). Fluorescent dyes were 
dissolved into the hypertonic sucrose solution and filtered (0.22pm syringe filter unit) 
prior to the addition of PEG.
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3.2.6. Immunohistochemistry
Pressurized (50mmHg) arteries were incubated with papaverine (150pM) to maintain 
artery diameter during fixation. Arteries were then fixed in a 2%wv_1 paraformaldehyde 
solution (lOmin; 37°C; please see section 3.2.8 for solution compositions). The pressure 
was then reduced (~7mmHg) and arteries washed and luminally-perfused (90pl min1; 
lmin) with phosphate-buffered saline (PBS) three times over 5min intervals. This was 
followed by luminal and abluminal incubation with blocking buffer (lh; 37°C; 
~7mmHg; section 2.7.4) containing propidium iodide (0.05%wv'1) as indicated. Arteries 
were then incubated overnight (4°C; ~4mmHg) with primary antibody (please see 
section 3.2.9) diluted (1:100) in blocking buffer applied both abluminally and 
luminally. Tissues were then allowed to warm to room temperature (30min) before 
washing with PBS as described. Secondary detection was performed with either Alexa 
Fluor®633 or Alexa Fluor®488 goat anti-rabbit IgG (H+L; Highly cross-adsorbed) in a 
modified blocking buffer (1:100) for 2h abluminally and lh luminally (90pl min'1; 
2min) at room temperature. Subsequently arteries were washed as described, 
pressurized to 50mmHg and visualized. For higher resolution images, arteries were 
removed from the cannulae and placed on a coverslip in an anti fade-buffered glycerol.
3.2.7. Confocal microscopy
Images were taken using an inverted microscope (1X71, Olympus UK) attached to a 
laser scanning confocal microscope (FV500-SU, Olympus UK) and processed using 
photometric software (Tiempo software, Olympus UK). The argon-ion laser with a 
primary excitation peak at 488nm was used for excitation of Di-8-ANEPPS, quinacrine, 
carboxyfluorescein, lucifer yellow, Alexa Fluor®488-conjugated secondary antibodies 
and IEL autofluorescence. Green and red helium-neon lasers with respective primary 
excitation peaks at 543nm and 633nm were used for excitation of propidium iodide and 
Alexa Fluor®633-conjugated proteins respectively. To enable comparison of protein 
expression, settings for the red helium-neon laser for visualization of IKca and SKca 
were maintained throughout both sets of experiments (laser intensity, 50%; confocal 
aperture, 130pm; photomultiplier tube 635-647V).
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3.2.8. Dyes and solutions
A lOmM stock solution of Di-8-ANEPPS was prepared by dissolving the anhydrous 
solid in DMSO to give a lOmM stock solution. A lOmM stock solution of quinacrine 
was prepared daily in MilliQ water. Alexa Fluor® 633 conjugated wheat germ 
agglutinin was prepared daily by dissolving into MOPS-buffered salt solution (please 
see section 2.6.1.1 for composition) to give a final stock concentration of lmg ml"1. 
Propidium iodide was prepared as a l%wv_1 stock solution in MilliQ water. Di-8- 
ANEPPS stock (lOmM) was diluted in a solution comprising 0.25%vv'1 pluronic acid 
dissolved in MOPS buffered solution immediately before loading and incubation. All 
other dyes were dissolved directly into the luminal or bath solutions unless otherwise 
stated.
Fixative for immunohistochemistry contained 2%wv_1 paraformaldehyde in phosphate- 
buffered saline (PBS) of composition (mM): NaCl 119.8, Na2HP0 4 .2 H2 0  7.0 and 
NaH2P0 4 .H2 0  2.6, containing NaOH (3mM) adjusted to pH 7.38±0.03. Blocking buffer 
was of composition: bovine serum albumin (BSA; l%wv_1) and Tween 20 (O.l'&vv'1) in 
PBS. Secondary antibody buffer comprised BSA (l%wv_1) and Tween 20 (O.Ol'&vv'1) 
in PBS. Anti fade-buffered glycerol comprised a 5%wv_1 solution of p- 
phenylenediamine made up with NaHCC>3 (500mM) in MilliQ water that had been 
adjusted to pH 8.6 with Na2CC>3 (500mM). Glycerol was then added to the final solution 
(66.6% vv'1).
All chemicals and dyes were purchased from Sigma (Poole, UK) with the exception of 
Di-8-ANEPPS and Alexa Fluor®633 conjugated wheat germ agglutinin (Molecular 
Probes Invitrogen, Paisley, UK).
3.2.9. Antibodies
Anti-von Willebrand factor antibody was raised in rabbits against human von 
Willebrand factor (SIGMA, Poole, UK). Anti-smooth muscle a-actin antibody was 
raised against the N-terminal synthetic decapeptide of a-smooth muscle actin in mouse 
clone 1 A4 (SIGMA, Poole, UK). Antibodies targeted against the Kca channels were 
raised in rabbits against either the N-terminus of human Kca2.3 (SKca3; 
DTSGHFHDSGVGDLDEDPKC) (Alomone, Jerusalem, Israel) or the C-terminus of
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Kca3.1 (IKCa4; RQVRLKHRKLEQV(C)) (Alomone, Jerusalem, Israel). The connexin 
40 antibody was raised in rabbits and targeted against a 19 amino acid peptide sequence 
within the C-terminal cytoplasmic domain of mouse connexin 40 (Chemicon, CA, 
USA). This peptide sequence is conserved in rat connexin 40. The secondary Alexa 
Fluor®633 and Alexa Fluor®488 goat anti-rabbit IgG (H+L; Highly cross-adsorbed) 
antibodies were purchased from Molecular Probes (Invitrogen, Paisley, UK). Each of 
the antibodies have been previously characterised either in HEK 293, Rin or Cos-7 cell 
culture systems or, epithelial, neuronal and endothelial cells within gastrointestinal tract 
and arterial tissues (Fujita et al, 2001; Gustafsson et al, 2003; Sandow et al, 2003b; 
Sandow et al, 2006; Taylor et al., 2003).
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3.3. Results
3.3.1. Identification of smooth muscle and endothelial cell layers of a rat 
mesenteric artery with propidium iodide and di-8-ANEPPS
By permeabilizing pressurized rat isolated small mesenteric arteries (n = 12) with 
blocking buffer (lh) containing the cell membrane impermeant nuclear stain propidium 
iodide (0.05%wv'1) it was possible to clearly stain both endothelial cell (horizontally 
aligned cells; Figure 3.2A) and smooth muscle cell nuclei (vertically aligned cells; 
Figure 3.2A). This highlighted the perpendicular orientation of the two cell types 
enabling differentiation between the two layers of the artery wall. The alignment of cell 
type seen in Figure 3.2A is used throughout this thesis. Luminal and abluminal 
incubation of isolated, pressurized rat mesenteric arteries with the membrane potential 
sensitive dye di-8-ANEPPS (lpM) resulted in clear endothelial cell (Figure 3.2B; 
38min) and smooth muscle cell (Figure 3.2C; 19min) membrane staining.
3.3.2. Quinacrine and Alexa Fluor® 633 staining of the endothelium, smooth 
muscle and adventitia of isolated arteries
Using the dye quinacrine, which has been reported to show high affinity for ATP 
(Bodin & Bumstock, 2001; Irvin & Irvin, 1954; Mitchell et al., 1998) the localization of 
ATP within each layer of the artery wall was investigated (n = 2). Abluminal incubation 
of rat isolated and pressurized small mesenteric arteries with quinacrine resulted in cell 
nuclei staining within all layers of the vascular wall (Figures 3.3A, B and C) and 
granular staining within the smooth muscle cells (Figure 3.3B) and perivascular nerves 
(Figure 3.3C). To further investigate arterial wall organelle structures we evaluated the 
effect of abluminal incubation of a rat isolated small mesenteric artery (n = 1) with the 
Alexa Fluor® 633-conjugated wheat germ agglutinin (Yang & Loscalzo, 2005). Figure 
3.3D illustrates the extensive linear and fibrous staining of the external layers of the 
artery with the fluorescent wheat germ agglutinin. Due to damage caused to the artery 
by imaging (results not shown) this methodology was not further explored.
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A. Propidium iodide nuclear staining
B. Di-8-ANEPPS staining of the endothelium
C.
Figure 3.2 Staining of isolated, pressurized rat mesenteric arteries 
with fluorescent dyes to identify cell layers
A, B, C, Single plane images of the A, B, endothelium (horizontally 
aligned cells), and A, C, smooth muscle (vertcally alighned cells) of 
isolated rat small mesenteric arteries following A, permeabilization with 
blocking buffer and incubation with the nuclear stain propidium iodide 
(0.05%wv1) o , B luminal and C, abluminal incubation with the potential 
sensitive membrane dye Di-8-ANEPPS (lpM). All images were captured 
at 50mmHg with a 40x water immersion objective. The smooth muscle 
cell and endothelial cell alignment illustrated in A is used throughout this 
thesis. Bar = 50pm
Di-8-ANEPPS staining of the smooth muscle
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A . Quinacrine staining for ATP vesicles in the endothelium
B. Quinacrine staining for ATP vesicles in the smooth muscle
C. Quinacrine staining for ATP vesicles in the adventitia
n n
D. Wheat germ agglutinin-conjugated Alexa Fluor® 633 staining of 
the adventitia
Figure 3.3. Quinacrine and Alexa Fluor® 633 staining of isolated, 
pressurized rat small mesenteric arteries
Single plane images of isolated pressurized rat mesenteric arteries 
following abluminal staining with A, B, C, quinacrine (lpM; green) and 
D, wheat germ agglutinin conjugated to Alexa Fluor® 633 (lOOpg ml"1). 
These techniques allow visualization of A, the endothelium, B, the 
smooth muscle and C, D, the adventitia of the arteries. B, C, Arrows 
indicate possible sites of ATP vesicles. All images were captured with a 
x40 water immersion objective. Bar = 50pm.
3.3.3. Pinocytic loading of fluorescent molecules into rat isolated mesenteric 
arteries to identify cell layers
In experiments carried out to evaluate the efficacy of the pinocytic loading protocol 
(Figure 2.4) as a method of selectively loading macromolecules into different layers of 
the arterial wall the fluorescent dyes carboxyfluorescein (~lmg ml; n -  3) and lucifer 
yellow (saturated solution; n -  3) were included in the hypertonic solution. The extent 
and location of fluorescence emitted from the artery was subsequently observed. 
Following inclusion of carboxyfluorescein into the luminally-applied hypertonic 
solution extensive endothelial cell loading could be observed with only a few smooth 
muscle cells seen to contain carboxyfluorescein (Figure 3.4A). In contrast when lucifer 
yellow was added to the luminally-applied hypertonic solution only the edges of the 
endothelial cells could be clearly seen, but lucifer yellow did also appear to bind 
uniformly to the IEL (Figure 3.4B). Inclusion of carboxyfluorescein in abluminally- 
applied hypertonic solution resulted in staining of the perivascular nerves with some 
smooth muscle cell staining also apparent (Figure 3.4C).
3.3.4. Immunohistochemical localization of endothelial and smooth muscle cell 
markers in isolated pressurized arteries.
Rat isolated pressurized mesenteric arteries that have been fixed and stained for von 
Willebrand factor and smooth muscle a-actin using the protocol of Murphy and 
colleagues (2001) were visualized whilst still cannulated and pressurized. Von 
Willebrand factor was observed as small punctate spots throughout the cytosol of 
endothelial cells (Figure 3.5A; n = 1). Punctate smooth muscle a-actin staining was 
observed in both the cytosol and on the edge of the outer layer of smooth muscle cells 
(Figure 3.5B; n = 1).
3.3.5. Distribution of endothelial connexin 40, SKca and IKca
Having established the efficacy of the methods of Murphy and colleagues the 
distributions of connexin 40 (n -  2), SKca (n = 1) and IKca in = 1) within the 
endothelium were determined. Using the nuclear stain propidium iodide as both a 
marker of cell permeability and alignment (Figures 3.6A and C) punctate staining of 
connexin 40 was localized to the periphery of the endothelial cells, highlighting the 
borders between adjacent endothelial cells (Figure 3.6B and D).
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A . Endothelial cell loading with carboxyfluorescein
B .  Lucifer yellow staining of the IEL
C. Nerve cell loading with carboxyfluorescein
Figure 3.4 Pinocytic loading of fluorescent molecules into isolated rat 
mesenteric arteries to identify cell layers
A, B, Merged and C, single plane images of the A, endothelium B, IEL 
and C, perivascular nerve cells of isolated rat small mesenteric arteries 
following A, B, luminal and C, abluminal application of the pinocytic 
loading protocol with A, C, carboxyfluorescein (~lmg ml) and B, lucifer 
yellow (saturated solution) included in the hypertonic solution. All 
images were captured at 50mmHg with a 20x water immersion objective. 
Bar = 100pm
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A . Von Willebrand factor localization in the endothelium
B. Smooth muscle a -actin localization
Figure 3.S Immumohistochemical localization of endothelial and 
smooth muscle cell markers in isolated pressurized arteries
A, Single plane image and B, montaged stack images of A, the 
endothelium and B, smooth muscle layers following cell 
permeabilization with blocking buffer and subsequent staining with A, 
anti-von Willebrand factor antibody (1:100) with an Alexa fluor® 488 
secondary antibody (1:100). and B, smooth muscle a-actin primary 
antibody (1:100) with an Alexa fluor® 488 goat anti-mouse secondary 
antibody (1:100). The images were taken at 50mmHg using a 40x water- 
immersion objective. Arrows indicate endothelial cells. Bar = 50pm.
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A. Propidium iodide nuclear staining
B .  Connexin 40 localization
C. Connexin 40 localization and propidium iodide nuclear staining
D. IEL autofluorecence E. Connexin 40 F. IEL & connexin 40
Figure 3.6 Immunohistochemical localization of endothelial cell 
connexin 40
A, B, D, E, Single plane and C, F merged images of the endothelial cell 
layer of isolated pressurized arteries following cell permeabilization with 
blocking buffer A, B, C, containing propidium iodide (0.05%wv1), and 
subsequently stained with B, C, E and F, anti-connexin 40 (1:100), A, B, 
C, with an Alexa fluor® 488 goat anti-mouse secondary antibody (1:100), 
or D, E, F, with an Alexa fluor® 633 goat anti-mouse secondary antibody 
(1:100). D, F, The IEL is made visible by autofluorescence. All images 
were taken at 50mmHg using a 40x water-immersion objective. Arrows 
indicate examples of sites where holes in the IEL align with punctate Cx40 
antibody staining. A, B, C, Bar = 50^1, D, E, F, bar = 10pm.
A . IEL autofluorescence
N
/
B. Connexin 40 localization
\
/
C . Connexin 40 localization and IEL autofluorescence
Figure 3.7 Increased resolution images of endothelial cell connexin 40
Arteries were dismounted, placed on a coverslip and visualized using a 60x 
oil-immersion objective to increase the available resolution. A, B, Single 
plane and C, merged images of the endothelium and IEL of an isolated 
pressurized artery following cell permeabilization with blocking buffer and 
subsequent staining with B, C anti-connexin 40 (1:100) with an Alexa 
fluor® 633 goat anti-mouse secondary antibody (1:100). A, C, The IEL is 
made visible by autofluorescence. Arrows indicate examples of sites where 
holes in the IEL align with punctate Cx40 antibody staining. Bar = 50pm.
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In separate experiments this punctate staining was also shown to correlate with holes in 
the IEL, as viewed by autofluorescence at ~488nm (Figures 3.6, D, E and F). Higher 
resolution images obtained by removal of the artery from the cannulae, subsequent 
longitudinal dissection and then observation with a x60 oil immersion objective 
illustrated the frequency with which the holes in the IEL correlated with the punctate 
staining of connexin 40 (Figure 3.7). Punctate staining for SKca was also found at the 
endothelial cell borders. Furthermore, SKca localization also correlated with holes in the 
IEL. However, in contrast to connexin 40, SKca could also be localized toward the 
centre of the cell (Figure 3.8). Punctate staining of IKca was restricted to holes in the 
IEL, with no endothelial cell border staining observed (Figure 3.9).
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A . IEL autofluorescence
B. SK^, localization
, localization and IEL autofluorescence
Figure 3.8 Immunohistochemical localization of endothelial cell SK ^
A, B, Single plane and C, merged images of the endothelium and IEL of an 
isolated pressurized artery following cell permeabilization with blocking 
buffer and subsequent staining with B, C, anti-SKCa (SK3; 1:100) with an 
Alexa fluor® 633 goat anti-mouse secondary antibody (1:100). A, C, The 
IEL is made visible by autofluorescence. All images were taken at 
50mmHg using a 40x water-immersion objective. Arrows indicate 
examples of sites where holes in the IEL align with punctate SKCa antibody 
staining. Bar = 50pm.
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A . IEL autofluorescence
B. IKCa localization
C . IK ^  localization and IEL autofluorescence
Figure 3.9 Immunohistochemical localization of endothelial cell IKCa
A, B, Single plane and C, merged images of the endothelium and IEL of an 
isolated pressurized artery following cell permeabilization with blocking 
buffer and subsequent staining with B, C, anti-IK^ (1:100) with an Alexa 
fluor® 633 goat anti-mouse secondary antibody (1:100). A, C, The IEL is 
made visible by autofluorescence. All images were taken at 50mmHg 
using a 40x water-immersion objective. Arrows indicate examples of sites 




Recent advances in imaging technology and the improved quality of fluorescent probes 
has led to a rapid increase in the number of reports utilising fluorescence-based imaging 
to evaluate tissue structure and function (Lichtman & Conchello, 2005). Of perhaps the 
greatest importance to whole tissue physiology experiments is the improved capacity to 
visualize deep into tissues using either confocal microscopy, or more recently two- 
photon microscopy (Lichtman & Conchello, 2005; Yuste, 2005). Given the large 
number of in vitro studies on vasomotor function we felt that it was important to 
evaluate different methods of arterial structure determination and subsequently protein 
localization in vitro. Within the present study a range of fluorescent dyes and loading 
methods were applied to rat isolated and pressurized small mesenteric arteries. The 
results were then visualized using confocal microscopy to determine the efficacy of 
each dye as a marker of arterial structure in vitro. Subsequently, immunohistochemical 
staining of pressurized small mesenteric artery preparations was performed to 
investigate the in vitro localization of ion channels fundamental to the mechanism of 
EDHF and to evaluate the efficacy of this method of protein detection.
3.4.1. Arterial staining with di-8-ANEPPS
The photometric dye di-8 -ANEPPS has been used in studies of vascular function to 
enable the measurement of membrane potential without impalement of the cell (Beach 
et al., 1998; Beach et al, 1996; Chen & Rivers, 2001; Cohen & Jackson, 2005; Dora & 
Duling, 1998; Marrelli et al., 2003; McGahren et al., 1998). When in aqueous solution 
di-8 -ANEPPS does not fluoresce. Fluorescence is activated following binding to 
phospholipids whereupon the absorption and emission peaks are at 467nm and 631nm 
respectively (Invitrogen, 2006). Given the membrane-bound nature of di-8 -ANEPPS we 
investigated its use as a cell marker for delineation of the different cell types comprising 
the artery wall. In support of previous studies luminal application of di-8 -ANEPPS 
selectively loaded the endothelium to produce extensive staining of endothelial cell 
plasma membranes (Dora & Duling, 1998). Endothelial cell morphology could be 
determined and was consistent with previous reports showing elongated cells (~1 0 0 jim) 
aligned with the longitudinal axis of the artery (Dora & Duling, 1998; Sandow et al., 
2002; Takano et al., 2004). Subsequent abluminal application of the photometric dye 
resulted in similar extensive membrane staining of the outer layer of smooth muscle
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cells that consistently with previous reports demonstrated their circumferential 
arrangement (Dora & Duling, 1998; Sandow et al, 2002; Takano et al., 2004). From the 
presented data it is estimated that ~ 1 2  smooth muscle cells may be spanned by one 
endothelial cell. Although further work is needed to confirm this, such a finding 
supports previous reports proposing an endothelial cell pathway for conduction of 
spreading dilatation responses in rat mesenteric arteries and hamster cheek pouch 
arterioles (please see sections 1.5.2 and 3.4.7; Haas & Duling, 1997; Takano et al, 
2004).
3.4.2. ATP localization with quinacrine
ATP may be released from various components of the arterial wall (Bodin et al, 1991; 
Bumstock, 2006; Bumstock, 1999; Pearson, 1979; Yamamoto et al, 2003) and can 
evoke EDHF-type dilatation responses in rat isolated small mesenteric arteries (Liu et 
al, 2006a; Malmsjo et al, 1999; Mistry et al, 2003). Therefore we investigated the 
localization of ATP within the adventitia, smooth muscle and endothelium of the 
isolated rat mesenteric artery using the high affinity ATP dye quinacrine (Bodin & 
Bumstock, 2001; Irvin & Irvin, 1954; Mitchell et al, 1998).
Consistent with previous reports describing quinacrine staining in various cells in 
culture, granular staining patterns were observed in both the perivascular cells and 
smooth muscle cells of isolated arteries (Bodin & Bumstock, 2001; Mitchell et al, 
1998; Romanello et al, 2005; Yegutkin et al, 2006). In contrast to previous studies 
granular staining of the endothelium was not observed (Bodin & Bumstock, 2001). This 
may reflect the release of ATP by mechanical stress on the endothelium during tissue 
isolation and preparation (Bodin & Bumstock, 2001; Pearson, 1979). Quinacrine did 
however stain the nuclei of endothelial cell, smooth muscle cell and perivascular nerve 
cell types, reflecting the intercalation of quinacrine with nuclear DNA (Aslanoglu & 
Ayne, 2004; Baldini et al, 1981; Stuhlmeier, 2000). The absence of nuclear staining in 
the reports studying cells in culture (Bodin & Bumstock, 2001; Mitchell et al, 1998; 
Romanello et al, 2005; Yegutkin et al, 2006) may reflect their position in the cell cycle 
(Duivenvoorden et al, 1995; Moser et al, 1981) or the frequency of guanosine-cytosine 
base pairs in the nucleic acid strands (Baldini et al, 1981). More simply, differences in 
the concentrations of quinacrine used or the methodological approaches may explain the
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conflicting observations. Given the preliminary nature of these findings (n = 2) it would 
be interesting to repeat the studies reported here and also investigate the results of 
luminal quinacine application following treatment with A-ethylmaleimide, an inhibitor 
of vesicle fusion with the plasma membrane (Bodin & Bumstock, 2001), to ascertain if 
ATP vesicles may be found in the endothelium of the isolated artery preparation.
3.4.3. Alexa Fluor ® 633-conjugated wheat germ agglutinin
In an effort to further evaluate sub cellular structures within in vitro vascular 
preparations Alexa Fluor® 633-conjugated wheat germ agglutinin was used to study the 
localization of the Golgi apparatus (Yang & Loscalzo, 2005). In contrast to the granular 
staining observed by Yang and Loscalzo (Yang & Loscalzo, 2005) in cultured 
endothelial cells, intersecting linear lines of fluorescence were observed that likely 
corresponded to staining of adventitial collagen fibres (Soderstrom, 1987). Damage to 
the artery caused by photo bleaching limited any further use of this compound. 
However, it is possible that by using faster acquisition rates over a smaller region of 
interest luminal application of this fluorescent agent may reveal the sub cellular 
structures previously reported (Stephens & Allan, 2003; Yang & Loscalzo, 2005).
3.4.4. Pinocytic loading of fluorescent dyes
In experiments carried out to evaluate the efficacy and viability of the pinocytic loading 
method (please see section 2.4) extensive endothelial cell staining was observed 
following luminal pinocytic loading of carboxyfluorescein. These results were 
consistent with previous reports from this laboratory (Mather et a l , 2005) and illustrate 
the longitudinal orientation of the endothelial cells. The transient nature of the 
endothelial cell staining with carboxyfluorescein, most likely due to active transport of 
the dye out of the cell (Mather et al, 2005; Rychlik et al, 2003), limits the use of this 
dye as an endothelial cell marker. However, given that similar, maintained staining with 
fluorescent dextran (3000Da) has also been achieved and the viability of the 
endothelium is maintained following the pinocytic loading protocol (please see section 
4.3.6; Mather et al, 2005) the method in combination with other dyes may prove useful 
for endothelial cell visualization in future studies.
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Abluminal pinocytic loading of rat isolated small mesenteric arteries with 
carboxyfluorescein showed clear visualization of the perivascular nerves to reveal 
staining patterns analogous to those previously reported in the same preparation 
following staining for calcitonin gene related peptide (Mupanomunda et a l , 1998) and 
a  and p-adrenoceptors (Briones et a l , 2005). However, as would be expected, the 
relatively selective loading of the endothelium observed following luminal application 
of the pinocytic loading protocol was not replicated following abluminal application. 
This could largely be due to the inconsistent external surface of the vascular wall 
allowing rapid uptake of the dye into the sub-adventitial, smooth muscle layers as has 
previously been described (Mather et a l , 2005).
Given the success of the luminal pinocytic loading method for the transfer of 
carboxyfluorescein and dextran into the endothelium, the effects of inclusion of the cell 
impermeant dye lucifer yellow into the luminally-applied hypertonic solution were 
studied. In contrast to the results seen with carboxyfluorescein and FlTC-labelled 
dextran, loading with lucifer yellow resulted in extensive staining of the IEL. Previous 
studies using microelectrodes to inject lucifer yellow into endothelial cells of intact rat 
isolated mesenteric arteries (Takano et a l , 2004), hamster cheek pouch arterioles (Little 
et al, 1995; Welsh & Segal, 1998), porcine ciliary artery (Beny et al, 1997) and sheets 
of calf aortic endothelial cells (Larson & Sheridan, 1982) showed extensive spread of 
the dye into adjacent cells from the site of injection. Furthermore the nature of the 
staining was very similar to that observed in the present study following pinocytic 
loading of carboxyfluorescein. The staining of the IEL by lucifer yellow reported herein 
could reflect a sensitivity of the pinocytic loading process to molecular charge or 
compound structure as the pinocytic process can be modulated by the molecule carried 
(Conner & Schmid, 2003; Davies et al, 1981; Simionescu & Simionescu, 1984). 
Further research on the processes involved would need to be undertaken to fully 
understand the mechanism of this loading protocol. However, the excellent staining of 
the IEL and the illumination of endothelial cell borders by the pinocytic loading of 
lucifer yellow may prove a useful tool in the localization of proteins and their 
contribution to cell-to-cell communication within the vascular wall (please see sections 
3.4.7 and 3.4.8).
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3.4.5. Identification of endothelial cell and smooth muscle cell markers with 
immunofluorescence
Using a method of immunofluorescence for intact arteries (Murphy et al., 2001) we 
investigated endothelial cell and smooth muscle cell staining with von Willebrand 
factor and smooth muscle a-actin respectively. These preliminary studies showed 
punctate cytosolic staining of the endothelium and smooth muscle with the two cell 
markers as is consistent with previous reports, supporting the use of this 
immunohistochemical method in future studies of arterial protein localization in vitro. 
Only abluminal staining for the smooth muscle layers and luminal staining for the 
endothelium were investigated so further positive and negative controls to confirm 
antibody specificity would be required in addition to those previously reported (Aznar- 
Salatti et al, 1990; Bryan et al, 2006; Del Pup et al, 2002; Reidy et al, 1989; Sandow 
et al, 2006; Simard et al, 2006; Slaninova et al, 1999; Stromer et al, 2002). The 
different staining methods employed for these two antibodies and the lack of staining of 
the other layers of the artery wall highlight the tissue selectivity that may be employed 
by using this method of cannulated artery immunohistochemistry. Furthermore, for 
visualization of endothelial cell protein expression the antibody volume and therefore 
experimental cost may be minimised by use of luminal application only. In contrast if 
antibodies are applied both luminally and abluminally the intact artery may provide its 
own positive or negative controls for analysing antibody specificity.
3.4.6. Propidium iodide as a nuclear stain and marker for cell permeabilization
Propidium iodide is well established as a cell-impermeant nuclear stain that will 
fluoresce when intercalated with DNA or RNA. In addition to its use as a nuclear stain 
it is also used in flow cytometry and studies of vascular function as a test of cell 
viability (Mather et al, 2005; Sasaki et al, 1987). The dependence of this dye on cell 
permeability in order to fluoresce makes it an ideal marker of cell permeability (Hill et 
al., unpublished observations). In the present study propidium iodide was included in 
the blocking buffer solution during the permeabilization stage of the 
immunohistochemistry protocol. This made it possible to evaluate when all layers of the 
artery were sufficiently permeabilized by the number of cells stained. Consistent with 
previous studies using propidium iodide in cultured cells and arterial tissue, propidium 
iodide staining appeared restricted to cell nuclei (Coats et al., 2003; Jones & Kniss,
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1987; Kansui et al., 2004; Mather et al, 2005; Takano et al, 2004). Based on the 
specific orientation of the nuclear staining it was clear that propidium iodide could also 
be used to determine cell type as endothelial cell nuclei could be clearly located along 
the longitudinal axis of the artery whilst smooth muscle cell nuclei were arranged 
circumferentially (Coats & Hillier, 1999; Dora & Duling, 1998).
The shift between the absorbance maximum of propidium iodide at 535nm and its 
emission maximum at 617nm makes it a suitable cell marker and nuclear stain during 
immunofluorescence studies using fluorescein-conjugated antibodies (Jones & Kniss, 
1987; Kansui et al, 2004; Virgintino et al, 2002). Therefore within the present study 
we used propidium iodide as a cell marker in conjunction with endothelial staining for 
connexin 40.
3.4.7. Immunofhiorescent staining of connexin 40
Connexin 40 is a member of the connexin family of gap-junction proteins that has been 
shown to be a central component of both radial and conducted dilatation responses 
(please see section 1.3.3 for review; (de Wit et al, 2000; Figueroa et al, 2003; Mather 
et al, 2005). Connexin 40 together with connexins 37 and 43 comprise the only gap 
junction proteins detected in rat mesenteric arteries to date (Goto et al, 2004; 
Gustafsson et al, 2003; Hong & Hill, 1998; Kansui et al, 2004; Mather et al, 2005). 
The punctate staining of endothelial cell borders by antibodies targeted against connexin 
40 observed in the present study is consistent with previous reports in preparations of 
rat isolated mesenteric arteries (Goto et al, 2004; Kansui et al, 2004; Mather et al, 
2005; Sandow et al, 2006). Gap junction coupling between endothelial cells is thought 
to mediate the spread of hyperpolarization that is fundamental to conducted dilatation 
responses as the longitudinal orientation and low resistance of these cells would provide 
a far quicker conduction pathway than the circumferentially orientated smooth muscle 
cells (please see sections 3.4.1 and 5.1; Haas & Duling, 1997; Yamamoto et al., 2001). 
Indeed, the abolition of ACh and LVK-evoked conducted responses following removal 
of the endothelium in rat isolated mesenteric arteries supports such a theory (Takano et 
al, 2004). The extensive staining for connexin 40 observed at endothelial cell borders 
within this study and others (Goto et al, 2004; Kansui et a l, 2004; Mather et al, 2005;
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Sandow et al., 2006) therefore supports a possible role for connexin 40 in conducted 
dilatation responses in this preparation.
In the present study connexin 40 staining was also imaged following secondary 
detection with antibodies conjugated to Alexa Fluor® 633. Detection of connexin 40 at 
this wavelength allowed for visualization of the IEL as elastin autofluoresces in the 488 
- 515nm range (Briones et al., 2003; Gonzalez et al., 2005).
The results presented herein together with those of previous studies (Haddock et al., 
2006; Sandow et al., 2003a; Sandow et al., 2006; Sandow et al., 2002) support an 
important structural role for the IEL in endothelial and smooth muscle cell-to-cell 
communication. In addition to the endothelial cell border staining of connexin 40 just 
described, staining of this gap junction protein with co-visualization of the IEL revealed 
the co-localization of connexin 40 with holes in the IEL. These results are consistent 
with previous observations that connexin 40 contributes to MEGJ structure within this 
preparation and that holes within the TEL of various preparations may be the sites where 
endothelial cells can project to the smooth muscle to form MEGJ plaques (Mather et al., 
2005; Sandow et al., 2003a; Sandow et al., 2004; Sandow et al., 2006; Sandow et al, 
2002).
3.4.8. Immunohistochemical staining of SKca and IKca
In the present study both IKca and SKca channels that are fundamental to the initiation 
of EDHF in contracted rat isolated small mesenteric arteries (please see chapter 4 for 
review), have also been found to co-localize with holes in the IEL. Staining of 
endothelial cell borders was not observed for IKca, however, consistent with previous 
reports, SKCa was found at these sites (Sandow et al., 2006). The restriction of punctate 
IKca staining to holes in the IEL is consistent with a recently published report (Sandow 
et al, 2006) within which the different spatial localization of the two Kca channels and 
connexins 37 and 40 was related to the functional distinction between the two K+ 










Figure 3.10 Activation of IKCa and SKCa in the absence and presence of PE-evoked 
smooth muscle stimulation
Cartoon illustrating a summary of the current hypothesis for the differential activation 
of IKCa and SKca following ACh stimulation of rat isolated small mesenteric arteries in 
the presence and absence of PE. PE stimulation would stimulate a rise in Ca2+ that may 
be transferred to the EC via gap junctions (green). In the absence of PE stimulation ACh 
would evoke a rise in EC Ca2+ only in areas away from IKca localization. EC, 
endothelial cell; SMC, smooth muscle cell. + represents stimulation.
Crane and co-workers (2003) demonstrated that under basal conditions in the presence 
of L-NAME, application of ACh evoked a hyperpolarization response in isolated rat 
mesenteric arteries that was fully blocked by the SKca channel inhibitor apamin. 
Although the response could be replicated with CPA it could not be achieved with the 
IKca channel opener 1-EBIO. Stimulation with ACh subsequent to pre-contraction and 
depolarization with PE evoked a similar increase in membrane potential with a 
concomitant dilatation response. However, in contrast to the response evoked under 
basal conditions the repolarization evoked by ACh could only be blocked with a 
combination of the IKca channel blocker TRAM-34 and apamin. The authors proposed 
that IKca and SKca contribute to distinct components of the EDHF response dependent 
on the Ca2+ concentration within the signalling domains associated with each Kca 
channel and the characteristics of the hyperpolarization response evoked by each Kca 
channel. Our observation of SKca co-localization with the IEL in addition to that of 
connexin 40 and IKca as previously described (Mather et al., 2005; Sandow et al., 2006) 
supports such a hypothesis.
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Under resting conditions endothelial cell Ca2+ in response to ACh will arise solely from 
endothelial cell Ca2+ stores and endothelial cell influx of Ca2+ and therefore may be 
restricted to sites of Ca2+ influx or Ca2+ store release (McSherry et a l , 2005; Oishi et 
a l , 2001). Therefore, the high frequency of SKca localization around the edge of the 
endothelial cells would increase the likelihood of their activation (Figure 3.10). In 
contrast the predominant localization of IKca to the myoendothelial compartments 
would restrict their activation to times at which the Ca2+ concentration at the projection 
is sufficiently raised. This may occur following stimulation with PE whereupon it has 
been demonstrated in rat mesenteric artery preparations that an increase in smooth 
muscle cell Ca2+ may be transferred to the endothelium (Figure 3.10; Crane et al, 
2003b; Oishi et al, 2001), possibly via direct transfer of Ca2+, or via transfer of IP3 via 
gap junctions (Crane et al, 2003a; Dora et al, 1997; Martin et al, 2005; Schuster et al,
2 0 0 1 ). The additional localization of SKca to this site possibly reflects the dual IKca and 
SKca components of the EDHF response that may be activated under high tone. Indeed 
following PE-evoked contraction it has been demonstrated that EDHF may be released 
from the endothelium in the absence of direct endothelial cell stimulation by 
acetylcholine and independently of any direct effects of PE on the endothelium (Dora et 
al, 2 0 0 0 b).
Importantly it should be noted that both within this report and others (Mather et al, 
2005; Sandow et al, 2003b; Sandow et al, 2006) the incidence of holes in the IEL does 
not correlate with the incidence of MEGJ, or in our case connexin 40 localization. This 
has been proposed to either reflect a dynamic localization of MEGJ (Sandow & Hill, 
2000; Sandow et al, 2003b) or the provision of a pathway with a short diffusion 
distance that is suitable for the conduction of various EDHF candidates including K+ 
(Dora & Garland, 2001; Edwards et al, 1998; Edwards & Weston, 2004; Sandow et al, 
2006).
To summarize, the present preliminary report demonstrates the value of 
immunofluorescence and staining of isolated arteries to visualize arterial structure. As 
would be expected the structure of the arterial wall, by the nature of its function as a 
selective barrier to various molecules within the blood limits the passage of some 
fluorescent stains and antibodies using the techniques described. However, this facet of
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arterial structure may be used to ones advantage to independently stain different 
components of the artery wall. The use of dyes such as di-8 -ANEPPS, propidium iodide 
and lucifer yellow may be combined in future studies using immunofluorescence to 
assist in the localization of cell proteins as described here for propidium iodide. The 
localization of IKca, SKca and connexin 40 seen within this study is consistent with 
previous studies in vivo and supports the hypothesis that myoendothelial projections 
may be the site of a signalling compartment or microdomain that functions to produce 
signals to initiate smooth muscle relaxation in periods of high smooth muscle tone 
(Sandow et al, 2006). Such a signalling domain would be key to artery function and 
thus any disturbances in its structure may be associated with an increased incidence of 
vascular disease or hypertension. Indeed a decrease in connexins 37 and 40, both of 
which may be expressed at the MEGJ, has been observed in hypertensive rats (Goto et 
a l , 2004; Kansui et a l , 2004; Sandow et a l , 2006). Conversely, such changes in 
vascular tone as in cases of hypertension, may also increase the incidence of MEGJ to 
compensate for the decreased efficacy of other vasodilator mechanisms as observed in 
the caudal artery of the rat (Sandow et a l , 2003a). It is therefore proposed that further 
immunohistochemical studies investigating the relative localization of both smooth 
muscle and endothelial cell intracellular Ca2+ stores to the EEL, SKca and IKca channels 
be investigated to elucidate the nature of the differential activation of these channels 
under different levels of smooth muscle stimulation. Furthermore, given the excellent 
staining of the EEL that may be achieved using lucifer yellow, Ca2+ imaging 
experiments employing the use of the Rhod Ca2+ indicators (Molecular Probes 
Invitrogen, Paisley, UK) visible in the 580 to 602nm range may allow elucidation of the 
Ca signalling mechanisms associated with the differential activation of IKca and SKca 
and their association with the IEL.
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Hyperpolarization of endothelial cells following electrical, chemical or physical 
stimulation may be transferred radially (Figure 1.17) to the subjacent smooth muscle 
leading to vasodilatation. The transfer of hyperpolarization is facilitated by an EDHF 
(section 1.3.2.5), which may comprise the release of a diffusible messenger(s) from the 
endothelium and/or the direct passage of hyperpolarization from the endothelium to the 
smooth muscle through MEGJs (please see section 1.3.2.5 and references therein).
EDHF-mediated dilatation of the rat mesenteric artery has been found to comprise 
multiple components depending on the level of PE-evoked tone (Dora & Garland, 2001; 
Richards et a l , 2001). Of the potential candidates for EDHF (section 1.3.2.5) K+ and 
MEGJ transfer of hyperpolarization have been suggested to facilitate vasodilatation to 
ACh but only under conditions of low to moderate PE-evoked tone (Dora & Garland, 
2001; Dora et a l , 2002; Edwards et al, 1998; Edwards et al, 1999; Mather et al, 2005; 
Richards et al, 2001). Under conditions of high PE-evoked tone the K+ component of 
EDHF is inhibited as maximal activation of the smooth muscle Na+/K+ ATPase by K+ 
released from smooth muscle BKca prevents further activation by K+ released from the 
endothelium. As a result an unidentified EDHF component, possibly MEGJ-facilitated 
transfer of hyperpolarization, is thought to predominate (please see section 1.2.4.2; Dora 
& Garland, 2001; Dora et al, 2000b; Dora et al, 2002; Doughty et al, 2000; Mather et 
al, 2005; Richards et al, 2001; Weston et al, 2002).
Evidence for a gap junction-mediated pathway for transfer of hyperpolarization within 
rat mesenteric arteries has been demonstrated both morphologically using electron 
microscopy to show the existence of homocellular and heterocellular gap junctions 
(Gustafsson et al, 2003; Hill et al, 2002; Mather et al, 2005; Sandow & Hill, 2000; 
Sandow et al, 2006; Sandow et al, 2002) and with dye coupling techniques (Takano et 
al, 2004). The study of Takano et al. (2004) demonstrated a clear passage of propidium 
iodide both radially and longitudinally (Figure 1.17) supporting a gap junction-mediated 
pathway for EDHF-type responses and electrotonic conduction of vasodilatation (please 
see chapter 5; Emerson & Segal, 2001; Emerson & Segal, 2000b; Little et al, 1995). 
However, the incidence of dye and current transfer (particularly with lucifer yellow) has 
not always been shown to correlate precluding definitive conclusions as to the nature of
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the cell to cell coupling (Little et a l , 1995; Tare et al, 2002). Crucially, with regards to 
the clarification of a role for gap junctions in the radial EDHF-mediated response, it has 
also not been possible to selectively block MEGJ with pharmacological agents.
Attenuation of EDHF-mediated smooth muscle cell hyperpolarization and relaxation 
within isolated rat mesenteric arteries by the putative gap junction uncouplers, the 
glycyrrhetinic acid derivatives and the gap peptides, has been documented (Edwards et 
al, 1999; Goto et al, 2002; Hill et al, 2000; Sandow et al, 2002). Glycyrrhetinic acid 
derivatives such as carbenoxolone have been shown to increase input resistance and 
reduce Ca2+ synchronization between rat mesenteric artery smooth muscle cells, 
supporting a gap junction uncoupler mode of action (Matchkov et al, 2006; Tare et al,
2002). However this class of compounds, particularly those of the p subtype, have also 
been shown to directly reduce rat mesenteric artery and guinea-pig coronary artery 
endothelial cell hyperpolarization whilst also having additional effects on smooth 
muscle cell Ca2+ and tension. As such their inhibition of EDHF-type responses cannot 
be solely construed as an inhibition of gap junction communication and their reliability 
must be questioned (Chaytor et al, 2000; Matchkov et al, 2006; Tare et al, 2002).
The small synthetic gap peptides are reported to be specific to the first (Gap 26) and 
second (Gap 27) extracellular loop of individual connexin structures, and as such are 
more selective to inhibition of gap junctional communication (Evans & Boitano, 2001; 
Griffith, 2004; Martin et al, 2005; Matchkov et al, 2006; Warner et al, 1995). 
However, the possible heterogeneity of most gap junction channels means they still 
cannot be used to definitively target either myoendothelial or homocellular gap junction 
subtypes. This leads to speculation, particularly in larger calibre arteries, as to whether 
the gap peptides have blocked the direct transfer of hyperpolarization from the 
endothelium to the smooth muscle via MEGJ (i.e. EDHF) or whether they have blocked 
the relay of hyperpolarization throughout the smooth muscle or endothelial cell layers 
(Chaytor et al, 2005; Chaytor et al, 1997; Edwards et al, 2000; Yamazaki & 
Kitamura, 2003). Furthermore, although without non-junctional effects (Matchkov et 
al, 2006), the exact molecular mechanism of action of the gap peptides is unclear. It 
does appear to be independent of the formation of de novo gap junctions and plaques, 
indeed mechanisms associated with the modulation of channel gating have been
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proposed (Berman et al., 2002; Griffith, 2004; Martin et a l, 2005). However, definitive 
molecular and crystallographic data regarding channel modulation by the gap peptides 
is lacking.
The purpose of this study was to therefore assess whether targeting endothelial cell 
connexins with antibodies selective for the known vascular connexins (37, 40, 43; 
(Gustafsson et a l , 2003; Kansui et al, 2004; Matchkov et al, 2006) could block 
EDHF-mediated dilatations under conditions of high PE-evoked tone, thus minimising 
non-specific effects on smooth muscle gap junctions and the involvement of K+. Given 
the importance of gap junction communication to spreading dilatation in other vascular 
beds (de Wit et al, 2006a; de Wit et al, 2000; de Wit et al, 2006b; Figueroa et al,
2003), the results from this study would also act as a preliminary assessment of gap 
junction inhibitors for the study of gap junctions in spreading dilatation responses in rat 
intact mesenteric artery preparations (please see chapter 5).
Initial studies were performed to evaluate the effects of increased PE-evoked tone on 
EDHF-type responses and to confirm that the response in question was an EDHF-type 
response. Subsequently, the efficacy pf the established gap junction uncouplers 
carbenoxolone and the gap peptides as inhibitors of EDHF-type responses in rat isolated 
and pressurized mesenteric arteries were investigated. Finally the pinocytic loading 
technique (please see section 2.4; Figure 2.4) was validated and employed to luminally- 
load anti-connexin antibodies into the endothelium in an effort to inhibit EDHF- 
mediated dilatation responses by selective blockade of endothelial cell connexins.




4.2.1. Rat mesenteric artery isolation and cannulation
Please see section 2.1 for methods of artery isolation.
4.2.2. Pressure myography
Arteries were mounted in both custom-built organ baths (0.5 -  1ml; Figure 2.2) and a 
commercially available pressure myograph (10ml; 120CP, Danish Myo Technology, 
Denmark; Figure 2.1). For cannulation and equilibration methods please see section 2.2. 
Endothelial cell viability was assessed as a >90% control dilatation to ACh (lpM) 
following pre-constriction with PE (1 - 3fiM). Arteries were maintained at 50mmHg 
and 37°C unless otherwise stated.
4.2.3. Cumulative concentration-response curves
Experiments were performed in the presence of L-NAME (IOOjiM, 20min) where 
indicated. Inhibition of cyclooxygenase was not required as indomethacin (10pM) has 
been shown to have no effect on ACh-evoked hyperpolarization and dilatation 
responses within the rat mesenteric artery (please see section 1.3.2.4). Cumulative 
concentration-response curves to ACh (lnM-3pM) were performed following 
submaximal (-70%; low tone) and maximal (-90%; high tone) constriction to PE as 
indicated. Additional concentration-response curves to ACh were performed in the 
presence of high K+ (35mM with supplementary PE to obtain maximal constriction if 
required).
4.2.4. Pinocytic loading of cell impermeant molecules
The efficacy of the pinocytic loading method described in section 2.4 was tested by 
inclusion of carboxyfluorescein (~lmg ml'1) or FITC-conjugated 3000Da dextran 
(~6mg ml'1) in the hypertonic sucrose solution prior to filtration (0.22pm syringe filter 
unit) and addition of PEG. For endothelial cell loading anti-connexin antibodies and 
Alexa Fluor® 633-conjugated IgG were diluted (1:10) with complete hypertonic 
solution to give final luminal concentrations of O.lmg m l1 and 0.2mg ml'1 respectively. 
Endothelial cell viability was subsequently assessed by inclusion of propidium iodide in 
the bath solution (0.01% wv'1).
I l l
4.2.5. Fluorescent confocal microscopy
Propidium iodide, carboxyfluorescein and Alexa Fluor® 633-conjugated IgG were 
visualized as described (please see section 3.2.7). FITC-conjugated 3000Da dextran 
loading was visualized using the confocal settings established for carboxyfluorescein.
4.2.6. Electron microscopy
Arteries were fixed using a solution comprising (mM) betaine 10.0, sucrose 150.0, 
CaCh 0.2 glutaraldehyde (3%wv1), paraformaldehyde (l^owv'1), in sodium cacodylate 
100.0 buffer, adjusted to pH 7.35-7.40. Vessels were subsequently stained and 
embedded for electron microscopy using conventional methods (Sandow et al., 2002). 
From a section cut perpendicular to the longitudinal axis of each preparation, each of 
four 15 pm long regions of endothelium 90° apart were photographed at x20 000 and 
vesicle (50-200nm diameter) counts (excluding surface caveolae) made from prints. Dr. 
Shaun Sandow performed all methods, image construction and analysis.
4.2.7. Drugs and solutions
All drugs and solutions were prepared as detailed previously (please see section 2.6).
4.2.8. Antibodies
Antibodies targeted against connexins 37, 40 and 43 were raised in rabbits against a 19 
amino acid peptide sequence within the C-terminal cytoplasmic domain of rat connexin 
37 (Alpha Diagnostics, TX USA), mouse connexin 40 or mouse connexin 43 
(Chemicon, CA, USA). The antigen peptide sequences for mouse connexins 40 and 43 
are conserved in rats. These antibodies were chosen as they have been well 
characterised in both transfected Rin and HeLa cells and arterial tissue (Gustafsson et 
a l , 2003; Sandow et al., 2003b) whilst the C-terminal cytoplasmic domain has also 
been associated with the regulation of connexin channel gating and may influence gap 
junction assembly and trafficking (Bastide et a l , 1996; Burt & Steele, 2003; Contreras 
et a l , 2003; Lampe & Lau, 2000; Stergiopoulos et a l , 1999).
4.2.9. Data analysis




4.3.1. Dilatation responses to ACh at low and high levels of PE-evoked tone
Concentration-dependent dilatation responses to ACh (InM - 3pM) were evaluated 
following submaximal (0.3-3pM; Figure 4.1A) and maximal (3-10pM; Figure 4.1B) 
levels of PE-evoked constriction. A significant rightward shift of the concentration- 
response curve and a small, but significant decrease in the maximum dilatation response 
to ACh (Figure 4.1C) were observed with increased PE-evoked tone. Extracellular K+ 
(4.7 -  19.8mM; n = 4) was unable to evoke a dilatation response when tested on arteries 
with high levels of PE-evoked tone or low levels of PE-evoked tone in the presence of 
ouabain.
4.3.2. Effect of inhibition of K+ channels on dilatation responses to ACh
Following maximal pre-constriction with PE (1 - 5pM) concentration-dependent 
dilatation responses to ACh (n = 4) were largely unaffected by incubation with the 
selective inhibitor of eNOS, L-NAME (IOOjliM, 20min; n = 6; Table 4.1; Figure 4.2A). 
In contrast, combined selective blockade of IKca and SKca channels with TRAM-34 
(lpM, 20min) and apamin (50nM, lh) resulted in a significant rightward shift in the 
concentration-dependent dilatation response to ACh (n = 4; Table 4.1; Figure 4.2B). 
Subsequent incubation with L-NAME (lOOpM, 20min) in the presence of TRAM-34 
and apamin resulted in a further, significant attenuation of the dilatation responses to 
ACh with all but responses to the highest concentrations of ACh (3pM) abolished (n = 
4; Figures 4.2A and B). Constriction with high K+ (35 -  40mM) in the presence of L- 
NAME completely abolished all dilatation responses to ACh (Figure 4.2B; n = 6).
4.3.3. Effect of gap junction uncouplers on dilatation responses to ACh
The non-selective water-soluble p-glycyrrhetinic acid derivative carbenoxolone 
(lOOpM; 30min) had no significant effect on EDHF-type dilatation responses to ACh in 
arteries maximally contracted with PE (5 -  lOpM; Figure 4.3B; Table 4.2; n = 4 -8 ). 
However, a marked reduction in the maximum dilatation that could be evoked by 3pM 
ACh was observed in five of the eight arteries tested (Figure 4.3A). In paired 
experiments with submaximally contracted arteries (n = 4; 1 - 5pM PE) carbenoxolone 
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Figure 4.1 Dilatation to ACh at high and low levels of PE-evoked tone
A, B, Paired representative traces and C, meaned data (n= 12) illustrating 
concentration-dependent responses of isolated rat small mesenteric arteries 
to ACh following A, C, submaximal (0.3-3pM; low tone) and B, C, 
maximal (6-10pM; high tone) PE-evoked constriction. A, B, The triangles 
indicate addition of PE. * Significantly different to low tone following a 
student’s paired t-test. L-NAME (100pM) present in all experiments.
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Figure 4.2 Effects of inhibition of K+ channels on dilatation responses 
to ACh
A, Representative trace and B, meaned data (n=4-6 unpaired responses) 
illustrating concentration-dependent responses to ACh following K+ channel 
blockade with A, B, a combination treatment of or B, individual treatment 
with TRAM-34 (lpM , 20min) and apamin (50nM, lh) or B, by raising 
extracellular K+ (35-45mM). Broken lines indicate experiments performed 
in the absence of L -NAME (100pM), which was present in all other 
experiments. Filled triangle indicates addition of PE (lpM ). #, Significantly 
different to control, *significantly different to L-NAME, + significantly 
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Figure 4.3 Effects of carbenoxolone treatment on dilatation responses to 
ACh
A, Representative trace (of n=5 of 8 arteries) and B, meaned data (n=3-8) 
illustrating concentration-dependent responses to ACh following treatment 
with carbenoxolone (lOOpM, 30min). All experiments in the presence of L- 
NAME (lOOpM). Filled triangle indicates addition of PE (lOpM). Open 
triangle indicates addition of LVK (3pM). * Significantly different to L- 
NAME following an unpaired t-test (P<0.05).
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4.3.4. Effect of incubation time on ACh-evoked dilatation responses
To serve as a time control ACh-stimulated dilatation responses during maximal 
contraction evoked by PE (5 - 15pM) were investigated over a 120min period in control 
conditions (L-NAME, lOOpM). Dilatation responses to ACh were found to be 
unaffected by incubation time (n = 6; Figure 4.4A; Table 4.3).
4.3.5. Effect of the gap peptides on dilatation responses to ACh
In the presence of L-NAME (lOOpM) the effect of the inhibitory connexin mimetic 
peptide Cx37,Cx43Gap 27 on ACh-mediated dilatation responses following maximal PE- 
evoked constriction (3-10pM) was determined. Incubation with Cx37,Cx43Gap 27 
(300pM, 120min) had no significant effect on concentration-dependent dilatation to 
ACh (Figure 4.4A; Table 4.3; n = 2 - 5) despite one artery showing marked attenuation 
of ACh-evoked responses (Figure 4.4B). The effects of a triple combination of gap 
peptides Cx43Gap 26, Cx37,Cx43Gap 27 and Cx40Gap27 (300pM each giving a total peptide 
concentration of 900jiM, 120min) targeting all known endothelial cell connexins were 
subsequently evaluated. Remarkably, incubation with the triple combination of 
connexin-mimetic peptides had no effect on ACh-evoked dilatation responses (Figure 
4.4C; Table 4.3; n = 3).
4.3.6. Efficacy of the pinocytic loading protocol
The lack of effect with the connexin-specific gap peptides forced us to develop a new 
technique to inhibit, selectively, endothelial cell gap junctions. Therefore we employed 
the ability of antibodies to selectively target and inhibit connexins together with 
selective loading into endothelial cells using the pinocytic loading protocol (please see 
section 2.4; Figure 2.4).
The efficacy of the pinocytic loading protocol as a method of selectively loading 
molecules into the endothelium of intact arteries was established by including 
carboxyfluorescein (lmg ml'1) in the luminally-applied hypertonic solution. The extent 
and location of fluorescence emitted from the artery was subsequently observed. 
Endothelial cell loading predominated with only a few smooth muscle cells seen to 
contain carboxyfluorescein (Figure 4.5A; n = 3). As the small size of 
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Figure 4.4 Effect of the gap peptides on ACh-evoked dilatation 
responses
A, C, Mean concentration-dependent dilatation responses to ACh following 
treatment with A, Cx37Cx43 Gap27 (300pM, 120min; n=5) and C, a triple 
combination of gap peptides Cx43Gap26, Cx40Gap27, and Cx37Cx43Gap27 
(300pM each, total peptide concentration 900pM, 120min; n=3-6) vs 
unpaired time-matched controls (n=6). B, Trace showing the inhibition of 
ACh-evoked dilatation by Cx37Cx43Gap27 (300pM, 120min) in n- 1 artery. 
The filled triangle shows addition of PE (lOpM). The open triangle shows 
addition of LVK (lpM). L-NAME (lOOpM) present in all experiments. 
Please note gap peptides were added to the bath and the lumen of arteries 
for the entire incubation period.
Treatment pD2 ± s.e.mean Rmax ± s.e.mean n
L-NAME, Omin 6.5±0.1 97.2±1.3% 6
L-NAME, 120min 6 .6 ±0 .1 93.9±1.6% 6
L-NAME, Cx37,Cx43Gap 27,120min 6.9±0.2 75.3±15.7 5
L-NAME, Cx43Gap 26, Cx37Cx43Gap 
27 & Cx40Gap27,120min
6 .6 ±0 . 2 93.9±1.6 3
Table 4.3. Effect of the gap peptides on ACh-evoked dilatation responses
The effect of incubation with Cx37Cx43Gap27 (300pM, 120min) and a triple 
combination of gap peptides Cx43Gap26, Cx40Gap27, and Cx37Cx43Gap27 (300pM each, 
total peptide concentration 900pM, 120min) on concentration-dependent responses 
to ACh following maximal PE-evoked constriction (high tone; 3-10pM). Rmax 
corresponds to dilatation to 3pM ACh. No statistically significant differences were 
found using one-way ANOVA. L-NAME (lOOpM) present in all experiments.
Treatment pD2 ± s.e.mean Rmax ± s.e.mean n
L-NAME 6 .8 ±0 . 0 92.0±1.0% 39
L-NAME & Post-Load 6 .8 ±0 .1 96.0±1.2% 9
L-NAME & Anti-Connexin37 
Antibody
6.7±0.1 93.6±1.4% 9
L-NAME & Anti-Connexin40 
Antibody
n/a 36.6±9.5%
*P<0 .0 0 1
14
L-NAME & Anti-Connexin43 
Antibody
6.7±0.1 96.5±1.0% 7
Table 4.4. Effect of the luminal pinocytic loading of connexin antibodies on 
dilatation responses to ACh
The effects of luminal pinocytic loading of vehicle (post-load) anti-connexin 37, 
anti-connexin 40, and anti-connexin 43 antibodies (all 0.1 mg ml'1) on ACh-evoked 
dilatation responses following maximal PE-evoked constriction (high tone; 3- 
lOpM). Rmax corresponds to dilatation to 3pM ACh. L-NAME (lOOpM) present in 
all experiments. Anti-connexin 40 antibody data are also shown in Table 4.5. Some 
data shown matches data obtained from arteries used in the evaluation of the effects 
of luminal pinocytic loading of connexin antibodies on spreading dilatation 
responses to ACh and LVK (section 5.3). n/a; not applicable, an EC50 could not be 
accurately calculated for this data set so the pD2 value is excluded. Parts of these 
data were obtained by Dr. Simon Mather. * Significantly different to L-NAME 
following a one-way ANOVA with a Bonferroni post-test (P<0.05).
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staining observed herein may not accurately reflect the efficacy of the pinocytic loading 
method. Consequently, the larger molecular weight, gap junction impermeant, 
compounds FITC-coupled dextran (3000Da) (~6.0mgml‘l) and Alexa Fluor® 633- 
conjugated IgG were loaded into the endothelium using the same protocol. Both FITC- 
coupled dextran and Alexa Fluor® 633-conjugated IgG were seen to selectively and 
extensively load into the endothelium (Figures 4.5B and C) when applied luminally 
using the pinocytic loading protocol.
As expected in experiments carried out to determine the ultrastructural integrity of the 
arterial wall before, during and after luminal application of the pinocytic loading 
protocol (section 2.4) an ~4-fold increase in the number of intracellular endothelial cell 
vesicles (excluding surface caveolae) was observed in the hypertonic stage of the 
treatment process (Figures 4.6A and B; n = 3). After the protocol was fully completed 
the number of endothelial cell vesicles returned to levels seen before the treatment 
process was carried out (Figures 4.6A and 4.6C; n = 3).
43.7. Arterial viability and ultrastructural integrity following luminal pinocytic 
loading
Radial cross-sections were taken through isolated and pressurized (50mmHg) arteries 
fixed before (Figures 4.6A, 4.7A and 4.7D), during (Figures 4.6B, 4.7B and 4.7E) and 
after (Figures 4.6C, 4.7C and 4.7F) luminal pinocytic loading (vehicle only) (n = 3). 
Cellular integrity was maintained throughout the protocol (Figures 4.6 and 4.7A-C) 
although disruption of gap junctions was apparent during the hypertonic treatment stage 
(Figure 4.7E) when compared to images of untreated arteries (Figure 4.7D). Gap 
junction integrity appeared restored upon completion of the full pinocytic loading 
protocol Figure 4.7F). Smooth muscle cell morphology was unaffected at any stage of 
the treatment (Figures 4.7A-C). Functional viability was assessed by evaluating 
concentration-dependent dilatation responses to ACh following maximal PE-evoked 
constriction (3-10pM) before and after luminal pinocytic loading (vehicle only). 
Consistent with the intact structural integrity of arteries following the treatment,
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A . Endothelial cell loading with carboxyfluorescein
B. Endothelial cell loading with FITC-coupled 3kDa dextran
C. Endothelial cell loading with Alexa Fluor® 633-coupled IgG
Figure 4.5 Luminal pinocytic loading of fluorescent molecules into 
intact vascular cells
Confocal, fluorescent images o f rat isolated, pressurized mesenteric arteries 
showing endothelial cell loading o f A, carboxyfluorescein (~ lm g m l'1), B, 
FITC-coupled 3kDa dextran (~6mg m l'1) and C, Alexa Fluor® 633 IgG 
(0.2mg m l'1 luminal solution) following luminal application o f the 
pinocytic loading protocol. Images were taken at 50mmHg using a 20x 
water-immersion objective. Bar: 100 pm. Please note similar results to A 
(different n) are shown in section 3.3 (figure 3.4). Dr. Simon Mather 




pD2 P (n) Rmax ± 
s.e.mean
Rmax P (n )
Control 6.8±0.0 n.a. 93.6±0.4% n.a.
L-NAME 6.7±0.1 P>0.05* 87.8±2.2% P>0.05* (6)
(6)
TRAM-34 & Apamin 5.9±0.1 PcO.Ol* 84.2±2.8% P>0.05* (4)
(4)
L-NAME, TRAM-34 & 5.8±0.1 P<0.001** 30.1 ±4.0% PcO.OOl** (6)
Apamin (6) P<0.001***
L-NAME & K+ n.a. n.a. 5.6±1.8% PcO.OOl** (6)
Table 4.1. Effects of inhibition of K+ channels on dilatation responses to ACh
The effect of K+ channel blockade with either a combination of TRAM-34 (lpM , 
20min) and apamin (50nM, lh) or by raising extracellular K+ (35-45mM) on 
concentration-dependent responses to ACh. Rmax corresponds to dilatation to 3pM 
ACh. * Significantly different to control **significantly different to L-NAME, and 
*** significantly different to TRAM-34 and apamin following a one-way ANOVA 
with a Bonferroni post-test (PcO.05). L-NAME (lOOpM) present where indicated.
Treatment pD2 ± s.e.mean Rmax ± s.e.mean n
L-NAME & Low Tone 6.6±0.2 94.7±2.9% 4
L-NAME & High Tone 6.4±0.1 92.5±2.6% 3
L-NAME, Low Tone & 
Carbenoxolone
6.3±0.3 90.0±1.0% 4
L-NAME & High Tone 
Carbenoxolone
5.5±0.5 52.0±12.6% 8
Table 4.2. Effects of carbenoxolone treatment on dilatation responses to ACh
The effect of treatment with carbenoxolone (lOOpM, 30min) on concentration- 
dependent responses to ACh at high (5-15pM) and low (l-5pM) levels of PE- 
evoked tone in unpaired arteries. Rmax corresponds to dilatation to 3pM ACh. No 
statistically significant differences were found using one-way ANOVA. L-NAME 






Figure 4.6 Effect of the luminal pinocytic loading protocol on number of 
intracellular endothelial vesicles
Representative («=3) electron micrographs o f radial cross-sections through 
isolated, pressurized arteries fixed A, before, B, during and C, after fully 
completing the pinocytic loading protocol. Bar: Main panels 1pm; insets 
200nm. Modified from Mather et al., 2005. All electron microscopy work, 
























Figure 4.7 Effect of the luminal pinocytic loading protocol on arterial 
ultrastructural and functional integrity
Representative electron micrographs o f radial cross-sections through 
isolated, pressurized arteries fixed A, D, before, B, E, during and C, F after 
fully completing the pinocytic loading protocol («=3). G, Effect o f the 
luminal pinocytic loading protocol on dilatation responses to ACh {n=9-39). 
Bar: A - C, 10pm; D, 1pm; E, F, 50nm; D, inset lOOnm. D, E, F, Arrows 
indicate gap junction plaques. Modified from Mather et al., (2005). All 
electron microscopy work, image production and structural analyses were 












dilatation to ACh was unaffected by the pinocytic loading protocol (Figure 4.7G; Table
4.4, n = 9 -39).
4.3.8. Effect of luminal pinocytic loading of connexin antibodies on ACh-evoked 
dilatation
Antibodies targeted against the intracellular C-terminus of connexin 37, connexin 40 or 
connexin 43 were included in the hypertonic solution (0.1 mg ml'1) during luminal 
treatment of isolated, pressurized arteries with the pinocytic loading protocol. Pinocytic 
loading of anti-connexin 37 in = 6 - 9) and 43 in = 3 - 7) antibodies had no effect on 
concentration-dependent dilatation responses to ACh (Figure 4.8A; Table 4.4). In 
contrast inclusion of anti-connexin 40 antibodies in the hypertonic solution resulted in a 
rightward shift in the concentration-response curve to ACh and a significant attenuation 
of the vasodilatation to 3pM ACh (Figure 4.8A; Table 4.4; n = 2 - 14). Endothelial cell 
viability remained intact following luminal pinocytic loading of connexin antibodies as 
evidenced by the minimal endothelial cell staining by propidium iodide (0.01 %wv'1) 
when compared to tissue damaged by cannulation (Figures 4.8C and D).
Experiments were performed to evaluate the influence of the Na+/K+ATPase and tone 
on EDHF-type responses prior to and following pinocytic loading of anti-connexin 40 
antibodies. Under conditions of low PE-evoked tone ouabain (lpM; n = 4) evoked a 
significant rightward shift in the concentration-response curve to ACh. In separate 
experiments endothelial cell loading of anti-connexin 40 was without effect on ACh- 
evoked vasodilatation, further supporting a minimal effect of this protocol on cell 
viability (Figure 4.8B; n = 4). Endothelial cell loading of anti-connexin 40 antibodies in 
the presence of ouabain did not evoke any further inhibitory effects (Figure 4.8B, n = 
4). In contrast under conditions of high PE-evoked tone, the inhibitory effects of 
endothelial cell loading with anti-connexin 40 were unmasked to a similar extent 
whether in the presence (n = 4) or absence of ouabain (Figure 4.8B; n -  2 -  14).
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Treatment pD2 ± s.e.mean Rmax ± s.e.mean
(P)
n
Low Tone & L-NAME 7.1±0.1 98.5±0.5% 8
Low Tone, L-NAME & Ouabain 6.3±0.1 99.2±0.7% 
(ns)
4





High Tone, L-NAME & Anti- 
Connexin40 Antibody
n/a 36.6±9.5% 14
Low Tone, L-NAME, Anti- 
Connexin40 Antibody & Ouabain
6.3±0.2 (n=3/4)* 96.0±2.2% 4
High Tone, L-NAME, Anti- 




Table 4.5. Effect of PE-evoked tone, ouabain and anti-connexin 40 antibody on 
dilatation responses to ACh
The effects of luminal pinocytic loading of anti-connexin 40 (0.1 mg ml'1), the level 
of PE-evoked tone (low, 0.3-3pM; High 3-10pM) and the inhibitor of Na+/K+- 
ATPase, ouabain (lpM ) on ACh-evoked dilatation responses. Rmax corresponds to 
dilatation to 3pM ACh. L-NAME (lOOpM) present in all experiments. The anti- 
connexin 40 antibody data has been shown previously (please see Table 4.4). n/a and 
*, an EC50 could not be accurately calculated so the pD2 value is excluded. Parts of 
this work were obtained by Dr. Kim Dora and Dr. Simon Mather. * Significantly 
different to Low Tone & L-NAME following a one-way ANOVA with a Bonferroni 
post-test (P<0.05).
Figure 4.8 Effect of luminal pinocytic loading of anti-connexin antibodies on 
dilatation responses to ACh
A, B, Concentration-response curves illustrating the effects of luminal pinocytic loading 
(0.1 mg ml'1) of A, anti-connexin 37 («=6-9), A, B, anti-connexin 40 (n =2-14) and A, 
anti-connexin 43 antibodies (n=3-7) on ACh-evoked dilatation responses under 
conditions of high PE-evoked background tone (3-10pM). B, The effects of different 
levels of background PE-evoked tone (low, 0.3-3pM; and high 3-10pM) and the 
Na+/K+-ATPase inhibitor ouabain (lpM ) on ACh-evoked dilatation responses prior to 
and following luminal pinocytic loading of anti-connexin 40 (O.lmg ml'1). L-NAME 
present throughout all experiments (100pM). C, D, Representative images of propidium 
iodide (O .O ^w v1) staining of damaged endothelial and smooth muscle cells at C, the 
site of cannulation and D, the middle of the artery following pinocytic loading of anti- 
connexin 40 antibodies. C, D, bar 50pm. Images were taken using a x40, water 
immersion objective. Some (n=2-6) concentration-response data are also shown in 
section 5.3. Parts of this work were obtained by Dr. Kim Dora and Dr. Simon Mather. 
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Gap junctional communication has been demonstrated to be an integral part of both 
EDHF-facilitated vasodilatation and spreading dilatation responses by a number of 
investigators. However the lack of selective inhibitors of either homocellular or 
heterocellular gap junctions has precluded a definitive assessment of the pathways 
mediating these responses. Within this study conditions under which EDHF-mediated 
dilatation and in particular dilatation likely mediated by gap junctional communication 
were established in rat isolated and pressurized mesenteric arteries. This provided a 
model for evaluation of the efficacy of established gap junction uncouplers and enabled 
the effects of endothelial cell pinocytic loading of anti-connexin antibodies to be 
studied.
Consistent with previous reports, pre-contraction of the rat mesenteric artery to a high 
level of background tone with PE (3-10pM) in the presence of L-NAME prevented 
relaxations to K+ previously reported at lower levels of tension in rat mesenteric arteries 
(Dora & Garland, 2001; Dora et a l , 2000b; Dora et a l , 2002; Doughty et a l , 2000; 
Edwards et al, 1998; Richards et al, 2001; Weston et al, 2002). A significant 
rightward shift of the ACh concentration-response-curve was also observed, which 
could imply a degree of physiological antagonism of the PE-evoked response. However 
a number of studies have also demonstrated that the inhibition of K+-evoked dilatation 
by raised PE-evoked background tone could be almost completely prevented by 
treatment with the BKca blockers iberiotoxin and charybdotoxin in this preparation. 
These findings support the hypothesis of maximal 3Na+/2K+ATPase activation by 
smooth muscle cell K+ under conditions of high tone and suggest that a K+ component 
of the EDHF response to ACh could be prevented under these conditions (Dora & 
Garland, 2001; Dora et al, 2000b; Dora et al, 2002; Richards et al, 2001).
The complete attenuation of ACh-evoked vasodilatation under high levels of PE-evoked 
tone in the presence of L-NAME and following blockade of K* channels was consistent 
with the remaining relaxation component being driven by an EDHF, which according to 
previous studies would most likely comprise a gap junction-facilitated component 
(Chen & Cheung, 1997; Dora et al, 1999; Doughty et al, 1999; Edwards et al, 1998; 
Hinton & Langton, 2003; Sandow & Hill, 2000; Sandow et al, 2006; Sandow et al,
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2002; Ungvari et a l , 2002; Walker et al, 2001; Zygmunt & Hogestatt, 1996). The 
inconsistent, or even absent blockade of ACh-evoked responses by either carbenoxolone 
or the gap peptides was therefore surprising. Although the specificity and effectiveness 
of carbenoxolone may have been questioned (Chaytor et al, 2000; Goto et al, 2002; 
Griffith, 2004; Matchkov et al, 2004b; Tare et al, 2002) previous reports have clearly 
demonstrated the efficacy and reliability of the gap peptides as inhibitors of vascular 
gap junctional communication, particularly when administered as a triple combination 
of Cx43Gap 26, Cx37’Cx43Gap 27 and Cx40Gap27 (Chaytor et al, 1998; Chaytor et al, 
2001; Dora et al, 1999; Doughty et al, 2000; Edwards et al, 1999; Griffith, 2004; 
Matchkov et al, 2006; Sandow et al, 2003a; Sandow et al, 2002). Inconsistencies in 
their efficacy have been documented previously and shown not to correlate with the 
incidence of MEGJ (Dora et al, 2003a). However, such an occurrence is still difficult to 
mechanistically resolve. Within this study the pH of the peptides was adjusted to 
physiological levels, an aspect that has not been reported in previous studies and one 
that may have significant implications on peptide structure and interaction with gap 
junctions. However, an influence of pH on gap peptide efficacy can only be deemed as 
speculation and a definitive assessment of the discrepancies, perhaps also evaluating the 
likelihood of protein digestion or supplier differences would need to be performed to 
fully understand the results of this study.
Given the poor efficacy of the gap peptides in our hands we employed a new technique 
that had the capacity to facilitate the selective blockade of endothelial cell gap junctions 
in the isolated artery preparation. Vequad & Thorin (2001) recently described the use of 
a commercially available kit to selectively load antibodies into the endothelium by a 
method of enhanced pinocytosis (please see section 2.4). However, within this 
laboratory we were unable to maintain the functional integrity of the artery using this 
method so a technique based on the osmotic lysis of pinocytic vesicles originally 
developed for cells in culture was adapted for use in the intact artery (please see section 
2.4; Mather et al, 2005; Okada & Rechsteiner, 1982).
Inclusion of carboxyfluorescein, FITC-conjugated dextran (3000Da) or Alexa Fluor® 
633-conjugated IgG in the hypertonic solution during luminal application of the 
pinocytic loading protocol demonstrated the selectivity and efficiency with which this
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method loads molecules into the endothelium (please also see 3.3.3). The increased 
number of intracellular vesicles during the hypertonic stage of the process is consistent 
with the original work of Okada & Rechsteiner (Okada & Rechsteiner, 1982) and 
supports the proposed mechanism behind the loading protocol whereby the increased 
osmotic pressure in the presence of a hypertonic solution stimulates the formation of 
intracellular vesicles containing the extracellular solute (please see section 2.4). 
Electron micrographs and functional responses to ACh demonstrated the maintained 
structural integrity and endothelial cell viability following the pinocytic loading 
protocol.
Subsequent studies evaluating the contribution of gap junctions, and more specifically 
the known vascular connexins to EDHF responses in the rat isolated mesenteric artery 
were performed. By luminal pinocytic loading of antibodies directed against the C- 
terminus of connexin 40 a significant role for connexin 40 in EDHF-type dilatation 
responses to ACh under conditions of high PE-evoked tone was revealed. Given that the 
inhibition of EDHF-type responses was without detrimental affects on endothelial cell 
Ca2+ or smooth muscle cell function (Mather et al, 2005) the current study directly 
supports the contribution of MEGJ to EDHF responses in isolated rat mesenteric 
arteries.
Ultrastructural and immunohistochemical studies have localized both connexins 37 and 
40 to MEGJ plaques in primary and secondary rat mesenteric arteries. Given that 
MEGJs were shown to occur with a frequency of ~0.79 per endothelial cell in these 
preparations it is likely that both connexin subtypes could contribute to EDHF-type 
responses in this vascular bed (Sandow et al, 2006; Sandow et al, 2002). Indeed 
functional studies performed using Cx37, Cx43Gap27 (Doughty et al, 2000; Edwards et 
al, 1999; Sandow et al, 2002) and the triple combination of gap peptides described 
herein (Matchkov et al, 2006) report a significant attenuation of EDHF-mediated 
hyperpolarization and relaxation within this preparation. As staining for connexin 43 
was much more scarce compared to connexins 37 and 40 in the endothelium of rat 
mesenteric resistance arteries and connexin 43 was seen to be absent from the MEGJ of 
the primary mesenteric artery (Kansui et al, 2004; Matchkov et al, 2006; Sandow et 
al, 2006) it perhaps follows that within this study antibodies directed against connexin
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43 were without effect. However, the extensive endothelial cell staining for connexin 37 
in the rat mesenteric artery, and its localization to MEGJ (Gustafsson et al, 2003; 
Kansui et a l , 2004; Sandow et a l , 2006) would lead us to expect at least a small 
contribution of connexin 37. The lack of any inhibition of EDHF-type responses by 
antibodies and peptides directed against various domains of connexin 37 (Mather et a l ,
2005), including the C-terminus as described herein could therefore reflect a sensitivity 
of connexin 37 to smooth muscle tone. Indeed under conditions of low PE-evoked 
background tone the rightward shift in the concentration-response curve to ACh by 
ouabain was not augmented by pinocytic loading of anti-connexin 40 antibodies. This 
would suggest that another compensatory mechanism possibly involving gap junctions 
composed of connexin 37 is providing an alternative pathway for an EDHF-mediated 
dilatation response.
An important role for connexin 40 in the regulation of vascular function has been 
previously documented following the development of connexin 40 knockout mice (de 
Wit et al, 2000; Figueroa et al, 2003). Within the two reports it was found that the 
knockout mice were hypertensive and showed impaired conducted vasodilatation 
responses to ACh, bradykinin and electrical stimulation (de Wit et al, 2000; Figueroa et 
al, 2003). Indeed, consistent with our studies de Wit et al. (2000) demonstrated an 
-30% attenuation of ACh-evoked vasodilatation responses of cremaster arterioles from 
connexin 40 knockout animals. However, ongoing developmental changes that may be 
a result of, or compensate for, the deletion of a connexin channel cannot be dismissed 
and cannot be differentiated from the supposed direct effects of connexin deletion (Liao 
et al, 2001). Indeed, in mice in which connexin 43 was selectively deleted from 
vascular endothelial cells, increased plasma NO levels, bradycardia, hypotension and 
increased levels of angiotensin I and II were all reported but the influence of connexin 
43 deletion on these parameters could not be confirmed (Liao et al, 2001).
Acute, pharmacological dissection of the individual connexin channels mediating either 
the MEGJ or smooth muscle transfer of hyperpolarization has been attempted 
previously by elegant use of a range of gap peptides in the rabbit iliac artery (Chaytor et 
al, 2005). By taking advantage of the larger number of smooth muscle layers in this 
artery (-10) the authors were able to differentiate between homocellular coupling
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mechanisms and heterocellular coupling mechanisms by measuring endothelium- 
dependent smooth muscle cell hyperpolarization in sub-adventitial and sub-intimal 
layers of the media respectively. Using this technique combined with the selective 
application of the gap peptides (Cx37' Cx40Gap26, Cx40Gap27, Cx37' Cx43Gap27 and 
Cx43Gap26) the authors were able to dissect a role for connexins 37 and 40 in the 
heterocellular transfer of hyperpolarization to the sub-intimal smooth muscle layer and a 
role for connexin 43 in the relay of hyperpolarization throughout the sub-adventitial 
layers. Furthermore, the electrophysiological data were found to correlate with 
immunohistochemical staining patterns for each of the connexin subtypes within the 
rabbit iliac artery wall (Chaytor et al, 2005). Crucially however, no ultrastructural 
evidence supporting the existence of MEGJ and the localization of connexins 37 and 40 
to sites of heterocellular coupling were provided such that definitive conclusions as to 
the discrete connexin subtypes contributing to the MEGJ could not be made.
To summarize, within this study preliminary steps have been taken to show that the 
pinocytic loading method may be used as a tool for incorporating large cell-impermeant 
molecules into the endothelium of intact pressurized arteries. By using this protocol to 
load antibodies directed against the C-terminus of connexin 40 we have shown that 
MEGJ at least partly composed of connexin 40, contribute to EDHF-mediated 
dilatations in rat small mesenteric arteries under conditions of high PE-evoked tone.
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5. The role of connexins in conducted vasodilatation 
responses in rat isolated small mesenteric arteries
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5.1. Introduction
Mechanisms associated with the radial endothelium-dependent dilatation response to 
bath application of agonists such as ACh are continually reported. However focal 
vasodilatation, at a restricted site of metabolite release for example, may be insufficient 
to adequately increase blood flow to provide for the metabolic needs of the tissue. 
Therefore an ascending vasodilatation from the site of stimulation to the level of the 
feed arteries that occurs independently of stimulus diffusion can more effectively 
facilitate tissue perfusion due to a greater reduction in vascular resistance (Kuijiaka & 
Segal, 1995; Segal, 1991; Segal, 2005; Segal & Duling, 1986b). In support of this, these 
“conducted vasomotor” responses are frequently observed over distances greater than 
1mm and have been documented following the release of metabolites such as ATP, 
adenosine, H* and K+ from the downstream tissue (Berg et al, 1997; Duza & Sarelius, 
2003; Folkow et al, 1971; Hilton, 1959; Kajita et al, 1996; McCullough et al, 1997; 
Murrant & Sarelius, 2000; Segal & Duling, 1986a; Segal & Jacobs, 2001; VanTeeffelen 
& Segal, 2006).
Spreading vasomotor responses were first documented 85 years ago when in a study on 
the vasomotor mechanisms of the capillaries of the frog hind leg Krogh et al., (1922) 
applied silver nitrate to the web between two toes of the frog and observed the spread of 
vasodilatation to vessels in an adjacent webbed region (Krogh et al, 1922). Cutting of 
the sciatic nerve was found not to abolish the propagated vasodilatation the authors thus 
proposing local neuronal mechanisms to mediate the phenomenon (Krogh et al, 1922). 
Later studies using the cat femoral artery and hamster cheek pouch microcirculation 
also attributed the spreading vasodilatation to mechanisms intrinsic to the arterial wall, 
either proposing the direct electrical communication between cells of the arterial wall or 
the activation of an intrinsic neural pathway (Duling & Berne, 1970; Hilton, 1959).
It has since become apparent that the characteristics of the spreading response such as 
the extent of propagation upstream and the amplitude of vasodilatation or 
vasoconstriction can be dependent on the vascular bed, the type of preparation used and 
the agonist used to evoke the local response suggesting that multiple mechanisms 
contribute to this apparently conserved vasomotor function (Delashaw & Duling, 1991; 
Gustafsson & Holstein-Rathlou, 1999; Looft-Wilson et al, 2004; Neild & Crane, 2002;
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Segal & Duling, 1989; Segal et a l , 1999; Thengchaisri & Rivers, 2005). However, of 
the proposed mechanisms for spreading vasodilatation the electrotonic conduction of 
hyperpolarization from the site of stimulation upstream via gap junctions within the 
endothelium is perhaps the most widely accepted hypothesis (de Wit et a l , 2006a; de 
Wit et a l , 2000; Dora et a l , 2003b; Emerson & Segal, 2001; Figueroa et a l , 2003; 
Neild & Crane, 2002; Segal & Duling, 1986b; Segal & Duling, 1987; Segal et a l , 1999; 
Takano et al., 2004; Welsh & Segal, 1998; Xia & Duling, 1995).
Hirst & Neild (1978) first documented the longitudinal transfer of current along the 
guinea-pig mesenteric arteriole, at the time proposing an intrinsic electrical conduction 
pathway within the arterial wall. Based on accumulating data showing a direct gap 
junctional mediated pathway between both endothelial and smooth muscle cells and the 
close approximation of the length constants (the distance over which the response 
decays to -37% of its initial value) reported for electrotonic conduction and conducted 
vasodilatation, Segal & Duling (1991; 1989; 1989; 1986b) proposed that the mechanism 
of the conducted vasomotor response was associated with a conducted increase in 
membrane potential, transferred from cell to cell via gap junctions. This crucial role for 
the conducted change in membrane potential was highlighted by observations that 
conducted vasomotor responses were associated with agonists that evoked their local 
response by predominantly electromechanical mechanisms (for example ACh and PE; 
please see sections 1.2.4.2 and 1.3.2.6). Whereas pharmacomechanically-evoked 
vasomotor responses (for example sodium nitroprusside) were unable to conduct 
(Delashaw & Duling, 1991). Parallel conducted depolarization and vasoconstriction 
responses to KC1 and the attenuation of remote vasodilator responses to ACh by 
upstream application of depolarizing concentrations of K+ also supported the idea of an 
electrotonically-conducted response (Segal & Duling, 1989; Xia & Duling, 1995; Xia et 
al, 1995). However the cell-to-cell pathway mediating the conduction of this increase 
in membrane potential was unclear.
The longitudinal orientation of the endothelial cells favour a more rapid conduction 
pathway than that achieved via smooth muscle cell coupling (Haas & Duling, 1997; 
Yamamoto et al, 2001). Indeed, the circumferential arrangement of the smooth muscle 
cells observed in the hamster cheek pouch arteriole suggest that an electrical current
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would have to pass through the width of 140 smooth muscle cells to cover a 1mm 
segment of vessel whereas just 6 or 7 endothelial cell lengths would span the same 
distance (Haas & Duling, 1997). This combined with the equal to high coupling 
resistance between the smooth muscle cells versus the endothelium suggests that a 
smooth muscle cell pathway for the spread of the increase in membrane potential is 
unlikely (Emerson et al, 2002; Yamamoto et al, 2001). Experimentally, complete 
attenuation of conducted vasodilatation and hyperpolarization responses to both ACh 
and LVK following mechanical removal of the endothelium in the rat isolated and 
pressurized mesenteric artery has been described (Goto et al, 2004; Takano et al, 
2004). Given that the primary mechanism associated with LVK-evoked vasodilatation is 
one of direct smooth muscle hyperpolarization (please see section 1.3.1.1) the 
disruption of the LVK-evoked conducted response highlights an obligatory role for the 
endothelium. In pressurized hamster retractor muscle feed arteries focal (targeting an 
~300|um region) light dye treatment to selectively disrupt conduction through either the 
endothelium or smooth muscle layers supported an endothelial cell pathway for 
conduction of the response to ACh. This elegant study described blockade of conducted 
dilatation and hyperpolarization responses to ACh upon disruption of the endothelium 
whilst disruption of the smooth muscle had minimal effects (Emerson & Segal, 2000b).
Given the obligatory role for the endothelium in the longitudinal conduction of 
vasodilatation in the rat mesenteric artery and the extensive anatomical and 
immunohistochemical evidence for endothelial cell homocellular gap junctions within 
this vascular bed (please see chaper 3; Goto et al, 2002; Goto et al, 2004; Gustafsson 
et al, 2003; Kansui et al, 2004; Mather et al, 2005; Sandow & Hill, 2000; Sandow et 
al, 2006) a gap junctional pathway for the longitudinal transfer of an increased 
membrane potential would therefore seem likely (Segal et al, 1989; Segal & Duling, 
1989; Segal & Duling, 1986b). However to date, despite much evidence in support of 
the selective and specific blockade of vascular gap junctions with the gap peptides 
(please see sections 4.1 and 4.4), studies evaluating the contribution of the vascular 
connexins to conducted vasodilatation by use of these specific gap junction uncouplers 
have not been reported.
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Connexin knockout studies describing the deletion of connexin 40 have documented the 
attenuation of conducted dilatation responses to ACh, bradykinin (de Wit et al, 2000) 
and more recently direct electrical stimulation (Figueroa et al, 2003) in mouse 
cremaster muscle preparations. Indeed, conducted vasoconstrictions to K+ and electrical 
stimulation were unaffected (de Wit et al, 2000), implying that different connexins may 
contribute in a divergent manner to the conduction of either dilator or constrictor 
vasomotor responses (de Wit et al, 2006b). However, such studies must be regarded 
with caution as compensatory regulation of other associated channel proteins or even in­
direct effects associated with deletion of the channel may occur (please see section 4.4). 
Furthermore, knock out studies also currently restrict the experimenter to cell culture 
models or mouse preparations, which given the tissue variability associated with the 
conducted vasodilatation response, limits the usefulness of this methodology.
The aim of this study was to therefore examine the role of endothelial cell gap junctions 
on the conducted vasodilatation response to ACh and LVK in the rat isolated and 
pressurized mesenteric artery. Given the poor efficacy of the gap peptides in our hands 
(please see chapter 4; Mather et al, 2005) selective endothelial cell pinocytic loading of 
antibodies targeted against known vascular connexins was used. Characterization of the 
pinocytic loading protocol and the effects of endothelial cell connexin antibody loading 
on radial EDHF-type dilatation responses have been described previously (please see 
chapter 4; Mather et al, 2005) wherein a significant attenuation of the EDHF-type 
response was observed following endothelial cell loading of connexin 40 antibody 
under conditions of high tone. Preliminary experiments in this study were therefore 
designed to evaluate the effects of the pinocytic loading vehicle on the conducted 
vasodilatation response and evaluate the efficacy of carbenoxolone as an inhibitor of 
conducted vasodilatation responses. Subsequently, the effects of selective endothelial 
cell loading of antibodies directed against connexins 37,40 and 43 were evaluated.
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5.2. Methods
5.2.1. Rat mesenteric artery isolation and cannulation
Please see section 2.1 for methods of artery isolation.
5.2.2. Pressure myography
Arteries were mounted in custom-built organ baths (0.5ml; Figure 2.3) specifically 
designed to prevent upstream flow of focally-applied agonists. For cannulation and 
equilibration methods please see section 2.2. Endothelial cell viability was assessed as a 
>90% control dilatation to ACh (lpM) following pre-constriction with PE (1 - 3fiM). 
Arteries were maintained at 50mmHg and 37°C unless otherwise stated.
5.2.3. Cumulative concentration-response curves
All experiments were performed in the presence of L-NAME (lOOpM, 20min). 
Inhibition of cyclooxygenase was not required, as indomethacin (IOjiM) has been 
shown to have no effect on ACh-evoked dilatation responses within the rat mesenteric 
artery (please see section 1.3.2.4). Cumulative concentration-response curves to ACh 
(lnM-3pM) were performed following maximal (~90%; high tone) constriction to PE.
5.2.4. Focal stimulation of pressurized arteries
Please see section 2.3 for details of the methods used for the focal stimulation of 
arteries. In summary bolus doses of agonists were pressure-pulse ejected to the 
downstream end of arteries and dilatation responses simultaneously measured at sites up 
to 2mm upstream.
5.2.5. Pinocytic loading of cell impermeant molecules
For endothelial cell loading, anti-connexin antibodies were diluted (1:10) with 
hypertonic solution (containing PEG) to give final luminal concentrations of 0.1 mg ml' 
\  Endothelial cell viability was subsequently assessed by inclusion of propidium iodide 
in the bath solution (0.01% wv'1), which was visualized as previously described (please 
see section 3.2.7).
5.2.6. Drugs and solutions
All drugs and solutions were prepared as detailed previously (please see section 2.6).
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For experiments assessing vascular responses to focal stimulation PE, L-NAME and 
carbenoxolone were added to the superfusate reservoir prior to artery superfusion. L- 
NAME (lOOpM) was present throughout all experiments.
5.2.7. Antibodies
The antibodies used were described previously (please see section 4.2.8).
5.2.8. Data analysis
Data were initially collected and analysed as has been described previously (please see 
sections 2.5 and 2.7). To enable simultaneous observation of the local (Opm) and remote 
(500pm, 1000pm, 1500pm and 2000pm) sites full visualization (>2mm) of the artery 
required the use of a 4x objective, which limited the resolution of the images to ~5pm, 
circa 1.5% of the maximum diameter of the arteries. However, for the purposes of this 
study the capability of measuring spreading dilatation to a single application of agonist 
(not repeated stimuli visualized along the artery at multiple sites) outweighed the 
disadvantage of reduced image resolution. The ability to pair each remote response to 
the local dilatation response more clearly demonstrated the extent of decay over 
distance of the conducted vasodilatation response.
This approach also enabled us to evaluate the time taken for each artery to commence 
dilatation by 10pm at each of the remote sites (Figures 5.2C, 5.2D, 5.3C and 5.3D). Due 
to the latency and complexity of the evoked pathways associated with the dilatation 
response at the local site, measurements were only compared to the initiation of 
dilatation at the 500pm remote site (Emerson et a l , 2002). However even with this 
parameter accounted for, the analyses performed herein cannot be taken as a 
measurement of the electrical conduction as we did not attempt to concomitantly 
measure membrane potential or endothelial cell resistance. Indeed it is hoped that these 
data may simply provide a further indication of the effects of endothelial cell loading of 
anti-connexin antibodies. For example, were the endothelial cell loading of connexin 
antibodies to block inter-endothelial cell gap junctions only (Figure 5.1), we would 
expect a radial EDHF response at the site of stimulation, but minimal longitudinal 
communication of the response via the smooth muscle (Emerson et a l , 2002; Haas & 
Duling, 1997; Yamamoto et a l , 2001). Due to the high density of connexin expression
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at the endothelial cell borders (please see chapter 3)(Mather et al., 2005; Sandow et al.,
2006) it is unlikely that we would be able to inhibit all gap junctions. Therefore, we 
may only reduce the speed of the dilatation response rather than the magnitude. As we 
do not know how many gap junctions are required to enable the spread of current this, 
however, would be difficult to predict. Alternatively were the endothelial cell loading of 
connexin antibodies only to block MEGJ (Figure 5.1), which is highly unlikely under 
conditions of low tone given the expression of both connexins 37 and 40 at the MEGJ 
and endothelial cell border (Mather et a l, 2005; Sandow et al., 2006), local (radial) and 
conducted (longitudinal) dilatation responses to ACh would be reduced as the smooth 
muscle would not be stimulated at either the local or conducted sites. However a local 
response to LVK possibly coupled to a small spread of dilatation through smooth 
muscle gap junctions would be expected. Finally were we to block smooth muscle cell 
gap junctions only, the current would be dissipated less through the smooth muscle 
layers and so the magnitude of the conducted endothelial cell response would likely be 
increased. However, if the reduced passage of current though the smooth muscle cells 
would limit the number of smooth muscle cells able to relax this could be seen as a 
limited dilatation response.
Longitudinal cell-to-cell conduction
Inter-endothelial cell gap junction 
(ftD MEGJ
0 Inter-smooth muscle cell gap junction
Figure 5.1 Cell-to-cell conduction within the artery wall
Cartoon illustrating the gap junction cell-to-cell conduction pathways within the artery 
wall. EC, endothelial cell; SM, smooth muscle cell.
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5.3. Results
5.3.1. ACh and LVK-evoked conducted vasodilatation responses
L-NAME (lOOpM) was present throughout this study. Agonists were pressure-pulse 
ejected as a bolus dose through micropipettes positioned abluminally at the downstream 
end of the artery. Focal application of ACh (ImM, 1 -  100ms) stimulated robust 
dilatation at the local site (0pm, 81.5 ± 4.5%, n = 5; Figures 5.2A and 5.2B) that 
conducted rapidly upstream to more distal sites (please see Figure 2.5; 500 - 2000pm; 
Figures 5.2C and 5.2D) with little decay in the amplitude of dilatation (2000pm, 56.8 ± 
9.2%; Figures 5.2A and 5.2B). Focal application of LVK (ImM, 3 -  30ms,) also evoked 
a large local dilatation response (0pm, 92.9 ± 2.8%, n = 4; Figures 5.3A and 5.3B) that 
decayed to a similar extent as ACh (2000pm, 43.3 ± 4.4%; Figures 5.3A and 5.3B). 
However in contrast to ACh-evoked responses the time course of both the local and 
spreading dilatation responses was much slower (Figures 5.3C and D). Treatment of 
arteries with the pinocytic loading protocol (vehicle only) had no significant effects on 
either the time taken to dilate (Figures 5.2D and 5.3D) or the extent of dilatation at local 
and distal sites (Figures 5.2B and 5.3B) following focal stimulation with either ACh (n 
= 5 -  6) or LVK (n = 4).
Figure 5.2 Spreading responses evoked by abluminal application of ACh
ACh was pressure-pulse ejected as a bolus dose with a micropipette positioned at the 
downstream end of the artery. A, C, Representative traces (ImM, 30ms) B, mean peak 
amplitude of spreading dilatation responses (ImM, 1-100ms; n=5-6, unpaired 
experiments) and D, mean time taken to dilate by 10pm (ImM, l-100ms; n =4-5, 
unpaired experiments) at the local (0pm) and upstream (500-2000pm) sites under A, B, 
C, D, control conditions and B, D, immediately following the pinocytic loading 
protocol. C, Expanded view of the initial dilatation response to ACh as shown A, in 
full. Images were acquired at 12Hz. Diameter was measured simultaneously at all 
positions along the artery. Dashed lines indicate the measurements taken to evaluate the 
time taken to dilate by 10pm. L-NAME (lOOpM) present in all experiments.
Figure 5.3 Spreading responses evoked by abluminal application of LVK
LVK was pressure-pulse ejected as a bolus dose with a micropipette positioned at the 
downstream end of the artery. A, C, Representative traces (ImM, 3ms) B, mean peak 
amplitude of spreading dilatation responses (ImM, 3-30ms; n=4, unpaired experiments) 
and D, mean time taken to dilate by 10pm (ImM, 3-30ms; n=4, unpaired experiments) 
at the local (0pm) and upstream (500-2000pm) sites under A, B, C, D, control 
conditions and B, D, immediately following the pinocytic loading protocol. C, 
Expanded view of the initial dilatation response to LVK as shown A, in full. Images 
were acquired at 12Hz. Diameter was measured simultaneously at all positions along 
the artery. Dashed lines indicate the measurements taken to evaluate the time taken to 
dilate by 10pm. L-NAME (lOOpM) present in all experiments.
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5.3.2. Effect of carbenoxolone treatment on dilatation responses to ACh and LVK
The effect of treatment with carbenoxolone (lOOpM, 30min; n = 2) on spreading 
dilatation responses to ACh was difficult to ascertain (Figure 5.4A) as the extent of the 
conducted dilatation response was dependent on the magnitude of the local response, 
which itself, was affected by carbenoxolone treatment. Focal application of LVK, by the 
nature of its direct action on smooth muscle cells, was more able to evoke a local 
dilatation response and so the effect of carbenoxolone on conducted responses could be 
evaluated. Carbenoxolone treatment caused a marked increase in the decay of the 
spreading dilatation response to LVK at all upstream sites (500 - 2000pm; n -  3; Figure 
5.4B).
5.3.3. Effect of pinocytic loading of connexin antibodies into the endothelium on 
conducted vasodilatation responses evoked by ACh and LVK
Inclusion of antibodies targeted against the intracellular C-terminus of connexin 37, 
connexin 40 or connexin 43 in the hypertonic solution (O.lmg ml"1) during luminal 
treatment with the pinocytic loading protocol had no significant effect on the magnitude 
of spreading dilatation responses to ACh (connexin 37, ImM, 3 -  60ms, n = 6; connexin 
40, ImM, 1 -  10ms; n = 3; connexin 43, ImM, 1 -  30ms, n -  4; Figure 5.5). The time 
taken to dilate by 10pm at both local and distal sites in response to focal ACh 
application was also not significantly affected (Figure 5.6), however a tendency towards 
a decreased 10pm dilatation time was observed in 2 out of 4 arteries treated with the 
anti-connexin 43 antibody. Spreading dilatation responses to focal application of LVK 
following anti-connexin 37 antibody treatment tended towards a reduced magnitude of 
dilatation (2000pm, 23.1 ±6.1%, ImM, 3 - 100ms; n = 6; Figure 5.7A). The magnitude 
of dilatation of arteries treated with anti-connexin 40 antibody (ImM, 3 -  10ms; n = 2; 
Figure 5.7B) or anti-connexin 43 antibody (ImM, 10ms; n = 3; Figure 5.7C) was not 
affected. Further analysis of the time taken for the arteries to dilate by 10pm in each of 
the treatment groups showed that each of the antibody treatments showed a tendency 
towards increasing the initial time course of the dilatation response to LVK (Figure 5.8), 
however connexin 37 and connexin 43 antibody treatments appeared to have the most 
marked affects on LVK-evoked responses (connexin 37, 2000pm, 10.0 ± 2.9s, n = 4; 
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Figure 5.4 Effect of carbenoxolone treatment on spreading responses 
evoked by abluminal application of ACh and LVK
A, B, Mean spreading dilatation responses at the local (0pm) and upstream 
(500-2000pm) sites following downstream abluminal application of A, ACh 
and B, LVK under control conditions (A, ACh, n - 5, ImM, 1-100ms; B, 
LVK, n=4, ImM, 3-30ms) and following treatment with carbenoxolone 
(lOOpM, 30min; A, ACh, n=2, ImM, 30ms; LVK, n - 3, ImM, 100-300ms). 
Images were acquired at 12Hz. Diameter was measured simultaneously at all 
positions along the artery. L-NAME (lOOpM) present in all experiments. 
ACh-evoked responses are paired to LVK-evoked responses. Control and 
carbenoxolone treated arteries are unpaired but ACh and LVK-evoked 
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Figure 5.5 Effect of luminal anti-connexin antibody loading on spreading 
responses evoked by abluminal application of ACh
A, B, C, Mean spreading dilatation responses at the local (Opm) and upstream 
(500-2000pm) sites following downstream abluminal application of ACh 
under A, B, C, control conditions (n=5; ImM, 10-100ms) and following 
luminal pinocytic loading of A, anti-connexin 37 antibody {n-6; ImM, 3- 
60ms) B, anti-connexin 40 antibody (n=3; ImM, l-10ms) C, anti-connexin 43 
antibody (n=4; ImM, l-30ms). Images were acquired at 12Hz. Diameter was 
measured simultaneously at all positions along the artery. L-NAME (lOOpM) 
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Figure 5.6 Effect of luminal anti-connexin antibody loading on the initial 
dilatation rate of spreading responses evoked by abluminal application of 
ACh
A, B, C, Mean time taken to dilate by 10pm at the local (0pm) and upstream 
(500-2000pm) sites following downstream abluminal application of ACh 
under A, B, C, control conditions (n=5; ImM, 10-100ms) and following 
luminal pinocytic loading of A, anti-connexin 37 antibody (n=5-6; ImM, 3- 
60ms) B, anti-connexin 40 antibody (n=3; ImM, l-10ms) C, anti-connexin 43 
antibody (n=4; ImM, l-30ms). Images were acquired at 12Hz. Diameter was 
measured simultaneously at all positions along the artery. L-NAME (lOOpM) 
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Figure 5.7 Effect of luminal anti-connexin antibody loading on spreading 
responses evoked by abluminal application of LVK
A, B, C, Mean spreading dilatation responses at the local (Opm) and upstream 
(500-2000pm) sites following downstream abluminal application of LVK 
under A, B, C, control conditions {n-4; ImM, 3-30ms) and following luminal 
pinocytic loading of A, anti-connexin 37 antibody (n=6; ImM, 3-100ms) B, 
anti-connexin 40 antibody (n=2; ImM, 3-10ms) C, anti-connexin 43 antibody 
(«=3; ImM, 10ms). Images were acquired at 12Hz. Diameter was measured 
simultaneously at all positions along the artery .L-NAME (100pM) present in 
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Figure 5.8 Effect of luminal anti-connexin antibody loading on the initial 
dilatation rate of spreading responses evoked by abluminal application of 
LVK
A, B, C, Mean time taken to dilate by 10pm at the local (0pm) and upstream 
(500-2000pm) sites following downstream abluminal application of LVK 
under A, B, C, control conditions (n=3-4; ImM, 3-30ms) and following 
luminal pinocytic loading of A, anti-connexin 37 antibody {n-4-6; ImM, 3- 
100ms) B, anti-connexin 40 antibody (n=2; ImM, 3-10ms) C, anti-connexin 
43 antibody (n=2-3; ImM, 10ms). Images were acquired at 12Hz. Diameter 
was measured simultaneously at all positions along the artery.L-NAME 
(lOOpM) present in all experiments. Control data is also shown in Figures 
5.2 and 5.3.
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Concentration-response curves to ACh were assessed following evaluation of the effects 
of endothelial cell loading with anti-connexin antibodies on conducted dilatation 
responses. Endothelial cell loading with antibodies directed against either connexin 37 
(n = 6) or connexin 43 (n = 4) had no clear effect on concentration-dependent dilatation 
responses to ACh (Figure 5.9B). In contrast loading of antibodies directed against 
connexin 40 (n = 2 - 3) caused a rightward shift in the concentration-response curve to 
ACh and a depression of the maximal response attained with 3pM ACh (Figures 5.9A 
and B). Endothelial cell viability remained intact following luminal pinocytic loading of 
connexin antibodies as evidenced by the minimal endothelial cell staining by propidium 
iodide (0.01%wv_1) when compared to tissue damaged by cannulation (Figure 5.9C). 
Please note that the data obtained from these arteries also contributed to the 
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Figure 5.9 Effect of luminal pinocytic loading of connexin antibodies on 
dilatation responses to ACh
A, Representative trace and B, concentration-response curves illustrating the 
effects of luminal pinocytic loading of B, anti-connexin 37 (n=6), A, B, anti- 
connexin 40 (n =2-3) and B, anti-connexin 43 antibodies (n=3) on ACh- 
evoked dilatation responses. C, Representative images of propidium iodide 
(0.0 l% w v’) staining of damaged endothelial and smooth muscle cells at the 
site of cannulation (left hand panel; merged images) and the middle of the 
artery (middle and right hand panels) following pinocytic loading of anti- 
connexin 40 antibodies. All data is paired to spreading response experiments. 
L-NAME (lOOpM) present in all experiments. A, Triangle indicates addition 




The electrotonic conduction of hyperpolarization though the endothelium via gap 
junctions is thought to make a significant contribution to the longitudinal spread of 
vasodilatation. Indeed recent knock out studies in which the deletion of connexin 40 
was shown to abrogate both ACh- and electrically-evoked spreading vasodilatations 
support such a hypothesis (de Wit et al, 2000; Figueroa et al, 2003). However direct 
evidence by short-term manipulation of the gap junctions has not been described. 
Within the present study selective endothelial cell loading of antibodies directed against 
the known vascular connexins was therefore performed (please see chapter 4) in an 
attempt to evaluate the contribution of each connexin to the spreading vasodilatation 
response in rat isolated and pressurized small mesenteric arteries.
5.4.1. Characteristics of the conducted vasodilatation response to ACh and LVK
In the present study focal stimulation of rat small mesenteric arteries with either ACh or 
LVK was shown to evoke a robust local and spreading vasodilatation consistent with 
previous observations (Goto et al, 2004; Takano et al, 2004) that together may be 
indicative of the importance of ascending vasodilatation responses throughout the 
circulation (Takano et al, 2005). In contrast to previous studies however, the rate of 
decay appeared qualitatively slower (Takano et al, 2004). Based on previous reports 
(Dietrich et al, 1996) it is unlikely that the marginally increased spritz duration used 
within the present study facilitated an increased diffusion of the agonist upstream. 
Indeed small beads were included in the superfusate at various stages of the 
experimental protocol to enable direct observation of the flow direction. Furthermore, 
the severe attenuation of the conducted response to LVK in the presence of 
carbenoxolone documented herein would suggest that agonists were unable to diffuse to 
the upstream sites.
Passive, longitudinal cell-to-cell conduction of the hyperpolarization response is often 
characterised by a decay of -70% at a distance -  1500pm from the site of stimulation. 
Given the intrinsic link between vascular tone and membrane potential (please see 
section 1.2.4; Takano et al, 2004) this is likely also reflected by a pronounced decay of 
the spreading dilatation response at that site (Hirst & Neild, 1978; Segal et al, 1999; 
Takano et al, 2004). The slow decay of the responses documented in the current study
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may therefore be indicative of an active electrotonic conduction process, possibly 
associated with an additional or regenerative current source that is associated with the 
opening of ion channels but is not directly activated by agonist stimulation and/or 
improved cell-to-cell coupling (Neild & Crane, 2002; Segal & Neild, 1996; Segal et al, 
1999; Takano et al, 2004).
Importantly, facilitation of the conducted dilatation responses to agonists such as ACh 
occurs independently of the magnitude of the local hyperpolarization response 
(Emerson et al, 2002). Emerson et al (2002) demonstrated that despite identical local 
hyperpolarization responses, the length constant of the spreading response to ACh was 
almost 60% greater than that seen for current injection. Thus it has subsequently been 
proposed that some of the downstream signalling cascades activated by either ACh or 
LVK (please see sections 1.3.1.1 and 1.3.2) may contribute to amplification of the 
conducted dilatation response (Emerson et al, 2002; Takano et al, 2004).
Numerous reports examining the contribution of a neural mechanism to the conducted 
vasomotor response have described a minimal sensitivity of the spreading dilatation 
response to the Na+ channel inhibitor tetrodotoxin and thus rejected the hypothesis of a 
of a role for an intrinsic neuronal conduction of the vasomotor response (Berg et al., 
1997; Figueroa et al., 2003; Segal, 1994; Segal & Duling, 1989; Segal & Duling, 1987; 
Segal et al., 1999). More recently however, it has been suggested that a neural 
component may still be present, but one associated with the activation of sensory nerve 
fibres (Thengchaisri & Rivers, 2005). In support of such a mechanism Mupanomunda et 
al (1998) have described clear visualization of the perivascular nerves of the rat 
mesenteric artery following immunohistochemical staining for CGRP. However, the 
complete attenuation of conducted dilatation responses to ACh and LVK following 
denudation of the endothelium (Takano et al., 2004) would suggest that were this 
mechanism present, its contribution to conducted dilatation responses would not be 
significant, unless the endothelium was involved secondarily to nerve stimulation.
The influence of flow and shear stress on spreading vasodilatation in larger conduit 
arteries is well established and could perhaps also contribute to conducted vasomotor 
responses in the smaller resistance arteries and arterioles (Gustafsson & Holstein-
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Rathlou, 1999; Joannides et al., 1994; Lie et al., 1970; Pohl et al., 1986; Segal & Jacobs, 
2001; Thorsgaard et al., 2003). Indeed Thorsgaard et al (2003) have described a flow- 
dependent local vasodilatation response within the rat small mesenteric artery. 
However, an obligatory role for a flow-mediated mechanism of spreading vasodilatation 
is unlikely as conducted vasomotor responses in both isolated arteries and within in vivo 
and in situ preparations in which flow or pressure have been eliminated are unaffected 
(Duling & Berne, 1970; Hilton, 1959; Rivers, 1997b; Segal, 1994; Segal & Duling, 
1986a; Segal & Duling, 1987; Segal et al, 1999; Takano et al, 2004).
Multiple endothelium-dependent pathways could feasibly contribute to the conducted 
vasodilatation. Indeed many reports cite an obligatory role for both endothelial cell 
hyperpolarization and NO in the spreading vasodilatation response (Domeier & Segal, 
2007; Doyle & Duling, 1997; Rivers, 1997a; Segal et al, 1999). A recent report from 
Domeier & Segal (2007) demonstrated that at least in the hamster retractor muscle two 
interacting phases of the conducted vasodilatation response could be distinguished 
pharmacologically: The rapid initiation and amplitude of the response, sensitive to 
TRAM-34 and apamin termed the ‘electromechanical’ response followed by a second 
‘slow’ conducted vasodilator component visualized as the sustained phase of the 
response and mediated by the endothelium and Ca2+-dependent production of autacoids 
such as NO. This hypothesis is consistent with the results of Doyle & Duling (1997) and 
Segal et al (1999) who both described an attenuation of the duration of the conducted 
response following selective blockade of eNOS but no change in response amplitude. 
Given that our experiments were conducted in the presence of L-NAME and used 
relatively short pulse durations (Doyle & Duling, 1997) it is likely that we are only 
evaluating the contribution of the ‘fast’ hyperpolarization-dependent component. It 
would therefore seem that some mechanism able to regenerate the hyperpolarization or 
limit its dissipation as it is conducted upstream is apparent (Takano et al, 2004).
A role for endothelial cell in the conducted hyperpolarization response has been 
proposed, which given their increased conductance following hyperpolarization is 
indeed conceivable (Goto et al, 2004; Jantzi et al, 2006; Neild & Crane, 2002; Rivers 
et al, 2001; Takano et al, 2004). Within both porcine coronary arterioles (Rivers et al, 
2001) and hamster retractor muscle feed arteries (Jantzi et al, 2006) conducted
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dilatation responses to KC1 and bradykinin were attenuated by the K* channel blocker 
barium. Goto et al (2004) also documented a significant attenuation of ACh-evoked 
spreading hyperpolarization and vasodilatation responses in the rat primary mesenteric 
artery following incubation with barium (Goto et al, 2004). Results from this 
laboratory however, show that barium has no effect on the conducted dilatation 
responses to either LVK or ACh in the rat small mesenteric artery suggesting that 
within this preparation the conducted dilatation response is facilitated by at least one 
other mechanism (Takano et al, 2004).
The importance of endothelial cell intracellular calcium in regulating local vasomotor 
responses to ACh is clear (please see section 1.3.2; Freay et al, 1989; Fukao et al, 
1997b; McSherry et al, 2005; Oishi et al, 2001). A role for Ca2+ in the propagation of 
the vasodilatation response is, however, more ambiguous. A number of reports, 
including studies conducted within the isolated rat mesenteric artery, have shown that 
conducted hyperpolarization and vasodilatation responses are not accompanied by a 
remote rise in endothelial cell Ca2+ (Dora et al., 2003b; Segal & Duling, 1989; Takano 
et al., 2004). However, conversely, reports of a conducted rise in endothelial cell Ca2+, 
albeit associated with a slower, NO-dependent dilatation component have also been 
published (Domeier & Segal, 2007; Duza & Sarelius, 2003; Uhrenholt et al, 2007). 
Importantly, the studies of Segal et al (Domeier & Segal, 2007; Uhrenholt et al, 2007) 
demonstrated that the longitudinal conduction of the Ca2+ signal through the 
endothelium occurred after the decrease in smooth muscle cell Ca2+ and the longitudinal 
transfer of hyperpolarization, implying that these mechanisms are likely to be distinct 
from the conducted hyperpolarizing responses to LVK and ACh observed in the rat 
mesenteric preparation (Takano et al., 2004). However, discrete rises in endothelial cell 
Ca2+, for example in Ca2+ microdomains within the arterial wall would not be apparent 
by the Ca2+-imaging methods previously described (Domeier & Segal, 2007; Takano et 
al, 2004). Thus it is possible that elevations of Ca2+ in distinct microdomains, perhaps 
associated with the connexin channels themselves or with enzymes such as PLA2, could 
facilitate the production of endothelial cell factors such as 11,12-EETs, which could 
contribute to the magnitude of the distal vasodilatation response (Popp et al., 2002). 
Indeed, inter-endothelial cell and heterocellular gap junctional communication have 
been shown to be upregulated by PKA downstream of 11,12-EET production within
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sheets of porcine coronary artery endothelial cells (Popp et al, 2002) and by cAMP 
within the rabbit iliac artery respectively (Griffith et al, 2002).
5.4.2. The role of cell-to-cell coupling in the conducted vasodilatation response
As documented previously (please see chapter 4 (Goto et al, 2002; Mather et al, 
2005)) carbenoxolone resulted in disruption of the ACh-evoked response at the local 
site. However, this could not be overcome sufficiently to match the local vasodilatation 
seen under control conditions consequently impairing an accurate assessment of the 
conducted response. In contrast, LVK evoked a local dilatation response that was well 
maintained in the presence of the putative gap junction uncoupler, consistent with its 
direct hyperpolarizing action on the smooth muscle (please see section 1.3.1.1). The 
spreading vasodilatation response to LVK was however, severely attenuated by 
carbenoxolone, indicative of a gap junctional facilitated transfer of the response 
upstream. However, the endothelium-dependent nature of the conducted 
hyperpolarization to LVK (Takano et al, 2004) also meant that carbenoxolone may 
have attenuated the local transfer of hyperpolarization from the smooth muscle to the 
endothelium, disrupting the conducted response at the initiation site. Indeed, without 
any measurements of endothelial cell membrane potential, selective inhibition of the 
homocellular gap junctions cannot be assumed. Thus in order to more closely examine 
the effects of endothelial cell gap junction blockade we employed the pinocytic loading 
technique to selectively load antibodies targeted against known endothelial cell 
connexins into the endothelium (please see chapter 4; Mather et al, 2005).
The negligible effects of the pinocytic loading protocol on the conducted dilatation 
response crucially demonstrated that the blockade of conducted vasomotor responses 
that may occur using hypertonic sucrose solutions (Murrant & Sarelius, 2000; Segal & 
Duling, 1989) was either transient and restricted to the loading stage of the protocol or 
was not apparent within the present study. Indeed, selective endothelial cell loading of 
antibodies directed against connexins 37, 40 or 43 had no significant effect on the 
amplitude of the conducted vasodilatation responses to either ACh or, with the 
exception of connexin 37, LVK.
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A slight reduction in magnitude and increase in time taken for the arteries to dilate to 
LVK stimulation was seen at positions distal to the site of agonist application following 
loading of antibodies directed against connexin 37. However, this was non-significant 
and such a comparison of the time taken to dilate is instilled with inaccuracies 
associated with the mechanisms required to reverse smooth muscle cell contraction 
(please see section 1.3; Emerson et al, 2002). Indeed, the present observation that the 
time taken to dilate by 10pm in response to ACh was almost twice as fast as that with 
LVK likely reflects the differential dilatation mechanisms associated with each agonist 
(please see sections 1.3.1.1 and 1.3.2), i.e. the rate of dilatation at the local site was 
slower for LVK, therefore dilatation at the remote sites dilate would also take longer. 
Given that hyperpolarization is so intrinsically linked to the remote dilatation responses 
to both ACh and LVK (Takano et a l , 2004) the increased time taken to dilate by 10pm 
in response to LVK following loading of anti-connexin 37 antibodies may however, 
very loosely, reflect a decreased rate of conduction of the hyperpolarization response.
In contrast to previous results (Chapter 4; Mather et a l , 2005) only a small suppression 
of the maximal dilatation response to bath application of ACh (3pM) was seen 
following endothelial cell loading of anti-connexin 40 antibodies. The robust spreading 
responses observed herein might therefore reflect limited loading of the antibodies into 
the endothelium. Indeed without the use of fluorescently tagged connexin specific 
antibodies in the present study it is impossible to demonstrate that the antibodies are 
actually present at the time of agonist stimulation. Differences in antibody loading 
could reflect transport of the anti-connexin antibodies out of the endothelium, or despite 
previous reports to the contrary, the lysosomal degradation of the antibodies over the 
time taken to achieve the correct conditions for evaluation of the conducted dilatation 
response (Chakrabarti et al, 1989; Ober et al, 2004; Okada & Rechsteiner, 1982; 
Predescu et al, 2004). Repeated ACh concentration-response curves following selective 
endothelial cell loading of antibodies directed against connexin 40 could therefore be 
performed to evaluate whether the inhibitory effects of this protocol that were 
previously described are reversed over time (please see chapter 4; Mather et al., 2005).
Importantly, the concentrations of ACh used to evoke the conducted dilatation 
responses, although likely diluted at the time of focal application, are potentially far
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higher than the micromolar concentrations used previously when studying the effects of 
anti-connexin antibodies on the radial ACh-evoked dilatation response (Chapter 4; 
Mather et al., 2005). It is therefore conceivable that any effects of the connexin 
antibodies were masked by the near-maximal nature of the conducted dilatation 
response, or at least subtle changes could not be measured. Within this laboratory a 
novel triple cannulation method has recently been developed for the evaluation of 
conducted dilatation responses to luminally applied purinoceptor agonists (please see 
chapter 7; Figure 7.1) that may be of use for further development of the current study. 
Using a third cannulation pipette, the branch at an arterial bifurcation is cannulated, 
through which perfusate containing the agonist and carboxyfluorescein is infused. By 
applying a low level of flow (50jiL m in1) through the lumen of the feed artery diffusion 
of the agonist upstream is prevented (as visualized by the fluorescence of the 
carboxyfluorescein) and a conducted dilatation response spreading from the side branch 
upstream into the feed artery may be observed. By applying the agonist luminally, direct 
and maintained contact of the agonist with the endothelium occurs, enabling the use of a 
lower agonist concentration to evoke a sustained spreading response. Combining this 
approach with application of the pinocytic loading protocol to the feed artery would 
leave the local dilatation response in the branch unaffected, and as such the significance 
of any inhibitory effects observed at the remote sites can be measured reliably and in 
more detail.
A third explanation for the poor inhibitory effects of the anti-connexin antibodies is that 
maximal endothelial cell loading of the connexin antibodies did occur but the number of 
antibodies loaded was not sufficient to block every gap junction channel within the 
large homocellular plaques prevalent within the endothelium of this preparation 
(Sandow & Hill, 2000). Indeed, the small attenuation of the conducted response to LVK 
observed following treatment with the anti-connexin 37 antibody and the extensive 
endothelial cell border staining for connexin 37 would support such a hypothesis (Goto 
et al, 2004; Gustafsson et al, 2003; Kansui et al, 2004; Sandow et al, 2006). 
However, a simpler explanation may be that blockade of more than one connexin 
isoform is necessary to block conducted vasodilatation. Given the incomplete blockade 
of the radial EDHF-type dilatation response by endothelial cell loading of anti-connexin 
40 antibodies under conditions of low tone but in the presence of ouabain it is also
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likely that multiple connexins could contribute to both the radial and longitudinally- 
transferred (Figure 5.1) dilatation responses under the low tone conditions used within 
the present study (Chapter 4; Doughty et a l , 2000; Edwards et a l, 1999; Matchkov et 
al, 2006; Mather et al, 2005; Sandow et al, 2006; Sandow et al, 2002). It is therefore 
proposed that experiments be performed to assess the effects of the loading protocol on 
smooth muscle cell hyperpolarization responses to ACh under conditions of high tone, 
enabling a direct assessment of the effects of the protocol on the radial conduction of 
the hyperpolarization response. Subsequently, a re-evaluation of the pinocytic loading 
method would also be performed to enable selective endothelial cell loading of a greater 
volume of antibody to facilitate increasing the concentration of antibodies loaded and 
the targeting of multiple connexin subtypes.
To summarize, the present report describes the simultaneous observation of local and 
remote vasodilatation responses to ACh and LVK at distances up to 2mm from the point 
of stimulation that showed little decay in the extent of vasodilatation with distance. 
Incubation with the non-selective gap junction uncoupler carbenoxolone attenuated 
conducted dilatation responses to LVK and both local and conducted responses to ACh. 
In contrast selective endothelial cell loading of antibodies directed against the known 
endothelial cell connexins had minimal effects on the conducted vasodilatation 
responses to either agonist. Due to the preliminary nature of the gap junction uncoupler 
methods presented, exact conclusions as to the nature of the cell-to-cell coupling 
response cannot be made and further work is proposed.
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6 . Characterisation of nucleotide-evoked dilatation responses
160
6.1. Introduction
The contribution of endothelium-dependent dilatation responses to the regulation of 
vascular tone is now well established. Key roles for the diffusible factors NO, EDHF, 
PGI2 and the direct cell-to-cell transfer of hyperpolarization from the endothelium to the 
smooth muscle via MEGJs have been identified (please see section 1.3.2; Chen et a l , 
1988; Ignarro et a l , 1987; Mather et a l , 2005; Moncada & Vane, 1978; Palmer et al, 
1987; Sandow & Hill, 2000; Taylor et al, 1988; Vane, 1994). The activation of these 
mechanisms is associated with a variety of stimuli including the mechanical forces 
associated with shear stress and both the direct and indirect actions of various agonists 
on the endothelium (Busse et al, 2002; Busse & Fleming, 2003; Dora et al, 1997; Dora 
et al, 2000b; Fleming & Busse, 2003; Ledoux et al, 2006; McGuire et al, 2001; White 
& Hiley, 1997b).
Historically, ACh has been used to evoke the endothelium-dependent dilatation 
response for its study (Furchgott & Zawadzki, 1980). The robust nature of the ACh- 
evoked response and the selectivity of the agonist for the endothelium make it an ideal 
candidate for the study of endothelium-dependent dilatation. Indeed such robust 
vasoactive responses could be construed as supporting the physiological relevance of 
this agonist. However, despite localization of acetylcholinesterase to the adrenergic 
perivascular nerves of the rat mesentery no direct cholinergic innervation of this 
vascular bed could be seen (Furness, 1973). Atropine-sensitive dilatation responses of 
the hamster retractor muscle microcirculation have been reported (VanTeeffelen & 
Segal, 2006). However, plasma concentrations of ACh in the rat and human were found 
to be in the low nanomolar range (Fujii et al, 1995), rather than the high nanomolar/ 
low micromolar range associated with robust endothelium-dependent dilatations. 
Although release of ACh from circulating cells directly adjacent to target cells such as 
the endothelium would minimise degradation by acetylcholinesterase possibly enabling 
concentrations to reach levels sufficient to evoke a response (Fujii et al, 1995), these 
findings have yet to be verified.
In contrast, the release of purinoceptor agonists such as ATP, adenosine diphosphate 
(ADP) and UTP into the vasculature has been documented and shown to come from a 
variety of sources (Dubyak & el-Moatassim, 1993; Ralevic & Bumstock, 1998). These
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include sympathetic and sensory nerve terminals (Su, 1983), circulating cells within the 
lumen of the vessel, particularly red blood cells responding to low PO2 and platelets 
(Beigi et al, 1999; Dietrich et al, 2000; Ellsworth, 2004; Ellsworth et al, 1995; 
Gonzalez-Alonso et al, 2002; Lazarowski & Harden, 1999; Motte et al, 1995), 
damaged cells and the vascular endothelium itself (Bodin & Bumstock, 2001; Milner et 
al, 1992; Pearson, 1979; Saiag, 1995; Yamamoto et al, 2003). Indeed, during exercise, 
micromolar concentrations of plasma ATP have been measured in the femoral 
circulation of humans (Rosenmeier et al, 2004). The action of these nucleotides on the 
P2X and P2Y receptors present within the vascular wall may therefore represent a key 
mechanism for the physiological regulation of vascular tone.
Previous studies have suggested the presence of the P2Xi, P2Xt, P2 X5, and P2 X7 
nucleotide-gated ion channels and the P2Yi, P2 Y2, P2 Y4, P2Y6 and P2Yn G protein- 
coupled receptors within the rat mesenteric arterial bed. Of these P2Yi, P2 Y2, P2 Y4, 
P2Yn, P2Xi and P2 X7 have been associated with vasodilator responses (Buvinic et al, 
2006; Galligan et al, 2001; Gitterman & Evans, 2000; Harrington & Mitchell, 2004; 
Lewis & Evans, 2000; Liu et al, 2004; Malmsjo et al, 2000a; Malmsjo et al, 2002; 
Malmsjo et al, 2000b; Malmsjo et al, 1999; Mistry et a l, 2003). However of the 
studies described, many employed wire myograph techniques that can limit the 
investigator to bath application of agonists. This leads to activation of smooth muscle 
purinoceptors and subsequent vasoconstriction. More recently however, this 
complication has been overcome by the luminal application of purinoceptor agonists in 
the pressurized artery set-up (Liu et al, 2004). Luminal perfusion of agonists such as 
ATP and UTP evoked an apparently flow-dependent dilatation response via activation 
of both P2Y and P2X receptors. The dilatation response to ATP was shown to be 
dependent on the release of a raised K+-sensitive, EDHF-like, H2O2 component (Liu et 
al, 2004; Liu et al, 2006a) and is consistent with previous studies documenting the 
contribution of both NO and EDHF to the vasodilator and hyperpolarization responses 
to purinoceptor agonists within rat mesenteric arteries (Malmsjo et al, 1999; Mistry et 
al, 2003). However, the individual contribution of the two characteristic K+ channels 
activated in the EDHF response (please see section 1.3.2.6), the IKca and SKca 
channels, has not been ascertained for purinoceptor-mediated vasodilatation responses. 
Therefore, within the present study the relative contributions of IKca and SKca to the
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EDHF-type responses evoked by ATP, UTP and the non-hydrolyzable ADP analogue, 
ADPpS were investigated in rat isolated and pressurized small mesenteric arteries. 
Using the selective P2Yi inhibitor MRS2179, the contribution of P2Yi receptor 
activation to the dilatation response to luminal perfusion of the three agonists was also 
evaluated.
In addition to the EDHF-type response evoked by the luminal perfusion of purinoceptor 
agonists, Liu et al (2004) documented an attenuation of the dilatation response to the 
non-hydrolyzable purinoceptor agonists ATPyS and adenosine 5’-(P,y- 
imido)triphosphate tetralithium salt hydrate (AMP-PNP) upon repeated agonist 
exposure. The decay of the response was attributed to a lower concentration of agonist 
at the cell surface upon each successive period of flow (agonist delivery) as a result of 
limited ectonucleotidase breakdown (Liu et a l , 2004). However, it could also be 
explained by desensitization of the receptors. Given previous reports detailing a role for 
PKC in the desensitization of the P2Yi and P2 Y2 purinoceptors (Chen & Lin, 1999; 
Hardy et a l , 2005) the possible influence of PKC on the profile of the responses to 
ATP, UTP, ADPpS and ATPyS was also examined in the present study.




6.2.1. Rat mesenteric artery isolation and cannulation
Please see section 2.1.
6.2.2. Pressure myography
Arteries were mounted in a commercially available pressure myograph (10ml; 120CP, 
Danish Myo Technology, Denmark; Figure 2.1). For cannulation and equilibration 
methods please see section 2.2. Endothelial cell viability was assessed as a >90% 
control dilatation to ACh (lpM) following pre-constriction with PE (1 - 3pM). Arteries 
were maintained at 50mmHg and 37°C unless otherwise stated.
6.2.3. Concentration-response curves
All experiments were performed in the presence of L-NAME (lOOpM, 20min). 
Inhibition of cyclooxygenase was not required, as indomethacin (10|iM) has been 
shown to have no effect on purinoceptor agonist or ACh-evoked dilatation responses 
within the rat mesenteric artery (please see section 1.3.2.4)(Mistry et al, 2003).
6.23.1. ACh concentration-dependent responses
Cumulative concentration-response curves to ACh (lnM-3pM) were performed 
following submaximal (-70%) constriction to PE (0.5-10p,M).
6.23.2. Purinoceptor agonist concentration-dependent responses
The purinoceptor agonists were perfused through the lumen at -90 pL/min for two 
2min periods (unless otherwise stated), interspersed with one 2min no flow period using 
a BeeHive® syringe pump system (Figure 6.1; Bioanalytical systems, West Lafayette, 
Indiana, USA). This perfusion flow rate equates to a shear stress of -10 dyn/cm2 in fully 
dilated arteries. Consecutive, non-cumulative concentration-responses to ATP (lOnM - 
3pM), UTP (0.3pM - 30pM), ADPpS (30nM - lpM) and ATPyS (1 and 3pM) were 
obtained upon stabilization of submaximal levels of PE-evoked background tone 
(-70%; 0.5 - lOpM). Arteries were luminally-perfused with MOPS and left to 
equilibrate for lOmin between each agonist and concentration-response curve to 
minimise receptor desensitization. Indeed, reversal of the desensitization response is
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Inlet tube to pipetteRat mesenteric artery 
cannulated with two 
glass pipettes (~200iim)
Multiple inlet tube
Outlet tube from 
the pipette to a 
MOPS-filled 








The BeeHive® syringe pump system for luminal perfusion
Cartoon illustration of the pressure myograph with BeeHive® syringe pump system set­
up for luminal perfusion of a range of purinoceptor agonists, or concentrations of 
agonist.
thought to be mediated within ~5min following removal of the agonist (Otero et al., 
2000)
6.2.4. Drugs
All drugs and solutions were prepared as detailed previously (please see section 2.6).
6.2.5. Data analysis
Arteries were visualized and data analysed as described previously (please see sections 




6.3.1. Dilatation responses to luminal perfusion of nucleotides
Following pre-contraction with PE (0.5 - 10pM) luminal flow of MOPS-buffered salt 
solution had no effect on arterial diameter (Figure 6.2A; n = 5). In contrast, luminal 
perfusion of ATP evoked a concentration- and flow-dependent dilatation (pD2: 6.4 ± 
0.1, Rmax = 87.1 ± 5.3%, n = 5 - 14; Figures 6.2B and C) that was preceded by a short 
delay of ~30s reflecting the time taken to void the tubing and pipette dead-space 
volume. Once evoked, dilatation was maintained until cessation of flow when an 
immediate contraction of the artery was observed. Dilatation responses of similar 
magnitude were evoked almost immediately upon the second instigation of luminal 
ATP perfusion (Rmax = 96.1 ± 2.7%, n = 5 - 11). The NOS inhibitor, L-NAME (lOOpM) 
had no effect on ATP-evoked dilatation (Figure 6.2C).
Luminal perfusion of UTP evoked concentration- and flow-dependent dilatation 
responses that had a similar profile to those seen with ATP (Figure 6.3A) but were 
evoked at higher agonist concentrations (pD2: 5.5 ± 0.1, Rmax = 87.1 ± 5.3%, n = 4 - 5; 
Figure 6.3C). The potency of the non-hydrolyzable analogue of ADP, ADPpS, was only 
slightly lower than ATP (pD2: 6.2 ±0.1, Rmax = 94.2 %, n = 2; Figure 6.3C) but the time 
course of dilatation was markedly different: A transient dilatation was evoked during 
the first period of luminal perfusion, the magnitude of which could not be reproduced 
with repeated ADPpS (lpM) exposure (Figure 6.3B). Using submaximal 
concentrations, both UTP (3pM) and ADPpS (lpM)-evoked responses were unaffected 
by eNOS inhibition (L-NAME, lOOpM; UTPcontroi- 66.7 ± 10.0%, n = 12; U T P L-name: 
53.9 ± 13.1%, Yi— 1\ ADPpScontroi* 69.7 ± 5.8, n = 12; A D P P S l-n am e- 61.5 ± 5.0, n = 8).
The effects of endothelium removal on dilatation responses to the purinoceptor agonists 
are not described in the present study as this work has been reported previously 
(Buvinic et al., 2002; Malmsjo et a l , 2000a; Malmsjo et al, 2002; Malmsjo et al, 
1998; Malmsjo et al, 2000b; Malmsjo et al, 1999; Mistry et al, 2003). However, on 
occasion when the endothelium was removed by passage of an air bubble through the 
lumen the dilatation response to luminally-perfused UTP was abolished and a 
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Figure 6.2 Dilatation responses to luminal perfusion of ATP
A, B, Representative traces illustrating the effects of luminal perfusion of 
isolated rat small mesenteric arteries with A, MOPS-buffered salt solution 
and B, ATP (lpM). Filled triangles indicate addition of PE. Bars indicate 
periods of luminal perfusion of A, MOPS or B, ATP (lpM). L-NAME 
(lOOpM) present in B. C, Consecutive, non-cumulative concentration- 
dependent responses to ATP following constriction with PE (0.5-10pM) 
under control conditions and in the presence of L-NAME (lOOpM). Values 
are mean±s.e.mean n=4-14 responses. Arteries were perfused with MOPS 
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Figure 6.3 Dilatation responses to luminal perfusion of ATP, UTP and 
ADPpS
A, B, Representative traces illustrating the effects of luminal perfusion of 
A, UTP (3pM) and B, ADPpS (lpM) following constriction with PE (0.5- 
lOpM) . Filled triangles indicate addition of PE. Bars indicate periods of 
luminal agonist perfusion. C, Summary data illustrating mean consecutive, 
non-cumulative concentration-dependent responses to luminal perfusion of 
ATP (n =3-10), UTP («=4-5) and ADPpS («=2). Arteries were perfused 
with MOPS between each agonist concentration. L-NAME (lOOpM) 
present in all experiments.
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6.3.2. Activation of P2Yi and Kca by luminally-perfused agonists
The P2Yi receptor antagonist MRS2179 (lpM) significantly inhibited ATP (lpM; 
Figures 6.4A and C) and ADPpS (lpM; Figures 6.4B and C)-evoked dilatation 
responses but dilatations to UTP (3pM) and the M3 receptor agonist ACh (lpM) 
remained unaffected (Figure 6.4C).
In the presence of L-NAME (lOOpM), incubation with the selective IKca channel 
blocker, TRAM-34 (lfiM), had no effect on dilatation to luminally-perfused ATP 
(lOnM - 3pM; n -  5-6) ,  UTP (3|nM; n = 8) or ADPpS ( I j iM ;  n = 8) (Figure 6.5). In 
contrast, incubation with the selective SKca channel blocker, apamin (50nM), inhibited 
ATP-evoked vasodilatation causing a rightward shift of the concentration-response 
curve (Figure 6.5A; n = 5 - 10). This inhibition of ATP-evoked dilatation was most 
apparent when comparing responses to submaximal concentrations of ATP (lpM; 
Control: 77.4 ± 4.2, n = 9; Apamin: 33.6 ± 10.3%, n = 12; Figure 6.5B). Apamin had no 
significant effect on dilatation responses to either UTP (n = 10) or ADPpS (n = 11). 
Blockade of both IKca and SKca channels with a combination of TRAM-34 and apamin 
significantly inhibited dilatation responses to ATP, UTP and ADPpS (ATP: 12.9 ± 
3.5%, n = 9; UTP: 12.7 ± 6.1%, n = 9; ADPpS: 12.9 ± 3.5%, n = 9; Figure 6.5). This 
level of blockade by TRAM-34 and apamin is similar to that seen with ACh-evoked 
dilatation (lpM; Control: 89.6 ± 1.0%, n = 38; TRAM-34 and apamin: 21.1 ± 6.4%, n = 
20).
Raising extracellular K+ (35 - 40mM) in the presence of L-NAME (lOOpM) in both the 
bath and the lumen of isolated arteries completely abolished the relaxation response to 
each of the luminally-perfused purinoceptor agonists (n = 3) and ACh (lpM; n -  11).
6.3.3. Contribution of PKC to regulation of nudeotide-evoked vasodilatation 
responses
Experiments using a range of purinoceptor agonists were subsequently performed in an 
attempt to clarify some of the mechanisms contributing to the reversal of the dilatation 
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Figure 6.4 Effect of selective inhibition of P2Y, on dilatation to luminal 
perfusion of nucleotides
A, B, representative traces and C, summary data of paired responses 
illustrating the effect of the selective P2Yj inhibitor MRS2179 (lpM ) on 
dilatation responses to luminal perfusion of A, C, ATP (lpM ; n = 3), B, C, 
ADPpS (lpM ; n = 7) and C, UTP (3pM; n = 3) and ACh (lpM ; n = 6). Bars 
indicate periods of luminal agonist perfusion. Filled triangle indicates 
addition of PE. Clear triangle indicates addition of ACh. *, Significantly 
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Figure 6.5 Effect of K+ channel inhibition on dilatation to luminal 
perfusion of nucleotides
Summary data of unpaired responses showing A, the effects of TRAM-34 
(lpM ) and apamin (50nM) on consecutive, non-cumulative, concentration- 
dependent responses to ATP (n=3-14), and to compare, B, submaximal 
concentrations of ATP (lpM ; n=6-12), ADPpS (lpM ; «=8-ll) and UTP 
(3pM; rc=6-10). A, B, L-NAME (lOOpM) present in all experiments. *, 
Significantly different to control using the Kruskal-Wallis test followed by 
Dunn's multiple comparison post-test. Experiments performed by Dr. Kim 
Dora and Miss Hanna Norris contributed to the data collected for the ATP- 
evoked responses.
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reversal of the vasodilatation response, the first period of agonist luminal perfusion was 
extended such that upon attainment of the peak dilatation response luminal perfusion 
was continued for 4min. All experiments were performed in the presence of L-NAME 
(lOOpM).
6.33.1. ATP
When the period of ATP perfusion was extended compared to that shown in Figure 
6.2B, the initial peak dilatation response to ATP (lpM; 50.4 ± 6.1%, n -9) rapidly 
(within -lmin) reversed to a plateau value of 31.1 ± 5.3% maximal diameter. Cessation 
of flow completely reversed the dilatation response. During a second period of luminal 
perfusion dilatation responses were limited to the extent observed during the plateau 
phase of the first perfusion period (Figures 6.6A and C). Increasing the concentration of 
ATP to 3pM however, resulted in a dilatation response that was maintained at peak 
level (91.3 ± 1.5%, n -3) for the duration of the first and second luminal perfusion 
periods (Figures 6.7A and C). Cessation of flow resulted in a small reversal of the ATP 
(3pM) dilatation response.
In paired experiments, luminal incubation (to minimize smooth muscle effects) with the 
selective PKC inhibitor BIS I (lpM) tended to augment the vasodilatation to lpM ATP 
(Figure 6.6). This was observed together with a delay in the onset of the reversal of 
dilatation, a reduced reversal during the flow off period, and a rapid dilatation during 
the second flow on period (Figure 6.6). Thus BIS I tended to make the profile of the 
response to lpM ATP more closely match that of the control response to 3pM ATP 
(Figures 6.6B and 6.7A).
Incubation with BIS I during luminal perfusion of increased concentrations of ATP 
(3|iM; n -3, paired to L-NAME controls) reduced the extent of reversal of the 
vasodilatation response during the flow off period such that a dilatation of 82.0 ± 7.9% 
(compared to 47.4 ± 15.0% under control conditions) could still be achieved after 2min 
without flow (Figures 6.7B and C). No effects of BIS I on the vasodilatation to ATP 
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Figure 6.6 Effect of selective inhibition of PKC on dilatation to luminal 
perfusion of ATP (lpM)
Paired A, B, representative traces and C, meaned (n=9) data illustrating 
dilatation responses to extended luminal perfusion of ATP (lpM ) in the 
presence of A, B, C, L-NAME (lOOpM) and B, C, following incubation 
with the selective PKC inhibitor BIS I (lpM ) under A, B, C, submaximal 
levels of PE-evoked tone (0.1-lpM). A, B, C, Bars represent periods of ATP 
(lpM ) luminal perfusion. A, B, Filled triangle indicates addition of PE. A, 
Open triangle indicates addition of ACh (lpM). C, Time = 0s corresponds 
to start of 4min post-peak period.
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Figure 6.7 Effect of selective inhibition of PKC on dilatation to luminal 
perfusion of ATP (3|iM)
Paired A, B, representative traces and C, meaned (n=3) data illustrating 
dilatation responses to extended luminal perfusion of ATP (3pM) in the 
presence of A, B, C, L-NAME (lOOpM) and B, C, following incubation 
with the selective PKC inhibitor BIS I (lpM ) under A, B, C, submaximal 
levels of PE-evoked tone (0.3-1.8pM). A, B, C, Bars represent periods of 
ATP (3|liM) luminal perfusion. A, B, Filled triangle indicates addition of PE. 
C, Time = 0s corresponds to start of 4min post-peak period.
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6.33.2. ADPPS
As demonstrated previously (Figure 6.3B), immediately upon reaching the peak 
vasodilatation response to luminal perfusion of ADPpS (lpM; 70.0 ± 6.6%, n=l) the 
dilatation was rapidly reversed such that within 2min of the peak response a plateau 
dilatation response of 41.5 ± 6.1% was observed. In contrast to lpM ATP, this plateau 
was maintained following cessation of flow and during the second period of luminal 
perfusion (Figures 6.8A and C). In paired experiments, subsequent luminal incubation 
with BIS I increased the amplitude of the peak vasodilatation response (94.8 ± 1.0%) 
and delayed the reversal of the vasodilatation to ADPpS by ~2min so that in contrast to 
the L-NAME control, no change in artery diameter could be observed during the first 
2min of the first luminal perfusion period. However, BIS I treatment had no effects on 
the dilatation responses observed during the second period of ADPpS perfusion.
633.3. UTP
The profile of responses evoked by the extended luminal perfusion of UTP (3pM; n=3) 
were similar to those seen following perfusion of ATP (3pM) such that any effects of 
BIS I (n=3, paired to L-NAME control) could only be observed during the flow off 
period where a decrease in the reversal rate of the relaxation response could be observed 
(Figure 6.9). Consequently, the effects of BIS I on the time course of vasodilatation 
evoked by luminal perfusion of a lower concentration of UTP (lpM; n -3) were 
investigated in further paired experiments (Figure 6.10). In contrast to ADPpS (lpM) 
and ATP (lpM)-evoked vasodilatation responses the amplitude (23.2 ± 10.8%) or time 
course of vasodilatation to UTP (lfiM) during the first luminal perfusion period was not 
significantly increased following luminal incubation with BIS 1 (lpM; 38.2 ± 17.8%). 
However, during the flow off and second luminal perfusion periods an increase in the 
amplitude of vasodilatation could be observed (Figure 6.10).
6.33.4. ATPyS
In the rat mesenteric artery it is thought that UTP evokes its vasodilator actions through 
stimulation of P2Y2 receptors on the endothelium (Buvinic et al, 2002; Malmsjo et al., 
2000a; Malmsjo et al, 2000b). To more fully investigate the profile of P2Y2 receptor 
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Figure 6.8 Effect of selective inhibition of PKC on dilatation to luminal 
perfusion of ADPpS (lpM)
Paired A, B, representative traces and C, meaned (n=7) data illustrating 
dilatation responses to extended luminal perfusion of ADPpS (lpM ) in the 
presence of A, B, C, L-NAME (lOOpM) and B, C, following incubation 
with the selective PKC inhibitor BIS I (lpM ) under A, B, C, submaximal 
levels of PE-evoked tone (0.2-1.7pM). A, B, C, Bars represent periods of 
ADPpS (lpM ) luminal perfusion. A, B, Filled triangle indicates addition of 
PE. Open triangle indicates addition of ACh (lpM). C, Time = 0s 
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Figure 6.9 Effect of selective inhibition of PKC on dilatation to luminal 
perfusion of UTP (3pM)
Paired A, B , representative traces and C, meaned (n=3) data illustrating 
dilatation responses to extended luminal perfusion of UTP (3pM) in the 
presence of A, B , C, L-NAME (100pM) and B , C, following incubation 
with the selective PKC inhibitor BIS I (lpM ) under A, B , C, submaximal 
levels of PE-evoked tone (0.5-1.6pM). A, B , C, Bars represent periods of 
UTP (3pM) luminal perfusion. A, B , Filled triangle indicates addition of PE. 
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Figure 6.10 Effect of selective inhibition of PKC on dilatation to luminal 
perfusion of UTP (lpM)
Paired A, B, representative traces and C, meaned (n=3) data illustrating 
dilatation responses to extended luminal perfusion of UTP (lpM ) in the 
presence of A, B, C, L-NAME (lOOpM) and B, C, following incubation 
with the selective PKC inhibitor BIS I (lpM ) under A, B, C, submaximal 
levels of PE-evoked tone (0.5-1.3pM). A, B, C, Bars represent periods of 
luminal UTP (lpM ) perfusion. A, B, Filled triangle indicates addition of PE. 
Open triangle indicates addition of ACh (lpM). C, Time = 0s corresponds 
to start of 4min post-peak period.
L-NAME 
L-NAME & BIS I
178
luminal perfusion of the non-hydrolyzable P2 Y2 agonist ATPyS (Malmsjo et al, 2000a) 
were investigated.
Initiation of ATPyS perfusion (lfiM; n=4; Figures 6.11 A and C) evoked a rapid 
dilatation response that after peaking (70.6 ±9.1%) was reversed to reach a plateau of 
41.1 ±4.5% maximum diameter. Upon cessation of flow the dilatation response was 
completely and rapidly reversed. During the second luminal perfusion period a small 
dilatation response was seen. As observed for ATP (lpM)-evoked responses, the 
amplitude of this response was limited to the diameter attained during the plateau phase 
of the first luminal perfusion period (Figures 6.11A and C). Increasing the concentration 
of ATPyS within the luminal perfusate to 3pM (n=5) evoked a vasodilatation response 
(80.5 ± 4.0%) that was maintained for nearly the duration of the 4min primary luminal 
perfusion period (Figures 6.12A and C). As seen for the lpM ATPyS-evoked response 
cessation of flow caused a rapid reversal of the dilatation response, however this was 
not complete and slowed towards the end of the 2min period. The extent of 
vasodilatation upon re-application of luminal perfusion was then limited to the 
amplitude of dilatation observed towards the end of the first luminal perfusion period 
(53.1 ± 6.5%; Figures 6.12A and 6.12C).
Inclusion of BIS 1 in the lpM (n=4; paired to L-NAME controls) and 3pM (n=5; paired 
to L-NAME controls) ATPyS perfusate solutions facilitated a maintained peak 
vasodilatation response throughout both periods of luminal perfusion (Figures 6.1 IB, 
6.11C, 6.12B and 6.12C). Upon cessation of flow an initial rapid reversal of the 
dilatation response was observed in the case of both agonist concentrations, however 
this quickly plateaued at -60% maximum diameter for both lpM and 3jiM ATPyS.
6.33.5. ACh
To ascertain whether inhibition of PKC with BIS I directly enhanced EDHF-type 
vasodilatation responses the effects of BIS I on concentration-dependent dilatation 
responses to ACh (InM - 3pM; n=7) were evaluated. There was no significant effect of 
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Figure 6.11 Effect of selective inhibition of PKC on dilatation to luminal 
perfusion of ATPyS (lpM)
Paired A, B, representative traces and C, meaned (n=4) data illustrating 
dilatation responses to extended luminal perfusion of ATPyS (lpM ) in the 
presence of A, B, C, L-NAME (lOOpM) and B, C, following incubation 
with the selective PKC inhibitor BIS I (lpM ) under A, B, C, submaximal 
levels of PE-evoked tone (0.3-0.9pM). A, B, C, Bars represent periods of 
luminal ATPyS (lpM ) perfusion. A, B, Filled triangle indicates addition of 
PE. A, Open triangle indicates addition of ACh (lpM). C, Time = 0s 
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Figure 6.12 Effect of selective inhibition of PKC on dilatation to luminal 
perfusion of ATPyS (3pM)
Paired A, B, representative traces and C, meaned (n=5) data illustrating 
dilatation responses to extended luminal perfusion of ATPyS (3pM) in the 
presence of A, B, C, L-NAME (100pM) and B, C, following incubation 
with the selective PKC inhibitor BIS I (lpM ) under A, B, C, submaximal 
levels of PE-evoked tone (0.4-1.7pM). A, B, C, Bars represent periods of 
luminal ATPyS (3pM) perfusion. A, B, Filled triangle indicates addition of 
PE. A, Open triangle indicates addition of ACh (lpM ). C, Time = 0s 
corresponds to start of 4min post-peak period.
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Figure 6.13 Effects of selective inhibition of PKC on ACh-evoked vasodilatation.
The effects of luminal BIS I (lpM ) on concentration-dependent dilatation responses to 
cumulative additions of ACh (lnM-3pM; n=7) following submaximal pre-constriction 




Aspects of the experiments detailed herein are consistent with previous reports: Luminal 
application of the P2Yi receptor agonists ATP, ADPpS and the likely P2 Y2 receptor 
agonist UTP evoked robust vasodilatation responses, which were shown to comprise a 
significant EDHF-facilitated component (Buvinic et al, 2002; Liu et al, 2004; Liu et 
al, 2006a; Malmsjo et a l , 2000a; Malmsjo et a l , 2002; Malmsjo et al, 1998; Malmsjo 
et a l , 2000b; Malmsjo et al, 1999; Mistry et al, 2003). On closer examination, 
however, EDHF-type dilatation responses to the luminal perfusion of purinoceptor 
agonists were also found to be differentially sensitive to inhibition of IKca and SKca. 
Submaximal concentrations of ATP evoked responses requiring SKca activation in order 
to evoke a full dilatation whilst UTP-, and to a large extent ADPpS-evoked dilatations 
were achieved by activation of either IKca or SKca alone. Additionally, experiments 
performed to begin to characterize the profile of the ATP-, ADPpS-, UTP- and ATPyS- 
evoked vasodilatations found PKC contribute to both the decay and blunting of the 
responses.
Within the present study ATP-evoked responses were almost completely attenuated by 
treatment with the selective P2Yi inhibitor MRS2179 (lpM) (Boyer et al, 1998). 
Previous reports citing inhibition of ATP-evoked dilatation responses in the rat 
mesenteric arterial bed document incomplete blockade with MRS2179, attributing the 
remainder of the dilatation response to activation of P2 Y2 receptors (Buvinic et al, 
2002; Malmsjo et al, 2002). However, within the present report ATP was 
approximately 10-fold more potent than UTP, which could tentatively (given the 
variability associated with ectonucleotidase activity; Chen & Chen, 1997) rule out a 
predominant role for P2 Y2 activation in the ATP-evoked response (Buvinic et al, 2002; 
Malmsjo et al, 2002; Ralevic & Bumstock, 1998). UTP- and ACh-evoked responses 
were both unaffected by MRS2179 suggesting that the concentration used would appear 
selective for P2Yi as demonstrated previously (Boyer et al, 1998). Thus the present 
results probably reflect the breakdown of ATP to ADP by endothelial cell 
ectonucleotidases (Figure 1.10) prior to its action on the endothelium (Alvarado- 
Castillo et al, 2005; Koziak et al, 1999). Why such activity should be observed in the 
present study and not in that of Buvinic et al (2002) is unclear. Further experiments 
employing the ectonucleotidase inhibitor ARL67156 to prevent ATP breakdown with
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subsequent evaluation of the MRS2179 sensitivity of the dilatation response are 
required to establish this.
6.4.1. The contribution of IKca and SKCa to nucleotide-evoked dilatation 
responses
The contributions of EDHF and NO to purinoceptor-mediated dilatation responses in 
the rat mesenteric artery are well documented. Thus the complete attenuation of ATP, 
ADPpS and UTP-evoked dilatation responses by selective inhibition of eNOS, IKca and 
SKca would support such data (Buvinic et al, 2002; Liu et al, 2004; Liu et al, 2006a; 
Malmsjo et al, 2002; Malmsjo et al, 1998; Malmsjo et al, 1999; Mistry et al, 2003). 
However, the differential contribution of the IKca and SKca channels to the P2Yi and 
P2Y2-evoked dilatation responses perhaps highlights a facet of EDHF-type dilatation 
responses, the differential contribution of IKca and SKca, that is becoming increasingly 
well recognised (Crane et al, 2003a; Sandow et al, 2006). Patch clamp studies have 
reported that ATP-evoked endothelial cell hyperpolarization was dependent on 
activation of SKca, attributing the lack of an IKca current to a spatial 
compartmentalization of the ATP-evoked Ca2+ response (Marchenko, 2002). More 
recently reports have been published (Sandow et al, 2006) that support the differential 
localization of SKca and IKca within the endothelium: SKca localized to endothelial cell 
borders, whilst IKca is localized to areas adjacent to holes in the IEL. It is therefore 
possible that the differential contribution of the two Kca channels to ATP and UTP- 
evoked dilatations is associated with a discrete localization of the P2Yi and P2Y2 
receptors themselves, or their associated Ca2+ responses (Figure 6.14).
A recent report from Marrelli et al (2006) using rat isolated and pressurized middle 
cerebral arteries describes an association of UTP-evoked dilatation responses with both 
apical and baso-lateral increases in endothelial cell Ca2+. Given the activation of EDHF- 
type responses in the current report by either IKca or SKca and the localization of IKca 
to the MEGJ, it is thus speculated, albeit with caution given results to the contrary in 
cultured calf pulmonary endothelial cells (Madge et al, 1997), that within the rat 
mesenteric artery similar baso-lateral and apical increases in endothelial cell Ca2+ in 
response to UTP would be observed. Interestingly, Marrelli et al (2006) documented a 
PLA2- and TRPV4-dependency of the baso-lateral increase in endothelial cell Ca2+ that
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Figure 6.14. Proposed pathways leading to the differential activation of IKca and 
SKca downstream of ATP and UTP stimulation
Cartoon illustrating the mechanisms by which ATP and UTP could differentially 
activate IKca and SKca channels downstream of receptor activation. ATP-evoked 
hyperpolarization and dilatation would be predominantly evoked by an apical increase 
in intracellular Ca2+ in the vicinity of SKca localized to the endothelial cell border 
(Marchenko, 2002; Sandow et al., 2006). A small IKca component could be facilitated 
by diffusion of Ca2+ to the MEGJ (dashed line). In contrast, UTP would facilitate 
endothelial cell hyperpolarization and dilatation by apical activation of SKca followed 
by a baso-lateral mechanism of Ca2+ release and activation of MEGJ IKca (Marelli et 
al., 2006; Sandow et al., 2006). The latter occurring by; 1), diffusion of signalling 
molecules and activation of a distinct Ca2+ release mechanism; 2), direct stimulation of 
P2Y2 receptors on the baso-lateral surface of the endothelium; or 3), by diffusion of the 
Ca2+ response from the apical surface.
was not characteristic of the apical Ca2+ response. ATP-evoked endothelial cell 
increases in cytosolic Ca2+ have been described, and their dependence on SOCC and 
IP3-mediated release from intracellular stores documented (please see section 1.2.3; 
Chen et al., 1996; Liu et al., 2006a; Madge et al., 1997). However, a role for PLA2 in 
the ATP-evoked Ca2+-dependent response has not. It would therefore be of interest to 
evaluate the sub-cellular localization of endothelial cell Ca2+ responses to both ATP and 
UTP within the rat mesenteric artery and elucidate the sensitivity of these responses to 
PLA2 inhibition.
Compartmentalization of endothelial P2Y receptors has been reported within guinea-pig 
aortic ring preparations (Kaiser et al., 2002). Upon p-methyl-cyclodextrin treatment to 
disrupt cholesterol-rich microdomains, Ca2+ release and NO-dependent dilatation 
responses to the P2Y agonists 2-methylthio-ATP, ADP, ATP and UTP were disrupted.
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In contrast Ca2+ responses to bradykinin or ACh and dilatation to the Ca2+ ionophore 
A23187 were unaffected, implying an association of P2Y receptors with cholesterol- 
rich microdomains (Kaiser et a l, 2002). A recent report from Weerth et al (2007) 
detailing Ca2+ responses in rat glial cells in response to activation of P2Yi documented 
the co-immunoprecipitation and expression of signalling proteins such as PLCpi, 
IP3R2 , PKCa, and TRPCi to these microdomains, detailing that the number of 
signalling proteins in the microdomains increased upon P2Yi stimulation (Weerth et al, 
2007). One component of the report of Weerth et al (2007) of interest is therefore the 
question whether complete association of all of the P2Yi downstream signalling 
proteins is required to evoke even the smallest increases in intracellular Ca2+? Can the 
degree of receptor stimulation influence the extent of signalling protein association and 
subsequently have a graded influence on the spatiotemporal characteristics of the 
downstream Ca2+ response? If so, this would highlight a mechanism by which the cell 
may differentiate between the apparently promiscuous physiological P2Y agonists.
Were our hypothesis of a differential contribution of IKca and SKca to P2Yi and P2 Y2- 
evoked responses to be true, the responses to ADPpS and ATP should be similarly 
dependent on activation of SKca- However, the results of the present study would 
suggest that the ADPpS-evoked dilatation response is facilitated by activation of either 
SKca or IKca alone. Such differences between the ATP and ADPpS response are 
unlikely to be associated with their differing capacity for breakdown by luminal 
ectonucleotidases as the flow-dependent nature of the UTP-evoked response could be 
facilitated by activation of either SKca or IKca- It is therefore proposed that these results 
may reflect a differential activity of ATP and ADPpS at the P2Yi receptor (Gallagher & 
Salter, 2003).
Addition of the thiol group to the p phosphate moiety of the adenine nucleotide may 
instill ADPpS with a greater affinity for the P2Yi receptor than ATP (ADP) by 
increasing the strength of binding of the negatively charged phosphate moieties with the 
positively charged binding site (Jiang et al, 1997). As a result ADPpS may associate 
with the P2Yi receptor for longer or evoke different conformational changes in the 










Figure 6.15. Proposed pathways leading to the differential activation of IKca and 
SKca downstream of ATP and ADPpS stimulation
Cartoon illustrating the mechanisms by which ATP and ADPpS could differentially 
activate IKca and SKca channels downstream of receptor activation. ATP-evoked 
hyperpolarization and dilatation would be predominantly evoked by an apical increase 
in intracellular Ca2+ in the vicinity of SKca localized to the endothelial cell border 
(Marchenko, 2002; Sandow et al., 2006). A small IKca component could be facilitated 
by diffusion of Ca2+ to the MEGJ (dashed line). In contrast, due to differential binding 
characteristics ADPpS, would facilitate endothelial cell hyperpolarization and dilatation 
by both apical activation of SKca followed by a baso-lateral mechanism of Ca2+ release 
and activation of MEGJ IKCa (Sandow et al., 2006). The latter occurring by; 1), 
diffusion of signalling molecules and activation of a distinct Ca2+ release mechanism; 
or, 2), diffusion of the Ca2+ response from the apical surface.
signalling proteins with the receptor and a larger or more diffuse endothelial cell Ca2+ 
response. Diffusion of Ca2+ to the baso-lateral portion of the endothelial cell, whether 
by signalling intermediates or by direct spread of Ca2+ would then facilitate activation 
of both SKca and IKca (Figure 6.15; Sandow et a l, 2006).
To test such a hypothesis it would be essential to study the Ca signal downstream of 
P2Yi and P2Y2 receptor activation by ATP, ADPpS, and UTP, possibly using the Rhod 
Ca2+ indicators in conjunction with Lucifer yellow staining of the IEL as has been 
described (please see chapter 3). However acceptance of such proposals for the 
differential activation of IKca and SKca by ATP, UTP and ADPpS is also limited by the 
lack of selective antibodies for the P2Y purinoceptors and therefore, the limited 
knowledge with regards to the in vitro localization of the receptors within the arterial 
wall. Therefore it is proposed that upon development of selective antibodies for the
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P2Yi and P2 Y2 receptors, further experiments be performed to elucidate the localization 
of the P2Y1 and P2 Y2 receptors relative to the IKca and SKca channels.
6.4.2. Contribution of PKC to desensitization of the nucleotide-evoked dilatation 
response
In contrast to previous reports (Liu et a l , 2004) dilatation responses in the present study 
could not be evoked by flow alone (n = 5). Given the large n value (99) documented by 
Liu et al (2004), the present results probably reflect the inconsistency with which flow- 
dependent responses are evoked in this preparation (54% of arteries tested; Liu et a l, 
2004). Upon inclusion of ATP or UTP in the perfusate, dilatation responses were 
observed that were of a similar profile to those described previously (Liu et a l , 2004) 
and as such are consistent with the idea that the flow-dependent nature of the responses 
reflects the breakdown of ATP and UTP by ectonucleotidases in the absence of flow. 
Luminal perfusion of the nucleotides increases the effective concentration at the 
endothelial cell surface thus increasing the likelihood of receptor activation (Berra- 
Romani et al, 2004). However, a flow-independent reduction in the dilatation response 
to the non-hydrolyzable analogues of ADPpS was also observed. Given the limited 
dilatation upon repeated luminal perfusion of ADPpS such a reduction in the dilatation 
response likely reflects a desensitization of the response that cannot be overcome. The 
limited breakdown of the ADPpS by ectonucleotidases minimizing the differences in 
agonist concentration seen in the presence and absence of flow (Liu et al, 2004).
The requirement for ATP and UTP to be continually perfused through the lumen in 
order to evoke a robust vasodilatation response reflects the nature with which the 
nucleotides may be released into the lumen physiologically. A decrease in PO2 in 
response to increased tissue metabolism would stimulate nucleotide release from 
circulating red blood cells, which would lead to vasodilatation (reflected by our luminal 
perfusion period). The subsequently increased blood flow would then increase the PO2, 
inhibiting nucleotide release and reversing the vasodilatation response (reflected by our 
‘flow off period) (Dietrich et al, 2000; Ellsworth, 2004; Ellsworth et al, 1995; 
Gonzalez-Alonso et al, 2002). The desensitization of the dilatation response to the non- 
hydrolyzable agonists thus possibly reflects a negative feedback mechanism that may be
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associated with limiting this vasodilatation response to ensure that adequate blood flow 
to other tissues is maintained.
Desensitization of P2Yi and P2Y2-evoked responses by various isoforms of PKC has 
been proposed for a number of cell types, including bovine pulmonary artery 
endothelial cells, mouse neuroblastoma cells, human platelets and rat renal mesangial 
cells (Chen & Lin, 1999; Chen & Chen, 1997; Hardy et al, 2005; Pfeilschifter & 
Huwiler, 1996; Ralevic & Bumstock, 1998). As yet there are no other reports 
documenting the modulation of endogenous P2Yi and P2Y2 receptors by PKC in intact 
arteries. The reduction of GPCR activity by PKC is associated with the phosphorylation 
of the C-terminus or third intracellular loop of the activated GPCR by the serine- 
threonine kinase, which prevents the association of the receptor with downstream 
signalling proteins. Receptor internalization and degradation are not associated with the 
PKC-mediated desensitization of agonist-evoked responses (Bailey et al, 2006; 
Gainetdinov et al, 2004; Garrad et al, 1998; Otero et al, 2000). At least 12 isoforms of 
PKC have been identified which are localized to and contribute differently to cell 
function depending on the cell type and receptor under study (Chen & Lin, 1999). Each 
isoform may belong to one of three classes, the conventional PKC isoforms (a, pi, p2 
and y), the new isoforms (8, e, r| and 0) and the atypical isoforms (£, X, i and p) (Chen 
& Chen, 1997). BIS I, a non-isoform selective PKC inhibitor was used in the present 
study, as the non-selective effects of the inhibitor on other protein kinases are relatively 
minimal (Davies et al, 2000).
Previous reports have shown that within bovine pulmonary artery endothelial cells 
PKCpi, e and p translocate to the cell membrane upon activation and that PKCpi 
mediates the rapid desensitization of P2Yi and P2Y2-evoked dilatation responses (Chen 
& Lin, 1999). The present results are therefore consistent with such an observation as 
the reversal of the P2Yi and P2Y2 receptor-stimulated responses were at least partly 
dependent on the activation of PKC. However, within the current study selective 
activation of P2 Y2 receptors with ATPyS was the only dilatation response that could be 
fully maintained in the presence of flow following inhibition of PKC. Given that both 
the ATPyS- and UTP-evoked dilatation responses are most likely associated with 
endothelial cell P2 Y2 receptor activation (Buvinic et al, 2002; Malmsjo et al, 2000a),
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dilatation responses to UTP would be expected to be similarly affected by BIS I. 
However, the differences between the dilatation responses to the two agonists could 
reflect concentration differences at the endothelial surface due to the breakdown of 
UTP. Indeed the ability of UTP to evoke a full and sustained dilatation response at 3pM 
(identical to the profile of dilatation to 3pM ATPyS) would support such a theory. In 
contrast, the remaining reversal of the dilatation response to both ATP and ADPpS in 
the presence of BIS I could possibly indicate an influence of other protein kinases such 
as PKA and the G protein receptor-coupled kinases (GRKs) on the P2Yi purinoceptor 
(Gainetdinov et a l , 2004).
In contrast to the present report, Otero et al (2000) have advanced the suggestion that 
the regulation of P2 Y2 receptors may be partly mediated by GRKs whilst Hardy et al 
(2005) have documented that desensitization of the P2Yi receptor is fully mediated by 
activation of PKC. These differences in the documented contributions of PKC to P2Y 
receptor desensitization most likely reflect the fact that the contribution of each protein 
kinase to the dilatation response is dependent on the agonist used to evoke receptor 
activation, the level of desensitization observed, the cell type studied and the duration of 
agonist exposure (Bailey et a l , 2006; Gainetdinov et al, 2004; Garrad et al, 1998; 
Otero et al, 2000).
Within the present study therefore, where agonists are applied luminally and the 
response controlled from the attainment of peak vasodilatation, a degree of 
experimental error must arise from the actual contact time of the agonist with the 
endothelium and the real concentration of agonist at the endothelial cell surface. Indeed, 
the lack of desensitization of the 3fiM ATP, 3pM ATPyS and 3 jiM  UTP-evoked 
responses suggest that concentration-dependent effects appear also to be involved. A 
limitation of the current technique was the inability to assess desensitization over the 
first 1 -  2min of agonist perfusion, due to the dead space volume (~100pl) that needed 
to be cleared before the agonists reached the artery lumen. Therefore if rapid 
desensitization occurred, the current set-up could not measure it. A more detailed 
interpretation of the contribution of PKC, or indeed other protein kinases to the 
dilatation response would therefore most likely be achieved by minimizing the dead 
space volume between the lumen of the artery and the start point of agonist perfusion
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and by analyzing the initial part of the dilatation response. Further improvements to the 
protocol may then also be achieved by inclusion of a fluorescent dye in the purinoceptor 
agonist solution. Using concurrent visualization of luminal fluorescence and artery 
diameter it would be possible to measure the rate of agonist delivery in the lumen of the 
artery and subsequently also the duration of agonist exposure, minimising variability 
within the experimental protocol.
In conclusion the present report demonstrates that EDHF-type dilatation responses 
evoked by ATP, UTP and ADPpS were differentially dependent on IKca and SKca. 
Pending the results of further work, we propose that the differential contribution of the 
two Kca may reflect differential activation of endothelial cell P2Y receptors and the 
subsequent activation of discrete spatiotemporal Ca2+ signals. Further preliminary 
results suggest that both P2Yi and P2 Y2 responses are modulated by downstream 
activation of PKC although a role for other protein kinases is not discounted by the 
results of the present study.
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7. Nucleotide-evoked conducted dilatation responses
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7.1. Introduction
Conducted vasodilatation responses are essential for the maintenance of sufficient tissue 
perfusion during periods of increased tissue metabolism and hypoxia (Dora et al, 
2000a; Kuijiaka & Segal, 1995; Segal, 2005; Segal & Duling, 1986a). As such, 
extensive studies have been performed to elucidate the mechanisms associated with 
these responses (please see chapter 5). Of the mechanisms described most investigators 
conclude cell-to-cell conduction of hyperpolarization through gap junctions within the 
endothelium to be the most significant (de Wit et al, 2000; de Wit et al, 2006b; 
Emerson & Segal, 2001; Emerson & Segal, 2000b; Figueroa et al, 2003; Takano et al, 
2004).
The majority of experiments performed to investigate this phenomenon employ the 
robust agonist ACh to evoke the local vasodilatation response. Conducted dilatation 
responses to more physiologically relevant agonists such as ATP and UTP, both of 
which may be prevalent in the blood stream under exercising conditions and instances 
of tissue ischaemia (please see section 6.1; Erlinge et al, 2005; Rosenmeier et al, 2004; 
Wihlborg et al, 2006) have, however, been scarcely documented. A few studies of 
conducted vasodilatation responses to ATP and adenosine have been performed within 
the small arterioles and vascular beds of the microcirculation (Delashaw & Duling, 
1991; Dietrich et al, 1996; Duza & Sarelius, 2003; Kajita et al, 1996; McCullough et 
al, 1997). However, given that the larger resistance-sized arteries of the vasculature 
may also contribute significantly to the regulation of total peripheral resistance (please 
see section 1.1.1; Fenger-Gron et al, 1997; Fenger-Gron et al, 1995; Mulvany & 
Aalkjaer, 1990) it would seem crucial that such responses are also investigated in 
vessels of this size.
Conducted vasodilatation responses to both ACh and LVK have been documented 
within the larger resistance arteries of the rat mesenteric bed and are most likely present 
to maintain perfusion to the smaller downstream feed arteries (please see chapter 5; 
Dora et al, 2000a; Goto et al, 2004; Kuijiaka & Segal, 1995; Takano et al, 2004). 
Importantly, radial EDHF-type dilatation and hyperpolarization responses, the latter a 
prerequisite for the conducted vasodilatation response, have also been documented 
within this preparation following application of a range of purinoceptor agonists (please
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see chapter 6; Delashaw & Duling, 1991; Dora et al, 2003b; Liu et al, 2006a; Malmsjo 
et al, 1999; Mistry et al, 2003; Neild & Crane, 2002; Takano et al, 2005). Therefore 
within the present study, experiments were performed to explore whether the 
vasodilatation response of the rat small mesenteric artery to purinoceptor agonists could 
propagate longitudinally through the wall of these resistance arteries to evoke a 
spreading vasodilatation s previously observed for ACh and LVK (please see chapter 5; 
Goto et al, 2004; Takano et al, 2004). As many purinoceptor agonists also evoke 
vasoconstriction responses when applied abluminally (Galligan et al, 2001; Gitterman 
& Evans, 2000; Harrington & Mitchell, 2004; Malmsjo et al, 2000a) conducted 
dilatation responses to luminally-perfused purinoceptor agonists were also evaluated 
using a novel triple cannulation technique.
Aspects of this work have been described previously (Winter & Dora, 2006a).
194
7.2. Methods
7.2.1. Rat mesenteric artery isolation and cannulation
Please see section 2.1 for methods of artery isolation.
7.2.2. Pressure myography
Arteries were mounted in custom-built organ baths (0.5ml; Figure 2.2). For cannulation 
and equilibration methods please see section 2.2, Endothelial cell viability was assessed 
as a >90% control dilatation to ACh (lpM) following pre-constriction with PE (1 - 
3pM). Arteries were maintained at 50mmHg and 37°C unless otherwise stated.
7.2.3. Focal abluminal stimulation of pressurized arteries
Please see section 2.3 for details of the methods used for the focal stimulation of 
arteries. In summary bolus doses of agonists were pressure-pulse ejected to the 
downstream end of arteries and dilatation responses simultaneously measured at sites up 
to 2mm upstream.
7.2.4. Focal luminal application of agonists
The three ends of arteries with a bifurcation at the downstream end were cannulated and 
mounted in a heated, 2ml chamber (Warner Instruments) and continuously superfused at 
2ml min'1. The upstream and downstream perfusion pressures through the feed artery 
were adjusted to generate luminal flow (7 -  9cmH20 gradient, 30 - 50pl m in1), whilst 
maintaining a constant pressure at the bifurcation to avoid upstream flow of infused 
agonists. Agonist solutions were luminally-perfused into one of the side branches for at 
least 2min at 50pl min1 using a BeeHive® syringe pump system (Bioanalytical 
systems, USA). In all experiments the movement of perfusion solution was monitored 
by including 0.1 pM carboxyfluorescein in the agonist solution (Figure 7.1).
7.2.5. Drugs and solutions
All drugs and solutions were prepared as detailed previously (please see section 2.6). 
Drugs used to characterise conducted dilatation responses were added to the superfusate 
reservoir prior to artery superfusion. Inhibitors were only applied luminally where 
necessary (please see section 2.6). L-NAME (lOOpM) was present throughout all 
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Figure 7.1 The triple cannulation technique for evaluation of spreading dilatation 
responses to luminally-perfused agonists
Diagrammatic representation and representative image of a triple cannulated rat small 
mesenteric artery for the study of conducted dilatation responses to luminally-perfused 
agonists. Using a third cannulating pipette, one branch at an arterial bifurcation (Branch 
1) was cannulated, through which perfusate containing agonists and carboxyfluorescein 
(0.1 pM) was infused. The second panel illustrates the limited upstream diffusion of the 
agonist using this method (the arterial wall visible due to autofluorescence), the small 
boxes indicating the positions of fluorescence measurement, and relate to the positions 
at which diameter was measured from the simultaneous brightfield images, 2000pm 
being the furthest upstream. Bar=500pm.
has been shown to have no effect on purinoceptor agonist or ACh-evoked dilatation 
responses within the rat mesenteric artery (please see section 1.3.2.4; Mistry et al., 
2003).
7.2.6. Data analysis
Data for conducted dilatation responses to abluminally-applied agonists were collected 
and analysed as has been described previously (please see section 5.2.8) with the 
exception that analysis of the speed of the conducted dilatation response was not 
performed. For analysis of conducted dilatation responses to luminally-perfused 
purinoceptor agonists arteries were visualized using a laser scanning confocal 
microscope (FV500-SU, Olympus, Japan, excitation 488nm, emission 505nm) to enable
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simultaneous fluorescence and brightfield imaging, with a 4x/0.13NA objective 
(UplanFl, Olympus, Japan), and images were recorded with Fluoview software 
(Olympus, USA) at 1Hz. As mentioned previously (please see section 5.2.8) the 
resolution of the system using the 4x/0.13NA objective was 5 pm (equivalent to 1 pixel, 
circa 1.5% of the maximum diameter of the arteries). There was a short delay in 
observing responses to luminal perfusion of agonists due to voiding the tubing and 
pipette dead-space volume.
For all spreading dilatation responses artery outer diameter was analysed using motion 
analysis software (Metamorph, Universal Imaging, USA) as has been described 
previously (please see section 2.5.2). For spreading dilatation responses to luminally- 
applied agonists fluorescence intensity was also measured offline simultaneously at 
multiple positions in the lumen of arteries and subsequently matched to the diameter 
measurements also made at those positions but on the outer edge of the artery wall 
(Figure 7.1). Fluorescence intensity (F) relative to the maximum fluorescence obtained 
during perfusion periods (Fmax) was expressed as the relative change (F/Fmax) for each 
luminal region of interest.
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7.3. Results
All experiments were performed in the presence of the selective eNOS inhibitor L- 
NAME (IOOjliM).
73.1. Spreading dilatation to focal abluminal application of nucleotides
When applied focally to the outside of isolated, pressurized arteries at a downstream 
position ATP (ImM, 30 - 300ms, n = 4) stimulated a biphasic response comprising a 
robust vasoconstriction (0pm; 50.2 ± 6.6%) immediately followed by a small 
vasodilatation (0pm; 17.53 ± 7.5%; Figures 7.2A and 7.4). Both phases were conducted 
upstream (2000pm; Constriction, 13.7 ± 1.5%, Dilatation, 21.1 ± 11.5%; n = 3; Figure
7.4) such that local (0pm) and spreading (500 - 2000pm) responses occurred 
synchronously (Figure 7.2A). In contrast, focal abluminal application of UTP (ImM, 30 
- 1000ms, n = 4) caused only a spreading vasoconstriction (0pm, 66.2 ± 13.9, n = 4; 
2000: 11.0 ± 4.8%, n = 3; Figures 7.2B and 7.4) that was synchronous at both local and 
upstream sites (Figure 7.2B).
In order to evaluate if the relatively small dilatation response to abluminal (versus 
luminal; Figures 6.2 and 7.8) application of ATP was due to its breakdown at the 
smooth muscle surface before it could reach the endothelium as either ATP or ADP, the 
response to focal abluminal application of ADPpS (ImM, 30ms, n = 4) was studied. 
The dilatation response to ADPpS was greater in amplitude at the local site than that 
seen for ATP (90.29 ± 5.9%) and, but for a small transient local constriction (23.1 ± 
3.7%), more closely resembled ACh-evoked spreading responses at local and distal sites 
(Figures 7.3A and 7.4). In contrast when similar experiments were carried out to 
evaluate the efficacy of ATPyS (ImM, 10 - 100ms, n = 4) as a dilator (rather than UTP, 
which may be broken down at the smooth muscle surface) a response akin to that seen 
with ATP was observed: A biphasic response constituting an initial spreading 
constriction (0pm: 54.2 ± 16.9%; 2000pm: 16.7 ± 7.4) followed by a spreading 
dilatation that in some cases appeared masked at the local site by the extensive 
constriction (0pm: 14.5 ± 7.9%; 2000pm: 33.6 ± 2.9; Figures 7.3B and 7.4).
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Figure 7.2 Local and spreading dilatation and constriction responses to 
abluminal application of ATP and UTP
Using a micropipette positioned at the downstream end of the artery, 
agonists were pressure-pulse ejected as bolus doses. The figure shows 
representative traces of the local (0pm) and spreading (500 - 2000pm) 
responses to A, ATP (ImM, 100ms) and B, UTP (ImM, 300ms). Images 
were acquired at 12Hz. Diameter was measured simultaneously at all 
positions along the artery. L-NAME (lOOpM) present in all experiments.
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Figure 7.3 Local and spreading dilatation and constriction responses to 
abluminal application of ADP0S and ATPyS.
Using a micropipette positioned at the downstream end of the artery, 
agonists were pressure-pulse ejected as bolus doses. The figure shows 
representative traces of the local (0pm) and spreading (500 - 2000pm) 
responses to A, ADP|3S (ImM, 100ms) and B, ATPyS (ImM, 300ms). 
Images were acquired at 12Hz. Diameter was measured simultaneously at 
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Figure 7.4 Summary of local and spreading dilatation and 
constriction responses to abluminal application of nucleotides
Summary data showing mean spreading responses to abluminal 
application of ATP (ImM, 30 - 300ms, n=4), ADPpS (ImM, 30ms, n=4), 
UTP (ImM, 30-1000ms, n=4), ATPyS (ImM, 10-100ms, n=4) and, for 
comparison, ACh (ImM, 30-100ms, n=5). The biphasic nature of the 
conducted responses to the nucleotides is represented by the peak 
dilatation (solid lines) and constriction (broken lines) responses to each 
agonist. L-NAME (lOOpM) present in all experiments.
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7.3.2. Effects of P2Yi and Kca inhibition on nucleotide-evoked spreading 
responses
Spreading dilatation responses evoked by abluminal application of bolus doses of ATP 
(ImM, 30ms, n = 3) and ADPpS (ImM, 10 - 30ms, n = 3) were reduced by selective 
inhibition of P2Yi receptors with MRS2179 (lpM; Figure 7.5). In contrast constriction 
responses to either agonist were not influenced by treatment with MRS2179 (Figure
7.5). Dilatation responses to ATPyS (ImM, 10 - 30ms, n = 3) and ACh (ImM, 3 - 
100ms, n = 3) were also largely unaffected although a larger ATPyS-evoked 
constriction response was observed at the local site (Figure 7.6).
Selective blockade of IKca and SKca with TRAM-34 (lpM) and apamin (50nM) 
completely blocked spreading dilatation responses to ATP (ImM, 100ms, n -  3; Figure 
7.7A) and ADPpS (ImM, 10-30ms, n = 3; Figure 7.7B).
7.3.3. Spreading dilatation to luminally-perfused nucleotides
Luminal perfusion of ATP (1 or 3pM; Figure 7.8A), UTP (3 or lOpM) or ADPpS (1 or 
3pM) into a side branch of a triple cannulated artery evoked a robust local (Branch 1; 
ATP, 90.0 ± 3.7%, n = 6- UTP, 81.5 ± 6.7%, n = 6; ADPpS, 85.8 ± 5.0% n = 6; Figure 
7.8B) dilatation response that was only slightly, if at all, reduced as it passed into the 
feed artery (0pm; ATP, 80.8 ± 3.5%; UTP, 75.8 ± 10.8%; ADPpS, 80.0 ± 6.6%; Figure 
7.8B). Dilatation responses to ATP, UTP and ADPpS all spread upstream into the feed 
artery to remote regions not directly stimulated by the agonist (Figure 7.8). Although 
the spreading dilatation responses decayed with distance (2000pm; ATP, 8.7 ±2.5%; 
UTP, 9.8 ± 1.1%; ADPPS, 9.3 ± 4.2%; Figure 7.8B) small dilatation responses were 
still observed at distances greater than 2mm from the site of stimulation. In contrast, 
local dilatation responses to concentrations of adenosine (lOOpM) sufficient to evoke a 
matched dilatation in Branch 1 (76.7 ± 5.0%) decayed to an extent such that even the 
local dilatation response in the feed artery was greatly reduced (0pm, 39.6 ± 7.1%). 
Local (Branch 1 and 0pm) and spreading dilatation (500 - 2000pm) responses to all 
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Figure 7.5 Effect of MRS2179 on local and spreading dilatation and 
constriction responses to abluminally-applied ATP and ADPpS
Summary data illustrating the effect of luminal and abluminal incubation 
with MRS2179 (lpM) on mean spreading responses to A, ATP (ImM, 
30ms, n-3, unpaired), and B, ADPpS (ImM, 10 - 30ms, n=3, paired). The 
biphasic nature of the responses is represented by the peak dilatation (solid 
lines) and constriction (dotted lines) responses to each agonist. L-NAME 
(lOOpM) present in all experiments. Please note that the control data for 
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Figure 7.6 Effect of MRS2179 on local and spreading dilatation and 
constriction responses to abluminally-applied ATPyS and ACh
Summary data illustrating the effect of luminal and abluminal incubation 
with MRS2179 (lpM ) on spreading responses to A, ATPyS (ImM, 10 - 
30ms, n -3, unpaired), and B, ACh (ImM, 3 - 100ms, n - 3, unpaired). The 
biphasic nature of the responses is represented by the peak dilatation (solid 
lines) and constriction (dotted lines) responses to each agonist. L-NAME 
(lOOpM) present in all experiments. Please note that all control data has 






























Figure 7.7 Effect of TRAM-34 and apamin on local and spreading 
dilatation and constriction responses to abluminally-applied nucleotides
Summary data illustrating the effect of luminal and abluminal incubation 
with TRAM-34 (lpM ) and apamin (50nM) on spreading responses to A, 
ATP (ImM, 100ms, n -3, paired), and B, ADP^S (ImM, 10-30ms, n=3, 
paired). The biphasic nature of the responses is represented by the peak 
dilatation (solid lines) and constriction (dotted lines) responses to each 
agonist. L-NAME (lOOpM) present in all experiments. All experiments 
were performed by Dr. Kim Dora.
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Figure 7.8 Spreading dilatation responses to luminal perfusion of 
nucleotides
A, Representative traces and B, summary data of arterial dilatation (upper 
panels) and relative fluorescence (F/Fmax in Branch 1, lower panels) 
simultaneously measured at local (Branch 1 and 0pm) and remote (500- 
2000pm) sites in response to luminal perfusion of A, ATP (3pM), B, ATP 
(1 or 3 pM, n=6), ADP(3S (1 or 3pM, n=6), UTP (3 or 10 pM, n=6), 
adenosine (lOOpM, n=5) and A, B, carboxyfluorescein (0.1 pM) into 
Branch 1. Images were acquired at 1Hz. Bars indicate periods of luminal 
perfusion. L-NAME (lOOpM) present in all experiments. All experiments 
were performed by Dr. Kim Dora.
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Within the present report conducted responses to the purinoceptor agonists ATP, UTP, 
ADPpS and ATPyS were studied and for the first time in an artery of this size, 
spreading dilatation responses to both abluminally- and luminally-applied nucleotides 
were revealed. Similar experiments have been performed previously wherein conducted 
vasomotor responses to ATP and adenosine were studied in the smaller vessels of the 
hamster retractor muscle preparation and the rat cerebral arteriole. However, with the 
exception of one study in which ATP was luminally applied with a micropipette 
(McCullough et al, 1997) all experiments were performed following abluminal 
application of either ATP or adenosine (Dietrich et al, 1996; Duza & Sarelius, 2003; 
Kajita etal., 1996).
The biphasic spreading response to focal abluminal application of ATP observed in the 
present study was locally of a similar profile to that previously documented in the 
microcirculation (Dietrich et al, 1996; Duza & Sarelius, 2003; Kajita et al, 1996; 
McCullough et al, 1997). However, in contrast to previous reports the vasoconstriction 
evoked by ATP spread to remote sites such that at a distance of 1500|Lim from the site of 
application a significant reduction in artery diameter was observed. Given the NO- 
dependent attenuation of conducted vasoconstriction responses to KC1 recently 
observed in the mouse cremaster muscle preparation such a difference may be explained 
by the use of L-NAME in the present study (McCullough et al, 1997; Rodenwaldt et 
al, 2007). The spreading vasoconstriction to ATP would be facilitated by the activation 
of P2X (most likely P2Xi) receptors on the smooth muscle and the subsequent 
depolarization caused by the inward current through these non-selective cation channels 
(Gitterman & Evans, 2000; Harrington & Mitchell, 2004; Lewis & Evans, 2000; 
Malmsjo et al, 2000a; Malmsjo et al, 2000b). However, the robust vasoconstriction to 
the P2 Y2 agonist ATPyS, a response that has been shown previously to be insensitive to 
P2X desensitization with ap-methylene-ATP, suggests that a P2 Y2 component may also 
contribute to the response (Malmsjo et al, 2000a). Studies performed to investigate 
P2Yi, P2 Y2 and P2 Y4 receptor mRNA expression within the rat mesenteric bed suggest 
that only P2Y6 is present in the smooth muscle (Buvinic et al, 2002). Given the high 
concentrations of ATPyS and ATP used in the present study activation of the P2Y6 
receptor although unlikely, cannot be ruled out (Malmsjo et al, 2000a). Further
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experiments following desensitization of P2X receptors with ap-methylene-ATP and 
inhibition of P2Y6 with MRS2578 would be required to establish which receptor(s) 
facilitate the ATP-evoked vasoconstriction (Alexander et al, 2006; Malmsjo et al., 
2000a).
A secondary small spreading vasodilatation was also evident following focal abluminal 
application of ATP; the temporal characteristics of which were probably indicative of 
the time taken for ATP to diffuse to the endothelium (Dietrich et al, 1996; McCullough 
et al, 1997). However, locally the extent and time course of the local vasoconstriction 
masked any vasodilatation response to abluminally-applied ATP (Dietrich et al, 1996; 
Malmsjo et al, 2000b; McCullough et al, 1997). Given that the vasoconstrictor 
component was enhanced following incubation with TRAM-34 and apamin, the current 
observation would suggest that the profile of the ATP-evoked response depends on the 
balance between the locally-evoked hyperpolarization response downstream of 
endothelial cell Kca activation and the extent of smooth muscle cell depolarization 
(Malmsjo et al, 2000b; Malmsjo et al, 1999).
The relatively small size of the conducted dilatation response, compared to that seen 
following luminal application of ATP, possibly also reflects the breakdown of the 
nucleotide by ectonucleotidases (please see section 1.3.1.2) as it passed though the 
adventitial and medial layers of the artery and the reduction in the active concentration 
of either ATP or ADP at the endothelium (Bumstock, 2006; Duza & Sarelius, 2003; 
Gorlach, 2005; Malmsjo et al, 2000a). Indeed, the robust nature of the spreading 
vasodilatation responses to abluminally-applied ADPJ3S, a non-hydrolyzable analogue 
of ATP, would support such a hypothesis.
Adenosine has been shown to evoke significant dilatation responses within rat 
mesenteric artery preparations (Mian & Marshall, 1995), and is capable of evoking, 
albeit inconsistently (Delashaw & Duling, 1991; McCullough et al, 1997), a conducted 
dilatation response within a variety of arteriolar and microcirculation preparations 
(Delashaw & Duling, 1991; Duza & Sarelius, 2003; Kajita et al, 1996; Rivers & 
Frame, 1999). Indeed, as a metabolite of ATP that is capable of evoking an 
endothelium-dependent vasodilatation and KATP-facilitated hyperpolarization in the rat
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aorta, adenosine may conceivably also contribute to the conducted dilatation response to 
ATP in the present study (please see section 1.3.1.2; Ray et a l , 2002; Ray & Marshall, 
2005; Ray & Marshall, 2006). However, the rapid decay of the conducted dilatation 
response to luminally-applied adenosine over distances greater than 500jnm would 
suggest that ATP-evoked spreading dilatation responses (whether following abluminal 
or luminal application of ATP) were not significantly dependent on an adenosine 
component.
Given the robust nature of the ADPpS-evoked conducted dilatation response (whether 
applied luminally or abluminally), and the MRS2179 sensitivity of local dilatations to 
luminally-perfused ATP and ADPpS in previous experiments (please see chapter 6), 
spreading vasodilatation responses to abluminally-applied ATP were evaluated in the 
presence of MRS2179 in an attempt to establish the involvement of the P2Yi receptor. 
Owing to the masked nature of the local vasodilatation response, the competitive nature 
of the antagonist (Boyer et a l , 1998) and the difficulties associated with evaluating the 
concentration of ATP released with each spritz the significance of these experiments is 
limited. However, using a concentration of MRS2179 previously demonstrated to 
abolish the dilatation response to luminally-perfused ATP (please see chapter 6) 
spreading dilatation responses to abluminal application of both ATP and ADPpS 
appeared attenuated, implying some action of endothelial P2Yi receptors in the 
conducted dilatation response.
Luminal application of ATP has been achieved previously by impaling an arteriole of 
the exteriorized hamster retractor muscle preparation with a pipette and then spritzing 
ATP onto the surface of the lumen by pressure-pulse ejection (McCullough et a l , 
1997). Dilatation responses up to a distance of 1200pm from the stimulation site were 
recorded and were, in contrast to the present report found to be sensitive to eNOS 
inhibition with L-NAME. Luminal perfusion of ATP in the present study evoked an 
extensive, L-NAME-insensitive spreading dilatation response that persisted for the 
duration of agonist perfusion. Such a response is consistent with the robust nature of the 
radial dilatation response to the luminally perfused agonists and thus is also likely 
dependent on the activation of P2Yi receptors (please see chapter 6; Liu et al, 2004).
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Given the extensive vasodilatation response to luminally-applied UTP previously 
described (please see chapter 6; Liu et al, 2004) experiments were subsequently 
performed to establish whether P2 Y2 activation could evoke a conducted vasodilatation. 
Luminal perfusion of UTP evoked a spreading dilatation response of equal magnitude 
and with equal decay characteristics as that observed for ADPpS and ATP, suggesting 
that stimulation of endothelial cell P2 Y2 receptors (Buvinic et al., 2002; Malmsjo et al, 
2000a) is indeed capable of evoking a robust conducted dilatation response. However, 
abluminal application of UTP evoked only a local and spreading vasoconstriction that 
was likely reflective of smooth muscle P2Y receptor activation with minimal actions of 
the nucleotide on the endothelium (Buvinic et al, 2006; Gitterman & Evans, 2000; 
Malmsjo et al, 2000a). Unlike ATP, the products of ectonucleotidase metabolism of 
UTP have negligible vasodilatation capabilities within this artery, even at millimolar 
concentrations, so the absence of a vasodilatation component should perhaps be 
expected (Bumstock, 2006; Malmsjo et al, 2000a; Malmsjo et al, 2002). This 
observation is confirmed by the more robust nature of the ATPyS evoked conducted 
dilatation response, which in contrast to UTP, when applied abluminally is not broken 
down as it diffuses to the endothelium to activate P2 Y2 receptors.
Conducted dilatation responses to abluminally-applied ATP and ADPpS were 
completely attenuated by blockade of SKca and IKca channels with TRAM-34 and 
apamin. Furthermore, although conducted dilatation responses were not directly 
examined, local dilatation responses to luminally-perfused agonists were blocked by 
raising extracellular K+ or by the combined blockade of SKca and IKca supporting the 
significant contribution of an endothelial cell hyperpolarization component to the local 
P2Yi and P2 Y2 receptor-evoked dilatation response (please see chapter 6; Malmsjo et 
al, 1999; Mistry et al, 2003). Given that longitudinal conduction of the 
hyperpolarization response within the rat mesenteric artery may occur irrespective of 
the agonist used to evoke the local increase in membrane potential (Takano et al, 2004) 
the P2Yi- and P2Y2-evoked spreading dilatation responses observed in the present study 
likely reflect the transfer of hyperpolarization upstream through the endothelium as 
previously described for ACh and LVK in the rat mesenteric artery (Goto et al, 2004; 
Takano et al, 2004). Indeed the matched rate of decay for the ACh- and ADPpS-
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evoked spreading dilatation responses would support such a hypothesis (Delashaw & 
Duling, 1991; Segal & Duling, 1989).
Conceivably the inhibition of the conducted dilatation response to ATP and ADPpS by 
TRAM-34 and apamin could reflect a blockade of the radial hyperpolarization response 
at the remote site and not an inhibition of the conducted hyperpolarization response. A 
local rise in endothelial cell Ca2+ has been documented within this preparation in 
response to luminal perfusion of micromolar concentrations of ATP (Liu et al, 2006a) 
that is consistent with the local Ca2+ response to abluminal application of ACh 
(McSherry et al, 2005; Takano et al, 2004) that facilitates the activation of endothelial 
cell IKca and SKca (Malmsjo et al, 1999; McSherry et al, 2005; Mistry et al, 2003). 
Conducted dilatation responses to both ACh and ATP within hamster retractor muscle 
feed arteries and hamster cheek pouch arterioles respectively have been shown to be 
dependent on a conducted endothelial cell Ca2+ response (Domeier & Segal, 2007; Duza 
& Sarelius, 2003; Uhrenholt et al, 2007). However, these responses were also 
dependent on an NO component, which was not required for the spreading dilatation 
responses observed within the present study. Crucially, within rat mesenteric arteries the 
conducted hyperpolarization response does not parallel a conducted rise in endothelial 
cell Ca2+, suggesting that the cell-to-cell transfer of hyperpolarization likely observed in 
the present study was independent of a remote rise in endothelial cell Ca2+, and thus was 
also independent of the remote activation of IKca and SKca channels.
Nucleotides may be released into the vasculature from a range of sources including 
circulating cells under conditions of low PO2 (Dietrich et al, 2000; Ellsworth, 2004; 
Ellsworth et al, 1995; Miseta et al, 1993), surrounding ischaemic tissues (Erlinge et 
al, 2005; Wihlborg et al, 2006) and sympathetic nerve terminals (Bumstock, 2006; Su, 
1983). As such they are considered to be key to the physiological regulation of vascular 
tone and thus have an inherent role in the regulation of tissue perfusion and total 
peripheral resistance. To ensure nucleotide-evoked dilatation responses are sufficient to 
maintain an increase in tissue blood flow and oxygen supply the response may be 
conducted upstream to the feed arteries (Dora et al, 2000a; Kurjiaka & Segal, 1995; 
McCullough et al, 1997).
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The conducted dilatation responses to luminally-applied nucleotides observed in the 
present study demonstrate that the physiological release of nucleotides from circulating 
cells under conditions of low PO2 could possibly be sufficient to evoke a conducted 
dilatation response within the resistance vasculature and thus also possibly increase 
blood flow to the downstream tissue (Rosenmeier et al, 2004). The maintenance of the 
conducted dilatation response for the duration of luminal nucleotide perfusion supports 
the hypothesis that under low levels of PO2 arterial perfusion with red blood cells will 
stimulate an ascending vasodilatation response via nucleotide activation of endothelial 
cell P2Y receptors that will be maintained for as long as the continual entry of the red 
blood cells into the artery is maintained. Only upon increased levels of PO2 and 
cessation of nucleotide release would the conducted dilatation response end 
(McCullough et al, 1997). The biphasic conducted response to abluminally-applied 
ATP observed in the present study thus reflects the fine balance that is likely to be 
present in vivo between the vasoconstriction evoked upon sympathetic nerve stimulation 
and the vasodilatation responses to luminally-released nucleotides just described: the 
balance between the hyperpolarizing and depolarizing influences having the final 
influence over tissue blood flow (Bumstock, 2006; Dietrich et al, 2000; Duza & 
Sarelius, 2003; Ellsworth, 2004; Ellsworth et al, 1995; Malmsjo et al, 2000b; Malmsjo 
et al, 1999; McCullough et al, 1997; Miseta et al, 1993; Rosenmeier et al, 2004; Su, 
1983).
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The studies documented within this thesis have explored how direct cell-to-cell 
communication within the arterial wall can facilitate EDHF-type radial and longitudinal 
dilatation responses in resistance arteries.
A correlation between the incidence of MEGJ and endothelium-derived hyperpolarizing 
responses is well established in a number of resistance arteries suggesting that 
myoendothelial cell-to-cell coupling is an important mechanism in the control of artery 
diameter (Sandow et a l, 2004; Sandow et al, 2002). Indeed the inhibition of the 
EDHF-type dilatation response by carbenoxolone and selective endothelial cell 
pinocytic loading of anti-connexin 40 antibodies as described herein and in other reports 
(Edwards et al, 1999; Goto et al, 2002; Mather et al, 2005) would support such a 
proposal. However, crucially, the results of the present study also highlight the 
difficulties that may be associated with trying to selectively inhibit gap junctions.
In contrast to a number of reports using the rat mesenteric artery (Matchkov et al, 2006; 
Sandow et al, 2002) the connexin-specific gap peptides were ineffective in the present 
study, even when used as a triple combination that targeted each of the known rat 
mesenteric artery connexins. Spreading dilatation responses, thought to at least partially 
rely on the longitudinal cell-to-cell conduction of hyperpolarization through gap 
junctions (de Wit et al, 2000; Figueroa et al, 2003; Segal et al, 1989; Segal & Duling, 
1989; Segal & Duling, 1986b), were also unaffected by endothelial cell loading of the 
anti-connexin antibodies. The heterogeneity in the connexin composition at each gap 
junction means that presently at least, selective pharmacological inhibition of either 
inter-endothelial or myoendothelial gap junction channels is virtually impossible. 
However, a number of other factors also preclude a definitive assessment of the efficacy 
of any of the inhibitors in the present study. In particular, the lack of 
electrophysiological data and the ambiguity associated with whether the antibodies are 
actually present at the site of cell-to-cell coupling.
Preliminary morphological studies described herein illustrated how the structure of the 
arterial wall could potentially facilitate the transfer of hyperpolarization from the 
endothelium to the smooth muscle and the longitudinal conduction of hyperpolarization. 
Staining of the rat mesenteric artery with di-8-ANEPPS revealed the narrow elongated
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shape of the endothelial cells, which were aligned along the longitudinal axis of the 
artery wall and spanned ~12 smooth muscle widths. The extensive endothelial cell 
border staining for connexin 40 observed in the present study and that of others 
therefore suggests that the endothelial cell-to-cell coupling within this preparation is 
potentially adequate for a low resistance longitudinal conduction pathway (Goto et a l , 
2004; Kansui et al, 2004; Mather et al, 2005; Sandow et al, 2006). The co-localization 
of connexin 40, SKca and IKca channels with holes in the BEL was also consistent with a 
role for myoendothelial projections as key signalling domains for the radial cell-to-cell 
communication of the EDHF-type dilatation response, supporting the functional data 
described herein (Mather et al, 2005; Sandow et al, 2006).
The physiological importance of these observations is however difficult to reconcile, 
particularly given that traditionally EDHF-type dilatation responses are commonly 
characterised following inhibition of NO and prostacyclin-dependent pathways, whereas 
under physiological conditions these other pathways may be active. Indeed, within the 
rat mesenteric arterial bed in vivo EDHF is not thought to contribute to the regulation of 
basal blood flow. A significant contribution is, however, observed under conditions of 
agonist-evoked dilatation (Coleman et al, 2004). This could possibly reflect an 
important role for the EDHF pathway under conditions of hypoxia or increased tissue 
metabolism where an increase in tissue blood flow may be associated with the release of 
vasodilator substances such as ATP (Dietrich et al, 2000; Ellsworth, 2004). Indeed, 
within this study and others (Malmsjo et al, 1999; Mistry et al, 2003) EDHF-type 
dilatation and hyperpolarization responses have been observed in response to nucleotide 
application. Furthermore luminal perfusion of the physiological nucleotides ATP and 
UTP was able to evoke a robust spreading dilatation response suggesting that the 
nucleotides may also activate longitudinal cell-to-cell communication pathways within 
the rat small mesenteric artery, which could contribute to the maintenance of adequate 
tissue perfusion (Dora et al, 2000a; Kuijiaka & Segal, 1995; Segal, 2005; Segal & 
Duling, 1986a).
Morphological data presented within this study made it apparent that SKca and connexin 
40, not IKca were visible at sites of inter-endothelial cell-to-cell contact. The 
preliminary nature of these experiments precluded robust conclusions. However, a
215
recent report from Sandow et al. (2006) reported similar findings and advanced the 
suggestion that the differential IKca and SKca staining possibly reflected the differential 
contribution of these two channels to the ACh-evoked EDHF response in the rat 
mesenteric artery under different levels of PE-evoked tone (Crane et al, 2003a; Sandow 
et al, 2006). Within the current study the contribution of the IKca and SKqi channels to 
the purinoceptor-evoked EDHF-type dilatation response was also shown to vary 
suggesting that the P2Yi and P2Y2 receptors could perhaps evoke differential Ca2+ 
signals upon agonist stimulation leading to the differential activation of the two Kca 
channels. Indeed, compartmentalization of the P2Y receptors has been documented 
previously (Kaiser et al, 2002). A role for PKC as a modulator of the nucleotide- 
evoked EDHF-type dilatation response was made apparent within this thesis and, 
although these and the Kca data are by no means conclusive they highlight the 
complexity associated with the EDHF-type dilatation response, particularly suggesting 
that the mechanisms associated with regulation of this response may be unique to each 
agonist. This could have significant implications for the study of EDHF type responses 
to nucleotides, particularly within the rat mesenteric artery preparation and thus should 
be considered in future studies.
Given that IKca knockout and SKca knockout mice were both hypertensive (Si et al, 
2006; Taylor et al., 2003) and an altered expression and function of both IKqi and SKca 
channels has been documented within various disease state models including cirrhosis, 
balloon catheter injury, chronic renal failure and diabetes (Barriere et al., 2001; 
Burnham et al., 2006; Ding et al., 2005; Kohler et al., 2001; Kohler et al., 2005), an 
understanding of how each ion channel contributes to the dilatation response could have 
potentially beneficial effects for the therapeutic modulation of vascular tone. If the 
results of the present study and those of previous reports documenting the hypertensive 
state of connexin 40 knockout mice are also taken into account (de Wit et al., 2000; 
Figueroa et al., 2003), ion channel expression and function at points of cell-to-cell 
contact apparently plays an important role in the modulation of vascular tone. Crucially, 
however, the results of this study also suggest that improved pharmacological tools are 
required to accurately evaluate the contribution of cell-to-cell communication to the 
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